glucagon has been researched along with Insulin Resistance in 694 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 148 (21.33) | 18.7374 |
1990's | 113 (16.28) | 18.2507 |
2000's | 141 (20.32) | 29.6817 |
2010's | 234 (33.72) | 24.3611 |
2020's | 58 (8.36) | 2.80 |
Authors | Studies |
---|---|
Asadi, F; Dhanvantari, S | 1 |
Chen, X; Tripathy, D | 1 |
Kamalanathan, S; Roy, A; Sahoo, J | 1 |
Bao, J; Li, L; Liu, D; Lv, Y; Ni, M; Qi, L; Sj, P; Su, J; Wang, L; Wang, Q; Wei, Q; Xia, H | 1 |
Borer, KT; Lin, PJ; Wuorinen, E | 1 |
Kareenhalli, V; Somvanshi, PR; Tomar, M | 1 |
Anno, M; Fujioka, Y; Imamura, T; Ito, Y; Izawa, S; Kato, M; Kitao, S; Matsumoto, K; Matsuzawa, K; Nakamura, R; Okura, H; Okura, T; Shoji, K; Taniguchi, SI; Ueta, E; Yamamoto, K | 1 |
Bao, J; Cheng, H; Li, L; Liu, D; Lv, Y; Qi, L; Qiu, Y; Su, J; Su, X; Sun, J; Wei, Q; Ye, Z; Yu, X; Zhang, Y | 1 |
Aas Holm, L; Ängquist, L; Christiansen, M; de Retana Alzola, IF; Fonvig, CE; Frithioff-Bøjsøe, C; Hansen, T; Hartmann, B; Holm, JC; Holst, JJ; Jonsson, AE; Lund, MAV; Pedersen, O; Stinson, SE; Sørensen, TIA | 1 |
Chepurny, OG; Collier, JJ; Cooney, RN; Holz, GG; Leech, CA; Meng, Q; Molnar, ME; Pruekprasert, N | 1 |
Jain, G; Kumar, R; Pahadiya, H; Srivastava, S | 1 |
Coskun, T; DeVries, JH; Haupt, A; Heise, T; Li, J; Mari, A; Mather, KJ; Milicevic, Z; Pratt, EJ; Thomas, MK; Urva, S | 1 |
Guanfu, L; Jun, S; Qiaoli, G; Xiaoyun, W; Xuanjun, W; Yinghao, W | 1 |
Barbot, M; Basso, D; Ceccato, F; Giordano, C; Guarnotta, V; Mondin, A; Regazzo, D; Scaroni, C | 1 |
Sahoo, B; Sharma, R; Srivastava, A; Tiwari, S | 1 |
Anderlova, K; Bendlova, B; Krejci, H; Pacini, G; Sladek, M; Sumova, A; Tura, A; Vankova, M; Vcelak, J; Vejrazkova, D | 1 |
da Silva, AA; Damasceno, DC; Dos Santos, VH; Ferreira, DOL; Fioratti, EG; Gonçalves, RC; Hooper, HB; Polizel, DM; Santarosa, BP; Sinzato, YK | 1 |
Ahlström, H; Bergsten, P; Forslund, A; Kullberg, J; Manell, H; Mangge, H; Maruszczak, K; Mörwald, K; Pixner, T; Radzikowski, K; Schütz, S; Weghuber, D | 1 |
Hüttl, M; Malinska, H; Markova, I; Miklankova, D; Stankova, B | 1 |
Eguchi, H; Fujita, Y; Horii, T; Ishibashi, C; Kawata, S; Kozawa, J; Miyagawa, JI; Nammo, T; Ozawa, H; Shimomura, I; Yoneda, S | 1 |
Chen, X; Liu, H; Lu, Y; Lu, Z; Meng, F; Zhao, H | 1 |
Han, C; Jiang, Y; Ma, W; Qiao, A; Qin, G; Yan, B; Zhou, J | 1 |
Li, R; Zhang, R; Zhao, Q | 1 |
Chen, X; DeFronzo, RA; Merovci, A; Tripathy, D | 1 |
Behn, CGD; Chan, CL; Finn, E; Garrish, J; Nadeau, KJ; Pyle, L; Sagel, SD; Severn, C; Vigers, T; Zeitler, PS | 1 |
Chen, L; Chen, W; Cui, W; Hu, X; Li, X; Shang, H; Sun, X; Wang, J; Wu, J; Xiao, RP; Yuan, Y; Zeng, F; Zhang, J; Zhang, X; Zheng, W | 1 |
Asadi, J; Jazi, MS; Kiaei, M; Safarzad, M | 1 |
Barhod, E; Brandt, B; Hemi, R; Mazaki-Tovi, S; Mdah, R; Rathaus, M; Ron, I; Tirosh, A; Ulman, RY; Zemet, R | 1 |
Chu, H; de Souza, CO; Holland, WL; Huang, L; Kohler, JJ; Mineo, C; Oh, DY; Paschoal, VA; Peng, J; Shaul, PW; Varre, JV; Xiao, X; Xu, L; Yu, L | 1 |
Kahn, BB; Nelson, AT; Peroni, OD; Saghatelian, A; Santoro, A; Siegel, D; Zhou, P | 1 |
Chen, S; Klein, S; Scherer, PE; Smith, GI; Stern, JH; Unger, RH | 1 |
Di Mauro, S; Di Pino, A; Filippello, A; Marchisello, S; Piro, S; Purrello, F; Rabuazzo, AM; Scamporrino, A; Scicali, R; Urbano, F | 1 |
Craig, SL; Flatt, PR; Gault, VA; Hasib, A; Irwin, N; Khan, D | 1 |
Abarkan, M; Gaitan, J; Jaffredo, M; Lang, J; Lebreton, F; Magnan, C; Mulle, C; Perrier, R; Raoux, M | 1 |
Chidlow, SJ; Fitches, MJ; Kelly, RA; Pop, SR; Webb, SD | 1 |
Bocchio-Chiavetto, L; Bonetto, C; Bruschi, C; D'Agostino, A; Faravelli, C; Furlato, K; Gennarelli, M; Imbesi, M; Lasalvia, A; Minelli, A; Preti, A; Ruggeri, M; Scocco, P; Tomassi, S; Tosato, S; Zanardini, R | 1 |
Dybjer, E; Engström, G; Helmer, C; Nägga, K; Nilsson, PM; Rorsman, P | 1 |
Feng, Q; Feng, Y; Hu, J; Qu, H; Song, X; Xu, X; Yin, S; Zhang, L | 1 |
Abdel-Wahab, YH; Conlon, JM; Flatt, PR; Graham, GV | 1 |
Flatt, PR; Irwin, N; Moffett, RC; Tanday, N | 1 |
Giau, VV; Nguyen, TKO; Nguyen, TT; Nguyen, TTD; Ta, QTH | 1 |
Kitamura, T; Kobayashi, M; Kusunoki, Y; Matsuo, T; Namba, M; Satoh, H; Tokushima, M; Watada, H | 1 |
Bandyopadhyay, GK; Brenner, D; Kisseleva, T; Lam, K; Lee, YS; Liu, X; Moon, JS; Riopel, M; You, S | 1 |
Crakes, KR; Gilor, C; Greathouse, RL; Huising, MO; Miller, M; Pires, J; Quach, N | 1 |
Cai, HL; Chen, T; Cheng, M; Cheng, XB; Huang, HY; Lu, Y; Su, JB; Wang, X; Wang, XH; Wang, XQ; Xu, F; Zhang, DM; Zhang, XL; Zhao, LH | 1 |
Brøsen, K; Bøtker, HE; Dollerup, OL; Frøkiær, J; Hansson, NH; Jespersen, NR; Jessen, N; Larsen, AH; Møller, N; Nørrelund, H; Wiggers, H | 1 |
Andersen, DB; Bisgaard, HC; Dall, M; Eriksen, PL; Galsgaard, KD; Gillum, MP; Gluud, LL; Hassing, AS; Holst, JJ; Hunt, JE; Jepsen, SL; Kjeldsen, SAS; Knop, FK; Kuhre, RE; Pedersen, J; Santos, A; Sulek, K; Torekov, SS; Trammell, SAJ; Treebak, JT; Vasilopoulou, CG; Vilstrup, H; Werge, MP; Wewer Albrechtsen, NJ; Windeløv, JA; Winther-Sørensen, M; Ørskov, C | 1 |
Di Mauro, S; Di Pino, A; Filippello, A; Malaguarnera, R; Piro, S; Purrello, F; Scamporrino, A; Scicali, R | 1 |
Ahrén, B; Pacini, G | 3 |
Adamski, J; Gar, C; Haschka, SJ; Holst, JJ; Kern-Matschilles, S; Lechner, A; Prehn, C; Rauch, B; Sacco, V; Seissler, J; Wewer Albrechtsen, NJ | 1 |
Flatt, PR; Irwin, N; McCloskey, AG; McKillop, AM; Moffett, RC; Mohan, S | 1 |
Chen, X; DeFronzo, RA; Maldonado, E; Tripathy, D | 1 |
Box, JR; Karikoski, NP; Raekallio, MR; Tanskanen, HE | 1 |
Birkenfeld, AL; Dannecker, C; Fritsche, A; Häring, HU; Heni, M; Hummel, J; Peter, A; Stefan, N; Vosseler, A; Wagner, R | 1 |
Abiru, N; Akazawa, S; Haraguchi, A; Hasegawa, Y; Horie, I; Ito, A; Kawakami, A; Miura, K; Miura, S; Miwa, M; Nagata, A; Natsuda, S; Shigeno, R | 1 |
Ahrén, B; Burattini, L; Göbl, C; Morettini, M; Pacini, G; Tura, A | 1 |
Bagger, JI; Becker, U; Bergmann, SS; Dalsgaard, NB; Demant, M; Foghsgaard, S; Gasbjerg, LS; Gether, L; Gillum, MP; Grønbæk, H; Grøndahl, MFG; Holst, JJ; Knop, FK; Knop, J; Kønig, MJ; Lanng, AR; Strandberg, C; Suppli, MP; Thomasen, M; Vilsbøll, T; Wewer Albrechtsen, NJ | 1 |
Han, DJ; Jung, CH; Jung, JH; Kim, DH; Kim, YH; Ko, Y; Kwon, H; Lim, SJ; Mun, S; Shin, S | 1 |
Ahrén, B | 1 |
Engelhardt, JF; Gibson-Corley, KN; He, N; Liang, B; Norris, AW; Sun, X; Uc, A; Yi, Y | 1 |
Boriboun, C; Deng, J; Habegger, KM; Kim, T; Ma, W; Ma, YC; Qiao, A; Qin, G; Qiu, H; Richard, S; Song, Y; Xu, S; Yan, B; Yang, L; Zhang, C; Zhang, E; Zhang, J; Zhou, J | 1 |
Baixeras, E; Decara, J; Gutiérrez-Adan, A; Ledesma, JC; Medina-Vera, D; Navarro, JA; Pavón, FJ; Rodríguez de Fonseca, F; Rosell-Valle, C; Sanjuan, C; Tovar, R | 1 |
Ameneiro, C; Beiroa, D; Bernardo, G; Bilbao, J; Bravo, SB; Carneiro, C; Cho, JW; Coppari, R; Cuñarro, J; Da Silva Lima, N; Dieguez, C; Dp Chantada-Vazquez, M; Fernandez, U; Fernández-Ramos, D; Ferno, J; Fidalgo, M; Fondevila, MF; Fruhbeck, G; Garcia-Vence, M; Gonzalez-Rellan, MJ; Guallar, D; Herzig, S; Iglesias, C; López, M; Lopitz-Otsoa, F; Martinez-Chantar, ML; Mato, JM; Millet, O; Müller, TD; Nogueiras, R; Novoa, E; Perez-Fernandez, R; Porteiro, B; Rodríguez, A; Sabio, G; Senra, A; Seoane, S; Tovar, S; Varela-Rey, M; Veyrat-Durebex, C; Vidal, A; Woodhoo, A; Yang, WH | 1 |
Benatti, FB; Bonfá, E; Borba, E; Dantas, WS; Gualano, B; Miyake, CNH; Neves, W; Pereira, RM; Pereira, RT; Roschel, H; Sá-Pinto, AL; Shinjo, SK; Silva, ER; Zambelli, VO | 1 |
Guo, J; Li, B; Wang, C; Xi, Z; Xu, J; Zuo, Z | 1 |
Li, YC; Li, YJ; Qiao, JY; Shen, JD; Wei, Y | 1 |
Deem, JD; Morton, GJ; Muta, K; Scarlett, JM; Schwartz, MW | 1 |
Greer, J; Kaur, K; Porter, RR; Wang, X; Youngstedt, SD | 1 |
Ahn, CW; Kang, S; Kim, KR; Kim, M; Lee, M; Lee, S; Park, JS; You, J | 1 |
Christensen, M; Galsgaard, KD; Holst, JJ; Hædersdal, S; Junker, AE; Knop, FK; Lund, AM; Vilsbøll, T; Wewer Albrechtsen, NJ; Wibrand, F | 1 |
Burrin, D; Chacko, S; Chan, L; Guan, X; Li, D; Li, F; Shi, X | 1 |
Bódis, K; Bönhof, G; Burkart, V; Markgraf, DF; Müssig, K; Püttgen, S; Roden, M; Strom, A; Szendroedi, J; Ziegler, D | 1 |
Bailey, KR; Cobelli, C; Man, CD; Rizza, RA; Shah, M; Sharma, A; Varghese, RT; Vella, A | 1 |
Goode, JP; McMahon, C; Poppitt, SD; Silvestre, MP; Tay, A; Vlaskovsky, P | 1 |
Jiang, ZH; Li, CG; Li, CJ; Li, Z; Ni, CL; Sun, B; Tang, YZ; Yang, M; Zhu, YJ | 1 |
Aithal, GP; Douglas, JA; King, JA; Misu, H; Nimmo, MA; Sargeant, JA; Stensel, DJ; Takamura, T; Takayama, H; Turner, MC; Webb, DR; Yates, T | 1 |
Færch, K; Galsgaard, KD; Hansen, T; Holst, JJ; Jensen, TM; Jonsson, AE; Jørgensen, ME; Knop, FK; Lauritzen, T; Mahendran, Y; Pedersen, J; Pedersen, O; Torekov, SS; Vistisen, D; Wewer Albrechtsen, NJ; Winther-Sørensen, M; Witte, DR | 1 |
Haluzík, M; Holubová, M; Hrubá, L; Kuneš, J; Maletínská, L; Mikulášková, B; Pražienková, V; Železná, B; Zemenová, J | 1 |
Boston, RC; Ehrensing, G; Frank, N; Newkirk, KM; Odoi, A | 1 |
Kelly, VP; Naito, A; Nakajima, M; Nakajima, O; Nakano, H; Nohara, H; Okano, S; Saitoh, S; Shirasawa, N; Takahashi, K; Tanaka, T; Yamamoto, M | 1 |
Adams-Huet, B; Burgess, S; Li, X; Lingvay, I; Mari, A; Mitchell, L; Pop, LM; Zhao, TJ | 1 |
Jun, HS; Lee, YS | 1 |
Benatti, FB; Bonfá, E; Borba, E; Dantas, WS; Gualano, B; Miyake, CNH; Pereira, RMR; Sá-Pinto, AL; Shinjo, SK; Silva, MER; Zambelli, VO | 1 |
Han, J; Zhao, M | 1 |
Li, WH; Nan, M | 1 |
Blüher, M; Heindl, M; Hoffmeister, A; Hollenbach, M; Kern, M; Klöting, N; Lorenz, J; Mössner, J; Sommerer, I | 1 |
Emfinger, CH; Hruz, PW; Hung, P; McAllister, W; Nichols, CG; Remedi, MS; Welscher, A; Yan, Z | 1 |
Araujo, TR; Bonfleur, ML; Boschero, AC; Carneiro, EM; da Silva, JA; Freitas, IN; Lubaczeuski, C; Magalhães, EA; Ribeiro, ES; Ribeiro, RA; Silva, JN; Vettorazzi, JF | 1 |
Alcala-Diaz, JF; Arenas-Larriva, AP; Camargo, A; Delgado-Lista, J; Jimenez-Lucena, R; Leon-Acuña, A; Lopez-Miranda, J; Malagon, MM; Ordovas, JM; Perez-Martinez, P; Rangel-Zuñiga, OA; Roncero-Ramos, I; Vals-Delgado, C | 1 |
Choi, D; Jung, CH; Kang, SK; Kim, BY; Kim, CH; Lee, B; Moh Moh, MA; Mok, JO | 1 |
Di Mauro, S; Di Pino, A; Filippello, A; Piro, S; Purrello, F; Rabuazzo, AM; Scamporrino, A; Scicali, R; Urbano, F | 1 |
Besse-Patin, A; Estall, JL; Jeromson, S; Laplante, M; Levesque-Damphousse, P; Secco, B | 1 |
Abdul-Ghani, M; Basu, R; DeFronzo, RA; Merovci, A; Tripathy, D | 1 |
Chamorro, R; Forck, N; Hallschmid, M; Lehnert, H; Mölle, M; Sayk, F; Schmid, SM; Schultes, B; Trost, D; Wilms, B | 1 |
Basu, A; Basu, R; Keenan, DM; Veldhuis, JD | 1 |
Galsgaard, KD; Gromada, J; Holst, JJ; Janah, L; Knop, FK; Pedersen, J; Suppli, MP; Vilstrup, H; Wewer Albrechtsen, NJ; Winther-Sørensen, M | 1 |
Bhansali, A; Bhansali, S; Bhat, K; Dutta, P; Kochhar, R; Kurpad, AV; Mudaliar, S; Mukherjee, KK; Sachdeva, N; Shekhawat, VS; Sinha, SK; Vaiphei, K | 1 |
Chen, Y; Guo, S; Guo, X; He, L; Li, L; Li, X; Pan, Q; Qi, Y; Shen, JZ; Sun, Y; Threadgill, D; Villarreal, D; White, MF; Wu, Y; Xie, W; Xu, Z; Yan, H; Zhang, K; Zhang, W; Zheng, H | 1 |
Alcala, M; Calay, ES; Claiborn, KC; Eguchi, K; Garg, R; Heianza, Y; Hollander, KS; Hotamisligil, GS; Inouye, KE; Livne, R; Qi, L; Rathaus, M; Ron, I; Shai, I; Tirosh, A; Tuncman, G | 1 |
Fujimoto, K; Ichikawa, R; Kitamura, T; Kobayashi, M; Motomiya, T; Shichiri, M; Takano, K | 1 |
Ahlers, M; Laferrère, B; Levesque, K; Mark, V; Patel, K; Pierini, E; Rojas, B; Shah, A | 1 |
da Silva, MER; Dagogo-Jack, S; de Sousa, MV; Fukui, R; Krustrup, P; Zouhal, H | 1 |
Fujimoto, K; Honzawa, N; Kitamura, T | 1 |
Calanna, S; Di Pino, A; Maria Rabuazzo, A; Maria Zagami, R; Piro, S; Purrello, F; Urbano, F | 1 |
Bagger, JI; Bonde, L; Holst, JJ; Knop, FK; Larsen, S; Nielsen, T; Svare, JA; Vilsbøll, T | 1 |
Abdul-Ghani, MA | 1 |
Akiyama, M; Hambro, B; Hu, J; Kennedy, RT; Kulkarni, RN; Liew, CW; Lu, S; Martinez, R | 1 |
Bano, G | 1 |
Arany, E; Bettler, B; Bonaventura, MM; Chamson-Reig, A; Crivello, M; Libertun, C; Lux-Lantos, V | 1 |
Ağbaht, K; Baskal, N; Emral, R; Erdogan, MF; Güllü, S | 1 |
Casamitjana, R; Delgado, S; Flores, L; Jiménez, A; Lacy, A; Vidal, J | 1 |
Bojsen-Møller, KN; Dirksen, C; Hansen, DL; Holst, JJ; Jacobsen, SH; Jørgensen, NB; Kristiansen, VB; Madsbad, S; Naver, L; Worm, D | 1 |
Khan, SA; Nanduri, J; Prabhakar, NR; Wang, N | 1 |
Chen, Y; Cheng, J; He, S; Jin, X; Li, H; Lu, Y; Ren, Y; Wang, C; Wang, D; Wang, L; Zhao, J | 1 |
Basu, A; Basu, R; Carter, R; Cobelli, C; Dalla Man, C; Hinshaw, L; Johnson, M; Kudva, Y; Mallad, A; Schiavon, M; Sparacino, G | 1 |
Anselmino, M; Astiarraga, B; Baldi, S; Camastra, S; Ciociaro, D; Ferrannini, E; Gastaldelli, A; Holst, JJ; Mari, A; Muscelli, E; Nannipieri, M | 1 |
Ito, R; Matsuda-Nagasumi, K; Mori, I; Negoro, N; Takeuchi, K; Tsujihata, Y | 1 |
Itoh, N; Konishi, M; Mochiyama, T; Murata, Y; Nishio, K; Ohta, H; Shimada, M | 1 |
Carlson, OD; de Cabo, R; Doyle, ME; Egan, JM; Farhang, K; Fiori, JL; Gadkaree, SK; González-Mariscal, I; Kim, W; Krzysik-Walker, SM; Mattison, JA; Moaddel, R; Pearson, KJ; Sanghvi, M; Shin, YK | 1 |
Bojsen-Møller, KN; Dirksen, C; Hansen, DL; Holst, JJ; Jacobsen, SH; Jørgensen, NB; Kristiansen, VB; Madsbad, S; Naver, LS; Worm, D | 1 |
Dent, SY; Hogan, MF; Lackey, D; Montminy, M; Olefsky, J; Ravnskjaer, K; Tora, L | 1 |
Anselmino, M; Baldi, S; Barsotti, E; Bellini, R; Berta, R; Camastra, S; Colligiani, D; Ferrannini, E; Guarino, D; Mari, A; Moriconi, D; Nannipieri, M | 1 |
Bhat, VK; Flatt, PR; Gault, VA; Irwin, N | 1 |
Berglund, ED; Elmquist, JK; Kim, MH; Lee, CE; Liu, C; Liu, T; Sohn, JW; Vianna, CR; Williams, KW; Xu, Y | 1 |
Bagnoli, F; Conte, ML; Pasqui, L; Sestini, F; Tomasini, B; Vodo, F; Vodo, S; Vodo, Z | 1 |
Bahekar, R; Dhanesha, N; Jain, M; Joharapurkar, A; Kshirsagar, S; Patel, K; Patel, V; Shah, G | 1 |
Brüssow, KP; Görs, S; Hammon, HM; Lang, IS; Metges, CC; Nürnberg, G; Otten, W; Rehfeldt, C; Weitzel, JM | 1 |
Bae, JC; Choi, DW; Choi, SH; Heo, JS; Jin, SM; Kim, JH; Kim, KW; Lee, MK; Lee, MS; Suh, S | 1 |
Björnholm, M; Chibalin, AV; Deshmukh, AS; Garcia-Roves, PM; Holmström, MH; Jiang, LQ; Sjögren, RJ; Vieira, E; Zachariah Tom, R; Zierath, JR | 1 |
Beglinger, C; Bernsmeier, C; Blaser, LS; Heim, MH; Jeker, L; Meyer-Gerspach, AC; Steinert, RE | 1 |
Bagger, JI; Hansen, T; Holst, JJ; Knop, FK; Pedersen, O; Vilsbøll, T; Østoft, SH | 1 |
Aw, DK; Sinha, RA; Xie, SY; Yen, PM | 1 |
Briscoe, CP; Chon, S; Leonard, J; Ma, JY; Polidori, D; Suckow, AT; Yan, W | 1 |
Bianchi, L; Bonaventura, A; D'Angelo, A; Derosa, G; Fogari, E; Maffioli, P; Romano, D | 1 |
de Oliveira, Mda S; Geloneze, B; Novaes, FS; Pareja, JC; Tambascia, MA; Vasques, AC | 1 |
Han, W; Lach, S; Mulvey, T; Petersen, N; Phillips, A; Shepherd, PR; Smith, GC; Wang, MW; Xiu, P; Zhang, ZY | 1 |
Beglinger, C; Beglinger, S; Drewe, J; Graf, S; Gutzwiller, JP; Meyer-Gerspach, AC; Zumsteg, U | 1 |
Gu, JJ; Hou, LQ; Liu, YH; Zhao, TY | 1 |
Hirshberg, B; Iqbal, N; Lu, J; Sjöstrand, M | 1 |
Flatt, PR; Moffett, RC; Thorens, B; Vasu, S | 1 |
Bowe, JE; Franklin, ZJ; Hauge-Evans, AC; Jones, PM; King, AJ; Persaud, SJ | 1 |
Basu, A; Basu, R; Bharucha, AE; Carter, RE; Cobelli, C; Hinshaw, L; Kudva, YC; Mallad, A; Man, CD; Schiavon, M | 1 |
Allister, EM; Cai, EP; Gaisano, HY; Luk, CT; Schroer, SA; Shi, SY; Wang, L; Wheeler, MB; Woo, M | 1 |
Bokhari, S; Emmerson, P; Gupta, A; Meyer, C; Plummer, E | 1 |
Pellitero, S; Puig-Domingo, M | 1 |
Baur, JA; Becker, LB; Guan, Y; Reilly, PM; Sims, CA; Wang, H; Widlund, AL | 1 |
De Jesus, DF; Dirice, E; Hu, J; Kahraman, S; Kulkarni, RN | 1 |
Nakamura, S; Nakazato, M; Sakoda, H; Tsubouchi, C; Tsuchimochi, W; Ueno, H; Yamashita, E | 1 |
Abdulla, H; Atherton, PJ; Idris, I; Phillips, B; Smith, K; Wilkinson, D | 1 |
Bahekar, R; Jain, MR; Joharapurkar, AA; Kshirsagar, SG; Patel, KN; Patel, V; Srivastava, BK | 1 |
Baretić, M; Troskot, R | 1 |
Brandt, C; Galle, P; Gehl, J; Hansen, JB; Hansen, RH; Hojman, P; Mandrup-Poulsen, T; Olsen, CH; Pedersen, BK | 1 |
Anzueto, DG; Blanco, CL; DeFronzo, RA; Gastaldelli, A; Johnson, MC; Leland, MM; Liang, H; McCurnin, DC; McGill-Vargas, LL; Musi, N; Seidner, SR | 1 |
Gyldenløve, M; Holst, JJ; Knop, FK; Skov, L; Storgaard, H; Vilsbøll, T | 1 |
Flatt, PR; Moffett, RC; Vasu, S | 1 |
Bolze, S; Fouqueray, P; Mari, A; Pacini, G; Roden, M | 1 |
Eguchi, H; Fujita, Y; Imagawa, A; Iwahashi, H; Kozawa, J; Nagano, H; Okita, K; Shimomura, I; Uno, S; Yoneda, S; Yoshikawa, A | 1 |
Bhonde, RR; Chalasani, M; Ganneru, S; Malakapalli, V; Nappanveettil, G; Singh, H; Venkatesan, V | 1 |
Bojsen-Møller, KN | 1 |
Abderrahmani, A; Beaucamps, C; Bonner, C; Delalleau, N; Deprez, B; Gmyr, V; Kerr-Conte, J; Malaisse, WJ; Moerman, E; Pattou, F; Popescu, I; Queniat, G; Sener, A; Staels, B; Thévenet, J | 1 |
Ahmed, L; Bantle, JP; Bessler, M; Billington, CJ; Connett, JE; Ikramuddin, S; Inabnet, WB; Korner, J; Nguyen, KT; Thomas, A; Vella, A; Wang, Q | 1 |
Cho, WK; Jung, MH; Park, MS; Park, SH; Suh, BK | 1 |
Chang, BC; Chen, LM; Ren, HZ; Shan, CY; Wang, Y; Xu, YG; Yang, JH; Yang, YH; Zheng, MY | 1 |
Lautt, WW; Macedo, MP; Patarrão, RS | 1 |
Chan, CB; Han, W; Hashemi, Z; Jin, A; Li, L; Ozga, J; Yang, H; Yang, K | 1 |
Andreassen, KV; Gydesen, S; Henriksen, K; Hjuler, ST; Karsdal, MA | 1 |
Chang, B; Chen, L; Ren, H; Shan, C; Wang, Y; Xu, Y; Yang, J; Yang, Y; Zheng, M | 1 |
Bindels, LB; Burkart, V; Hartmann, B; Henrich, B; Holst, JJ; Hwang, JH; Kolb, H; MacKenzie, C; Martinez, I; Nowotny, B; Nowotny, P; Pacini, G; Roden, M; Schloot, NC; Simon, MC; Stehle, P; Strassburger, K; Walter, J; Zivehe, F | 1 |
Flatt, PR; Gault, VA; Irwin, N; Pathak, NM; Pathak, V | 1 |
Abdel-Wahab, YHA; Conlon, JM; Flatt, PR; Ojo, OO; Owolabi, BO; Srinivasan, D | 1 |
Abdel-Wahab, YH; Conlon, JM; Flatt, PR; Ojo, OO; Owolabi, BO; Srinivasan, DK | 1 |
Bellomo, E; Herrera, PL; Hodson, DJ; Li, SM; Magnan, C; Meur, G; Philippe, E; Rutter, GA; Solomou, A; Tomas, A | 1 |
Asrih, M; Camporez, JP; Jornayvaz, FR; Jurczak, MJ; Kahn, M; Samuel, VT; Zhang, D | 1 |
Hara, K; Kaku, H; Kato, T; Mitsuzaki, K; Muraishi, K; Nakayama, H; Nakayama, S; Ohki, T; Tajiri, Y; Tanaka, K; Tokubuchi, I; Tsuruta, M; Wada, N; Yamada, K | 1 |
Deacon, CF; Eelderink, C; Holst, JJ; Koehorst, M; Noort, MW; Oudhuis, L; Poutanen, K; Priebe, MG; Rehfeld, JF; Sozer, N; Vonk, RJ | 1 |
Cho, YM; Lee, HJ; Oh, TJ | 1 |
Bailey, SR; Bamford, NJ; Baskerville, CL; Harris, PA | 1 |
Albury-Warren, TM; Altomare, DA; Masternak, MM; Pandey, V; Spinel, LP | 1 |
Bailey, KR; Cobelli, C; Dalla Man, C; Miles, JM; Piccinini, F; Rizza, RA; Shah, M; Varghese, RT; Vella, A | 1 |
Ahrén, B; Enerbäck, S; Kvist-Reimer, M; Omar, BA | 1 |
Chang, ES; Chen, CY; Chen, SC; Chen, YC; Inui, A; Lee, WJ | 1 |
Benatti, FB; Harder-Lauridsen, NM; Krogh-Madsen, R; Lyngbæk, MP; Møller, K; Nielsen, ST; Pedersen, BK; Wedell-Neergaard, AS | 1 |
Chang, B; Cheng, J; Ren, H; Shan, C; Xu, Y; Yang, J; Yang, Y; Zheng, M | 1 |
Adams-Huet, B; Bouza, B; Dart, L; Franklin, B; Mitchell, J; Phillips, M; Shah, M | 1 |
Engelhardt, JF; Gibson-Corley, K; Hara, M; He, N; Liang, B; Norris, AW; Ode, KL; Philipson, LH; Sun, X; Tyler, SR; Uc, A; Wang, K; Xie, W; Yi, Y | 1 |
Adams-Huet, B; Dimitrov, I; Harrison, LB; Hulsey, K; Jaster, AW; Lenkinski, RE; Li, X; Lingvay, I; Pedrosa, I; Pinho, DF; Pop, LM; Vanderheiden, A; Warshauer, JT; Yokoo, T; Yuan, Q | 1 |
Beglinger, C; Cajacob, L; Drewe, J; Herzog, R; Meyer-Gerspach, AC; Riva, D; Wölnerhanssen, BK | 1 |
D'Alessio, D; Davis, HW; Gastaldelli, A; Tong, J | 1 |
de la Peña, A; Del Prato, S; Karanikas, CA; Ludvik, B; Mari, A; Milicevic, Z; Pechtner, V; Shurzinske, L | 1 |
Franklin, ZJ; Hewage, CM; Irwin, N; McShane, LM; O'Flynn, D; O'Harte, FP | 1 |
Hansen, JS; Lehmann, R; Pedersen, BK; Plomgaard, P; Weigert, C; Xu, G | 1 |
Asrani, VM; Murphy, R; Pendharkar, SA; Petrov, MS; Windsor, JA; Xiao, AY; Yoon, HD | 1 |
Ahn, CH; Cho, YM; Oh, TJ | 1 |
Cicciò, F; Ciresi, A; Giordano, C; Radellini, S | 1 |
Birnbaum, MJ; Chen, H; Chen, J; Chu, Q; Li, C; Lu, M; Lu, W; Monks, BR; Quinn, WJ; Rabinowitz, JD; Titchenell, PM | 1 |
Chen, K; Chen, Y; Jia, S; Li, X; Lv, Q; Sun, C; Zhang, X | 1 |
Conlon, JM; Flatt, PR; Lynch, AM; Ng, MT; O'Harte, FP | 1 |
Asare-Bediako, I; Bergman, RN; Broussard, JL; Castro, AV; Ionut, V; Iyer, MS; Kabir, M; Kolka, CM; Liu, H; Mkrtchyan, HJ; Stefanovski, D; Woolcott, OO; Wu, Q | 1 |
Bao, X; Chen, Y; Gao, Z; Guo, Y; Hu, Q; Jin, G; Wang, S; Wang, Z; Xie, W; Xue, M; Zhang, H; Zhang, L | 1 |
Bennet, H; Bevilacqua, L; Fex, M; Koskinen, M; Panarsky, R; Paunio, T; Rautiainen, MR; Saukkonen, T; Sjöberg, RL; Tiihonen, J; Tikkanen, R; Virkkunen, M | 1 |
Ahrén, B; Færch, K; Hansen, T; Holst, JJ; Johansen, NB; Jonsson, A; Jørgensen, ME; Lauritzen, T; Pacini, G; Pedersen, O; Torekov, SS; Vistisen, D; Witte, DR | 1 |
Abdul-Ghani, M; Daniele, G; DeFronzo, RA; Eldor, R; Merovci, A; Norton, L; Solis-Herrera, C; Tripathy, D; Xiong, J | 1 |
Broadbent, RS; Medlicott, NJ; Reith, DM; Salis, ER; Wheeler, BJ | 1 |
Bartoszewicz, Z; Grodzicki, M; Kalinowski, P; Krawczyk, M; Paluszkiewicz, R; Remiszewski, P; Wróblewski, T | 1 |
Ding, L; Han, L; Li, Y; Yin, Y; Zhang, W; Zhao, J | 1 |
Bree, AJ; Daphna-Iken, D; Fisher, SJ; Kahn, BB; Puente, EC; Reno, CM; Routh, VH; Sheng, Z | 1 |
Borer, KT; Lin, PJ | 1 |
Chen, YY; Li, GW; Wang, X; Yang, ZJ; Zhang, B | 1 |
Ahn, CH; Cho, YM; Kim, EK; Min, SH; Oh, TJ | 1 |
Astiarraga, B; Camastra, S; Ciociaro, D; Ferrannini, E; Frascerra, S; Gastaldelli, A; Mari, A; Tura, A | 1 |
Ahlqvist, E; Fritsche, A; Gallwitz, B; Groop, L; Hakaste, LH; Häring, HU; Heni, M; Machann, J; Schick, F; Stefan, N; Tuomi, T; Van Obberghen, E; Wagner, R | 1 |
Bistrup, C; Feldt-Rasmussen, B; Hansen, JM; Hornum, M; Jørgensen, MB; Mathiesen, ER; van Hall, G | 1 |
Cavino, K; Cheng, X; Gromada, J; Kim, SY; Krumm, E; Murphy, AJ; Na, E; Okamoto, H; Yancopoulos, GD | 1 |
Chen, L; Chen, Q; Duan, Y; Liu, H; Wang, P; Xi, S | 1 |
Ekelund, M; Groop, L; Hedenbro, J; Lindqvist, A; Pierzynowski, S; Wierup, N | 1 |
Beaudry, JL; Campbell, JE; Cao, X; Drucker, DJ; Flock, GB; Panaro, BL | 1 |
Liu, H; Wang, L; Wang, X; Wei, C; Xue, N; Zhang, L | 1 |
Choong, YS; Chuang, CL; Cooper, GJ; Ferreira, A; Liu, H; Saafi, EL; Scott, DW; Wong, WP; Zhang, S | 1 |
Basu, A; Basu, R; Chandramouli, V; Cohen, O; Dicke, B; Landau, BR; Norby, B; Rizza, RA; Shah, P | 1 |
Hoist, JJ; Lasalle, JR | 1 |
Assmann, A; Hinault, C; Kulkarni, RN | 1 |
Baskin, DG; Cummings, BP; Digitale, EK; Graham, JL; Griffen, SC; Havel, PJ; Reed, BJ; Stanhope, KL; Sweet, IR | 1 |
Bastard, JP; Bonnet, F; Disse, E; Laville, M; Louche-Pelissier, C; Maitrepierre, C; Peyrat, J | 1 |
Roden, M | 1 |
Bodenner, DL; Coker, RH; Evans, WJ; Kern, PA; Kortebein, PM; Williams, RH; Yeo, SE | 2 |
Aaboe, K; Deacon, CF; Holst, JJ; Knop, FK; Krarup, T; Madsbad, S; Simonsen, U; Vilsboll, T; Vølund, A | 1 |
Barati, MT; Epstein, PN; Moore, JP; Portillo, J; Song, Y; Villafuerte, BC | 1 |
Ackermans, MT; Duran, M; Faas, L; Fliers, E; Houten, SM; Ruiter, AF; Sauerwein, HP; Serlie, MJ; Smeenge, M; Soeters, MR; Wanders, RJ | 1 |
Pratley, RE | 1 |
Berglund, ED; Bina, HA; Kharitonenkov, A; Li, CY; Lynes, SE; Michael, MD; Shanafelt, AB; Wasserman, DH | 1 |
Biller, BM; Cook, DM; Molitch, ME; Yuen, KC | 1 |
Chacko, SK; Haymond, MW; Maningat, PD; Mohammad, MA; Pontius, AS; Sunehag, AL | 1 |
Cognard, E; Shepherd, PR; Smith, GC; Vickers, MH | 1 |
Basu, S; Bjerve, KS; Frayn, KN; Grill, V; Mostad, IL; Sutton, P | 1 |
Ismail, AA | 1 |
Chisholm, DJ; Dore, GJ; Fragomeli, V; George, J; Jenkins, AB; Milner, KL; Smythe, G; Trenell, M; van der Poorten, D; Weltman, M; Xu, A; Zekry, A | 1 |
Buhl, M; Gjedsted, J; Granfeldt, A; Larsen, PØ; Møller, N; Schmitz, O; Tønnesen, E | 1 |
Cao, HW; Ji, QH; Tang, CW; Wang, L; Zhang, J | 1 |
Fuskevåg, OM; Gjessing, PF; Hagve, M; Irtun, Ø; Revhaug, A | 1 |
Spellman, CW | 1 |
Bagger, JI; Hansen, KB; Holst, JJ; Knop, FK; Vilsbøll, T | 3 |
Grønbaek, H; Holland-Fischer, P; Mengel, A; Nielsen, MF; Schmitz, O; Tønner-Nielsen, D; Vilstrup, H | 1 |
Declercq, J; Di Pietro, C; Ectors, N; Gysemans, C; Kumar, A; Mathieu, C; Van de Ven, WJ; Van Diepen, JA; Verfaillie, CM; Voshol, PJ; Vroegrijk, IO | 1 |
Balasubramanian, R; Cobelli, C; Dalla Man, C; English, PT; Firbank, MJ; Gerrard, J; Lane, A; Taylor, R | 1 |
Lele, RD | 1 |
Coulaud, J; Durant, S; Homo-Delarche, F | 1 |
Rizza, RA | 1 |
Aziz, NA; Frölich, M; Pijl, H; Roelfsema, F; Roos, RA; Snel, M; Streefland, TC | 1 |
Campbell, RK; Cobble, ME; Reid, TS; Shomali, ME | 2 |
Caprio, S; D'Adamo, E; Hershkop, K; Santoro, N; Weiss, R | 1 |
Genis, A; Huisamen, B; Lochner, A; Marais, E | 1 |
Arnqvist, H; Berne, C; Björk, E; Bolinder, J; Karlsson, FA; Nyström, L; Schölin, A | 1 |
Ferrannini, E; Gastaldelli, A; Iozzo, P | 1 |
Fleeman, LM; Morton, JM; Rand, JS; Verkest, KR | 1 |
Flatt, PR; Franklin, ZJ; Irwin, N; McDonnell, B; Montgomery, IA | 1 |
Guo, F; Wang, L; Wei, S; Zhao, R | 1 |
Anderwald, CH; Balkau, B; Bonnet, F; Ducluzeau, PH; Gastaldelli, A; Konrad, T; Laville, M; Mari, A | 1 |
Daily, JW; Kim, DS; Kim, SH; Park, S | 1 |
Arasaki, CH; Carneiro, G; Geloneze, B; Silva, EA; Umeda, LM; Zanella, MT | 1 |
Aguilera, A; Fernandez-Mejia, C; German, MS; Hafidi, ME; Larrieta, E; Vega-Monroy, ML; Vital, P | 1 |
Buhl, M; Clasen, BF; Jørgensen, JO; Krusenstjerna-Hafstrøm, T; Møller, N; Nielsen, R; Nielsen, S; Pedersen, SB; Vestergaard, ET | 1 |
Shepherd, PR; Smith, GC; Vickers, MH | 1 |
Damm, P; Nolan, CJ; Prentki, M | 1 |
Nakata, M; Yada, T | 1 |
Fernández-Real, JM; Frühbeck, G; Moreno-Navarrete, JM; Ortega, FJ; Ricart, W; Sabater, M | 1 |
Grarup, N; Hainerová, IA; Hansen, T; Hartmann, B; Holst, JJ; Jørgensen, T; Kielgast, U; Kissow, H; Lauritzen, T; Lebl, J; Linneberg, A; Ma, L; Madsbad, S; Madsen, OD; Pedersen, O; Rosenkilde, M; Sandbaek, A; Torekov, SS; Wang, J; Witte, DR | 1 |
Hermansen, K; Hong, J; Jeppesen, PB; Li, GW; Li, HL; Pan, L; Shen, XX; Xiao, J | 1 |
Axelsen, LN; Holstein-Rathlou, NH; Keung, W; Kjølbye, AL; Lopaschuk, GD; Meier, E; Pedersen, HD; Petersen, JS; Proctor, SD; Riber, D | 1 |
Bortolotti, M; Dubuis, J; Schneiter, P; Tappy, L | 1 |
Acitores, A; González, N; Gutiérrez-Rojas, I; Moreno, P; Nuche-Berenguer, B; Sancho, V; Valverde, I; Villanueva-Peñacarrillo, ML | 1 |
Babu, SR; Cao, SS; Da Zhang, Z; Hu, T; Hu, WM; Le Tian, B; Su, AP; Wang, ZL; Zhang, Y | 1 |
Otto-Buczkowska, E | 1 |
Brink, R; Chen, Z; Rui, L; Shen, H; Sheng, L; Wang, S; Zhao, Y | 1 |
Mundinger, TO; Taborsky, GJ | 1 |
Berglund, ED; Brule, LJ; Chuang, JC; Coppari, R; Donato, J; Elmquist, JK; Kim, MH; Lauzon, DA; Lee, CE; Lin, P; Scott, MM; Vianna, CR | 1 |
Almdal, T; Bojsen-Møller, KN; Clausen, TR; Dirksen, C; Hansen, DL; Holst, JJ; Hvolris, LE; Jacobsen, SH; Jørgensen, NB; Kielgast, U; Madsbad, S; Naver, LS; Olesen, SC; Rehfeld, JF; Worm, D; Wulff, BS | 1 |
Cuesta, S; García, C; Kireev, R; Rancan, L; Tresguerres, JA; Vara, E | 1 |
Bøtker, H; Frandsen, E; Halbirk, M; Holst, JJ; Møller, N; Nielsen, R; Nielsen, S; Nørrelund, H; Schmitz, O; Wiggers, H | 1 |
Stiefelhagen, P | 1 |
Chen, J; Fischer, WH; Goode, J; Li, G; Montminy, M; Ouyang, K; Paz, JC; Screaton, R; Tabas, I; Wang, Y | 1 |
Bojsen-Møller, KN; Clausen, TR; Dirksen, C; Holst, JJ; Hvolris, L; Jacobsen, SH; Jørgensen, NB; Lindqvist Hansen, D; Madsbad, S; Naver, L; Worm, D; Wulff, BS | 1 |
Fredholm, BB; Kieffer, TJ; Kwok, YN; Yang, GK | 1 |
Rodgers, RL | 1 |
Bianchi, L; Bonaventura, A; Carbone, A; Cicero, AF; Derosa, G; Fogari, E; Franzetti, I; Maffioli, P; Querci, F; Romano, D | 1 |
Castagneto-Gissey, L; Mingrone, G | 1 |
Cree-Green, M; Mizokami-Stout, K; Nadeau, KJ | 1 |
Brabant, G; Gläser, S; Kasim, E; Kroencke, T; Lochs, H; Ockenga, J; Omar, A; Schuetz, T; Schulzke, JD; Tietge, UJ; Valentini, L | 1 |
Borkowska, A; Chalubinska, J; Czupryniak, L; Durczynski, A; Hogendorf, P; Strzelczyk, J; Szymanski, D; Wojciechowska-Durczynska, K | 1 |
Bahekar, R; Detroja, J; Dhanesha, N; Dhote, V; Gandhi, T; Jain, M; Joharapurkar, A; Kshirsagar, S; Patel, K; Patel, V | 1 |
Shiota, M | 1 |
Han, W; Lee, P; Leong, W; Lim, M; Radda, GK; Tan, T | 1 |
Ananthakrishnan, G; Chabenne, JR; Chaudhary, N; DiMarchi, R; Drucker, DJ; Heppner, KM; Lockie, SH; Morgan, DA; Oldfield, BJ; Perez-Tilve, D; Rahmouni, K; Rohner-Jeanrenaud, F; Tschöp, MH; Veyrat-Durebex, C | 1 |
Anderwald, CH; Balkau, B; Bonnet, F; Disse, E; Hojlund, K; Laville, M; Mari, A; Piatti, P | 1 |
Holzhütter, HG; König, M | 1 |
Hauge-Evans, AC; Jones, PM; Persaud, SJ; Vilches-Flores, A | 1 |
Flatt, PR; Irwin, N; Moffett, RC; Montgomery, IA | 1 |
Funahashi, T; Imagawa, A; Iwahashi, H; Kozawa, J; Okauchi, Y; Okita, K; Shimomura, I | 1 |
Ali, S; Charron, MJ; Dai, C; de Chavez, V; Dean, ED; Drucker, DJ; Longuet, C; McGuinness, I; Powers, AC; Robledo, AM; Vuguin, PM | 1 |
Bettler, B; Bonaventura, MM; Crivello, M; Ferreira, ML; Libertun, C; Lux-Lantos, VA; Repetto, EM; Rodriguez, D | 1 |
Jacobs, RL; Li, L; Li, T; Lopaschuk, GD; Vance, DE; Wu, G; Zhang, L; Zuniga, A | 1 |
Gao, FY; Gu, JJ; Zhao, TY | 1 |
Brown, LD; Gadhia, MM; Hay, WW; Lavezzi, JR; Limesand, SW; Maliszewski, AM; O'Meara, MC; Rozance, PJ; Thorn, SR | 1 |
van der Klauw, MM; Wolffenbuttel, BH | 1 |
Cobelli, C; Dalla Man, C; Law, JH; Piccinini, F; Rizza, RA; Sathananthan, M; Smushkin, G; Vella, A; Zinsmeister, AR | 1 |
Arafat, AM; Belli, S; Cheng, C; D'Alessio, D; DiMarchi, RD; Gelfanov, V; Habegger, KM; Hembree, JL; Heppner, KM; Hofmann, SM; Holland, J; Itoh, N; Kapps, M; Kharitonenkov, A; Konishi, M; Konkar, A; Krishna, R; Müller, TD; Ottaway, N; Perez-Tilve, D; Pfluger, PT; Seeley, RJ; Smiley, D; Spranger, J; Stemmer, K; Tschöp, MH; Woods, SC | 1 |
Deane, AM; Horowitz, M | 1 |
Egan, JM; Elahi, D; Habener, JF; Meneilly, GS | 1 |
Christiansen, JS; Dall, R; Gravholt, CH; Møller, N; Schmitz, O | 1 |
Cherrington, AD; Igawa, K; Mugavero, M; Neal, DW; Shiota, M | 1 |
Bernroider, E; Bischof, MG; Krssak, M; Lahousen, T; Pacini, G; Roden, M; Schnedl, WJ; Stingl, H | 1 |
Gottschalk, WK; Lenhard, JM | 1 |
Bergman, RN; Brubaker, PL; Dea, MK; Kabir, M; Kim, SP; Mittelman, SD; van Citters, GW | 1 |
Egan, JM; Elahi, D; Meneilly, GS | 1 |
Chang, AM; Halter, JB | 1 |
Burchell, A; Hume, R; Jackson, L; McGeechan, A | 1 |
Büsing, M; Klempnauer, J; Meier, JJ; Nauck, MA; Pox, C; Ritzel, R; Schmiegel, W | 1 |
Smith, SA; Tadayyon, M | 1 |
Abbatecola, AM; Grella, R; Manzella, D; Paolisso, G; Ragno, E | 1 |
Dostou, JM; Gerich, JE; Mariuz, PR; Meyer, C; Popa, EM; Reichman, RC; Welle, SL; Woerle, HJ | 1 |
Crosson, SM; Khan, A; Pessin, JE; Printen, J; Saltiel, AR | 1 |
Besse, C; Giusti, V; Nicod, N; Tappy, L | 1 |
Dela, F; Holst, JJ; Jensen, CB; Madsbad, S; Storgaard, H; Vaag, AA | 1 |
Chen, CL; Chen, PJ; Chuang, LM; Jeng, YM; Kao, JH; Lai, MY; Lee, CZ; Lee, HS; Lu, JY; Tai, TY | 1 |
ALIVISATOS, JG; MCCULLAGH, EP | 1 |
CREUTZFELDT, W; DEUTICKE, U | 1 |
KODEJSZKO, E; NIEDZWIECKA, I; SENIOW, S | 1 |
KELLEY, VC; RUVALCABA, RH; SAMOLS, E | 1 |
KRETSCHY, A; PIETSCHMANN, H | 1 |
Burcelin, R; Cotecchia, S; Dacosta, A; Foretz, M; Nenniger-Tosato, M; Perrin, C; Seydoux, J; Thorens, B; Uldry, M | 1 |
Bendlová, B; Dvoráková, K; Hill, M; Stanická, S; Stárka, L; Vondra, K; Vrbíková, J | 1 |
Cherrington, AD; Dardevet, D; DiCostanzo, CA; Moore, MC; Neal, D; Snead, W | 1 |
Ahrén, B; Pacini, G; Sundler, F; Wierup, N; Wynick, D | 1 |
Bell, JD; Bloom, SR; Brynes, AE; Castroman, G; Edwards, R; Frost, G; Ghatei, MA; Goldstone, AP; Grossman, AB; Holland, AJ; Korbonits, M; Thomas, EL | 1 |
Brock, B; Chandramouli, V; Degn, KB; Jakobsen, G; Juhl, CB; Landau, BR; Rungby, J; Schmitz, O; Sturis, J | 1 |
Ahrén, B; Holst Jj, Jj; Olsson, T; Pacini, G; Rask, E; Söderberg, S; Tura, A | 1 |
Andersen, O; Dela, F; Haugaard, SB; Holst, JJ; Iversen, J; Madsbad, S; Nielsen, JO; Storgaard, H | 1 |
Beglinger, C; Bock, A; Drewe, J; Goeke, B; Gutmann, H; Gutzwiller, JP; Henzen, C; Huber, AR; Kreyenbuehl, M; Tschopp, S; Zehnder, CE | 1 |
Christiansen, JS; Jørgensen, JO; Møller, N; Nielsen, S; Nørrelund, H | 1 |
Bordenave, B; Claxton, S; Henry, K; Kane, E; Klebert, M; Powderly, WG; Tebas, P; Yarasheski, K | 1 |
Doverspike, A; Elahi, D; Hentosz, T; Huerbin, R; Nikolaidis, LA; Shannon, RP; Shen, YT; Stolarski, C; Zourelias, L | 1 |
Taegtmeyer, H | 1 |
Brock, B; Degn, KB; Djurhuus, CB; Fineman, M; Grubert, J; Han, J; Juhl, CB; Kim, D; Schmitz, O; Taylor, K | 1 |
Cecere, G; Franzese, A; Muzzi, G; Salerno, M; Shield, JP; Temple, KI; Valerio, G | 1 |
Bunck, MC; Diamant, M; Heine, RJ | 1 |
Ferrannini, E; Gastaldelli, A; Mari, A; Natali, A; Ostergard, T; Schmitz, O | 1 |
Belloli, AG; Cavallone, E; Doll, K; Hummel, M; Pravettoni, D; Re, M | 1 |
Sato, F; Tamura, Y | 1 |
Christiansen, JS; Engbaek, F; Gravholt, CH; Hjerrild, BE; Mosekilde, L; Naeraa, RW | 1 |
Ino, M; Ito, M; Miyamoto, N; Nagasu, T; Takahashi, E; Tanaka, I | 1 |
Burcelin, R | 1 |
Ballantyne, GH; Gumbs, AA; Modlin, IM | 1 |
De Vizcaya-Ruiz, A; Del Razo, LM; Izquierdo-Vega, JA; Sanchez-Peña, LC; Soto, CA | 1 |
Boutwell, JJ; Campbell, AG; Hart, CM; Kleinhenz, DJ; Olson, DE; Sutliff, RL; Thulé, PM | 1 |
Giacca, A; Kawamori, R; Kim, T; Klement, P; Lam, TK; Uchino, H; Williams, W; Yoshii, H | 1 |
Hahm, S; Mizuno, TM; Mobbs, CV; Montgomery, C; Salton, SR; Scherer, PE; Watson, E; Windsor, J | 1 |
Hill, M; Pelikánová, T; Stanická, S; Vlcek, P; Vondra, K; Zamrazil, V | 1 |
Carlson, O; Doyle, ME; Egan, JM; Juhaszova, M; Michopoulos, S; Petraki, K; Theodorakis, MJ | 1 |
Chen, M; Gavrilova, O; Jou, W; Lorenzo, J; Nackers, L; Nguyen, A; Pack, S; Shen, L; Weinstein, LS; Zhao, WQ | 1 |
Ke, L; Li, HL; Li, XJ; Wang, Y; Wu, YH; Zhang, XE; Zhang, XX | 1 |
Canu, T; Costantino, F; De Cobelli, F; De Taddeo, F; Del Maschio, A; Esposito, A; Lattuada, G; Luzi, L; Maffi, P; Perseghin, G; Scifo, P; Secchi, A | 1 |
Asghar, Z; Chan, CB; Chan, F; Leroith, D; Wheeler, MB; Yau, D | 1 |
Braun, M; Deng, S; Ebina, Y; Ju, W; Kumar, M; Liu, S; Obata, T; Wang, Q; Wendt, A; Wheeler, MB; Xu, E; Zhang, N; Zhang, Y | 1 |
Chou, HF; Ho, LT; Huang, PC; Hung, CJ; Li, YH; Lu, SC | 1 |
Brackenridge, A; Hattersley, AT; Pearson, ER; Russell-Jones, D; Shojaee-Moradie, F; Umpleby, AM | 1 |
Andersen, O; Deacon, CF; Dela, F; Haugaard, SB; Holst, JJ; Iversen, J; Madsbad, S; Pedersen, SB | 1 |
Berger, MM; Chioléro, R; Kim, S; Revelly, JP; Schneiter, P; Schwarz, JM; Tappy, L | 1 |
Hiriart, M; Larrieta, E; Vital, P | 1 |
Dedova, I; Duffy, L; Herzog, H; Karl, T; Lee, NJ; Lin, EJ; Matsumoto, I; O'brien, E; Sainsbury, A; Slack, K | 1 |
Cao, XY; Ding, H; He, LJ; Liu, M; Ma, SL; Ma, XG; Ma, XW; Wang, XH; Wang, XQ; Yang, XJ | 1 |
Aguayo-Mazzucato, C; Godinez-Puig, V; Gutiérrez-Ospina, G; Hiriart, M; Sanchez-Soto, C | 1 |
Bai, XP; Du, RQ; Li, HL; Lou, DJ; Pan, L; Wang, B; Xiao, JZ; Yang, WY | 2 |
Baldi, S; Buzzigoli, E; Casolaro, A; Ciociaro, D; Ferrannini, E; Frascerra, S; Gastaldelli, A; Mari, A; Nannipieri, M; Pettiti, M | 1 |
Baptista, T; Beaulieu, S; Contreras, Q; de Mendoza, S; Galeazzi, T; Lacruz, A; Rangel, N; Sandia, I; Vargas, D | 1 |
Busse, FP; Denti, V; Stumvoll, M | 1 |
Basu, R; Bock, G; Chandramouli, V; Chittilapilly, E; Cobelli, C; Landau, BR; Rizza, RA; Toffolo, G | 1 |
Gallo, S; Hanefeld, M; Henkel, E; Koehler, C; Siegert, G | 1 |
Ahrén, B; Brand, CL; Nishimura, E; Sidelmann, UG; Sundler, F; Wierup, N; Winzell, MS | 1 |
Escalante, B; Gonzalez-Granillo, M; Hernández-Pando, R; Noriega-López, L; Santillán-Doherty, P; Torres, N; Tovar, AR | 1 |
Ciechanowicz, A; Frankow, M; Majkowska, L; Parczewski, M; Pilarska, K; Safranow, K; Stefanski, A | 1 |
Agius, L; Arden, C; Lange, AJ; Payne, VA | 1 |
Cassidy, RS; Flatt, PR; Gault, VA; Irwin, N; McClean, PL | 1 |
Ando, H; Kaneko, S; Kato, K; Kurita, S; Sakurai, M; Shimizu, A; Takamura, T; Tsuchiyama, N | 1 |
Kocić, G; Kocić, R; Pavlović, D; Pesić, M | 1 |
Djurhuus, CB; Gjedsted, J; Gormsen, LC; Keiding, S; Møller, N; Nielsen, S; Schmitz, O; Tønnesen, E; Ørskov, H | 1 |
Ferrannini, E; Flyvbjerg, A; Gabriel, R; Golay, A; Hojlund, K; Mitrakou, A; Muscelli, E; Natali, A | 1 |
Cassidy, RS; Flatt, PR; Gault, VA; Holst, JJ; Irwin, N; McClean, PL | 1 |
Baz-Hecht, M; Bernier, R; Devine, E; Goldfine, AB; Holst, JJ; Jones, DB; Mun, EC; Patti, ME; Schneider, BE | 1 |
McIntosh, CH | 1 |
Ackermans, MT; Allick, G; Becker, H; Blumer, RM; de Haan, L; Fliers, E; Sauerwein, HP; Serlie, MJ; Storosum, JG; van Amelsvoort, T; van Nimwegen, LJ; Venema, HW | 1 |
Elias, AN; Hofflich, H | 1 |
Asgharian, H; Dorkhan, M; Groop, L; Malm, G; Tripathy, D; Tuomi, T | 1 |
Banks, MR; Klein, S; Patterson, BW; Polonsky, KS; Villareal, DT | 1 |
Boschero, AC; Bosqueiro, JR; Rafacho, A; Ribeiro, DL; Taboga, SR | 1 |
Kowarski, AA; Levin, PA; McLaughlin, J | 1 |
Besch, W; Ratzmann, KP; Schulz, B; Witt, S | 1 |
Berthezène, F; Beylot, M; Cohen, R; Martin, C; Mornex, R; Sautot, G | 1 |
Mandarino, L | 1 |
Groop, L | 1 |
Hübinger, A; Müller, HJ; Vogelberg, KH | 1 |
Bressler, R; Johnson, DG | 1 |
Ahuja, MM; Sharma, GP; Shivgnanasundaram, D | 1 |
Cramb, G; Langslow, DR; Phillips, JH | 1 |
Broer, Y | 1 |
Duckworth, WC; Jallepalli, P; Solomon, SS | 1 |
Hollingsworth, DR | 1 |
Abibova, EB; Gaĭnutdinov, MKh; Turakulov, IaKh | 1 |
Chan, IF; Horton, SC; Schipke, C; Stevenson, KB; Wilson, DE | 1 |
Aoki, TT; Bessey, PQ; Black, PR; Brooks, DC; Wilmore, DW | 1 |
Gossain, VV; Michelakis, AM; Rovner, DR; Sherma, NK | 1 |
Hidaka, H; Klimes, I; Nagulesparan, M; Unger, RH; Vasquez, B | 1 |
Freeman, RB; Izzo, MS; Lockwood, DH; McCaleb, ML; Mevorach, R | 1 |
Geffner, ME; Gillard, BK; Itami, RM; Kaplan, SA; Levin, SR; Lippe, BM; Taylor, IL | 1 |
Berger, M; Creutzfeldt, W; Ebert, R; Niederau, C; Siegel, E; Starke, A; Stremmel, W; Strohmeyer, G | 1 |
Bolli, GB; Campbell, PJ; Cryer, PE; Gerich, JE; Gottesman, IS; Haymond, MW | 1 |
Baker, SG; Joffe, BI; Lamprey, JM; Seftel, HC; Shires, R; Viljoen, M | 1 |
Charbonnel, B; Du Rostu, H; Guillon, J; Murat, A; Schneebeli, S | 1 |
Bratusch-Marrain, P; Ferenci, P; Korn, A; Nowotny, P; Waldhäusl, WK | 1 |
Bevilacqua, M; Dagani, R; Frigeni, G; Meroni, R; Norbiato, G; Raggi, U; Scorza, D; Vago, T | 1 |
Mahler, RJ | 1 |
Marliss, E; Steiner, G; Vranic, M; Zinman, B | 1 |
Efendić, S; Luft, R; Roovete, A; Vranić, M; Wajngot, A | 1 |
Bessey, PQ; Black, PR; Brooks, DC; Wilmore, DW; Wolfe, RR | 1 |
Ratzmann, KP; Schulz, B; Witt, S | 1 |
Betancor, P; Carrillo, A; Font de Mora, A; Franic, L; Larrodera, L; Sosa, M | 1 |
Feinglos, MN; Lebovitz, HE | 1 |
Morita, S; Steiner, G; Vranic, M | 1 |
Aubry, E; Deschamps, I; Desjeux, JF; Dieterlen, P; Grasset, E; Lestradet, H | 1 |
Altomonte, L; Bertoli, A; Ghirlanda, G; Greco, AV; Manna, R; Modugno, I; Palumbo, P | 1 |
Brissot, P; Meyrier, A; Simon, P | 1 |
Ballesta, F; Barguñó, JM; Hierro, FR; Lambruschini, N; Villanueva, C | 1 |
Dorner, M; Gandar, R; Jacques, C; Pinget, M; Truchetet, F; Zaehringer, M | 1 |
Bonora, E; Butturini, U; Buzzelli, G; Cambi, R; Coscelli, C; Gentilini, P; Orioli, S | 1 |
Chesnokova, TT; Kubyshkin, VA; Maslennikov, MF | 1 |
Christiansen, JS; Froesch, ER; Hussain, MA; Schmitz, O; Zapf, J | 1 |
Páv, J | 1 |
Eidemak, I; Feldt-Rasmussen, B; Kanstrup, IL; Nielsen, SL; Schmitz, O; Strandgaard, S | 1 |
Daneryd, P; Hafström, L; Karlberg, I; Svanberg, E | 1 |
Hartmann, H; Nolte, W; Ramadori, G | 1 |
Apps, KV; Finegood, DT; McBurney, MI | 1 |
Bonetti, F; Cortona, L; De Stefano, P; Locatelli, F; Lorini, R; Scaramuzza, A; Severi, F | 1 |
Langlois, WJ; Olefsky, JM; Pillay, TS | 1 |
Assan, R; Burcelin, R; Eddouks, M; Girard, J; Kande, J; Maury, J | 1 |
Rao, RH | 1 |
Girard, J | 2 |
Castillo, MJ; Lefebvre, PJ; Scheen, AJ | 1 |
Bogardus, C; Esposito-Del Puente, A; Feinglos, MN; Kuhn, CM; Lillioja, S; McCubbin, JA; Surwit, RS | 1 |
Bagger, JP; Bøtker, HE; Mengel, A; Møller, N; Orskov, H; Ovesen, P; Schmitz, O | 1 |
Efendic, S; Ostenson, CG | 1 |
Delamarche, P; Favier, R; Gratas-Delamarche, A; Koubi, HE; Mayet, MH; Monnier, M | 1 |
Guan, RJ | 1 |
Boyle, PJ; Krentz, AJ; Macdonald, LM; Schade, DS | 1 |
Bauman, DE; Boyd, RD; Ross, DA; Wray-Cahen, D | 1 |
Ekstrand, A; Eriksson, J; Forsblom, C; Groop, L; Groop, PH; Teppo, AM; Widén, E | 1 |
Diamond, MP; Jacob, RJ; Lapaczewski, P; Rossi, G; Sherwin, RS; Shulman, GI | 1 |
Durlach, V; Gross, A; Grulet, H; Hecart, AC; Leutenegger, M | 1 |
Bovo, P; Brunori, MP; Cavallini, G; Cigolini, M; Di Francesco, V; Frulloni, L; Rigo, L; Rossi, F; Tasini, E; Vaona, B | 1 |
Birkenhäger, JC; Docter, R; Fauser, BC; Jacobs, ML; Loriaux, DL; Pache, TD; Weber, RF | 1 |
Alford, FP; Best, JD; Galvin, P; Pestell, RG; Ward, GM | 1 |
Behme, MT; Dupré, J; Grant, DR; Guan, J; Williamson, MP; Zhong, R | 1 |
Ebeling, P; Koivisto, VA; Seppälä, M; Stenman, UH | 1 |
Alzaid, A; Basu, A; Caumo, A; Cobelli, C; Dinneen, S; Rizza, RA | 1 |
Chase, J; Chen, W; Duleba, A; Perseghin, G; Price, TB; Rothman, DL; Shulman, GI; Shulman, RG | 1 |
McCarty, MF | 2 |
Bergman, RN; Mittelman, SD; Rebrin, K; Steil, GM | 1 |
Boivin, A; Deshaies, Y | 1 |
Alvarsson, M; Grill, V | 1 |
Graal, MB; Wolffenbuttel, BH | 1 |
Scheen, AJ | 1 |
Giacca, A; Kawamori, R; Lekas, M; Matsuhisa, M; Rodgers, CD; Shi, ZQ; Vranic, M; Wan, C | 1 |
Ahrén, B; Mulder, H; Myrsén, U; Scheurink, AJ; Simonsson, E; Sundler, F | 1 |
Ahrén, B; Holst, JJ; Larsson, H | 1 |
Atkinson, P; Behme, MT; Dupré, J; Guan, J; Zhong, R; Zucker, PF | 1 |
Ebeling, P; Koivisto, VA; Tuominen, JA; Vuorinen-Markkola, H | 1 |
Coleman, TG; Hall, JE; Montani, JP; Summers, RL; Woodward, LH | 1 |
Bergman, RN | 1 |
Baratti, D; Battezzati, A; Bozzetti, F; Luzi, L; Mazzaferro, V; Perseghin, G; Pulvirenti, A; Regalia, E; Terruzzi, I; Vergani, S | 1 |
Efendic, S; Ljungqvist, O; Nair, KS; Nygren, J; Thorell, A | 1 |
DeFronzo, RA; Haywood, JR; Koopmans, SJ; Mandarino, LJ; Ohman, L | 1 |
Esser, U; Matthews, DE; Petrides, AS | 1 |
Barg, Y; Gefel, D; Zimlichman, R | 1 |
Alford, FP; Arackal, R; Barton, J; Best, JD; Boston, RC; Walters, JM; Ward, GM | 1 |
Gerich, JE | 2 |
Bonner-Weir, S; Clark, J; Kubstrup, C; Levisetti, M; Pick, A; Polonsky, KS; Pugh, W | 1 |
Alford, FP; Beck-Nielsen, H; Henriksen, JE; Hew, LF; Rantzau, C; Vaag, A; Ward, GM | 1 |
Amini, SB; Caritis, SN; Catalano, PM; Kalhan, SC; Roman-Drago, NM; Smigaj, D | 1 |
Ahrén, B; Filipsson, K; Pacini, G; Scheurink, AJ | 1 |
Atkison, P; Behme, MT; Dupré, J; Guan, J; Hramiak, I; Zhong, R; Zucker, P | 1 |
Díez, J; Gil, MJ; González, A; Laviades, C; Monreal, I | 1 |
Cseh, K; Salamon, D; Salamon, F; Simon, K; Speer, G; Winkler, G | 1 |
Ahrén, B; Simonsson, E | 1 |
Bodkin, NL; Ortmeyer, HK | 1 |
Chang, SL; Cheng, JT; Chi, TC; Lin, JG; Liu, IM | 1 |
Goodyear, LJ; Hayashi, T; Hirshman, MF; Horton, ES; Ljungqvist, O; Nair, KS; Nygren, J; Thorell, A | 1 |
Brynes, A; Frost, G; Leeds, A | 1 |
Efendic, S; Ljungqvist, O; Nair, KS; Nygren, J; Soop, M; Thorell, A | 1 |
Hata, J; Idehara, C; Ii, S; Itakura, M; Moritani, M; Tomonari, S; Yamada, T; Yamaoka, T; Yano, M; Yoshimoto, K | 1 |
Bloomgarden, ZT | 1 |
Bohrer, A; Cryer, PE; Dagogo-Jack, S; Halban, PA; Powderly, WG; Sigmund, C; Tebas, P; Turk, J; Yarasheski, KE | 1 |
Juhl, CB; Lund, S; Nyholm, B; Orskov, L; Schmitz, O | 1 |
Bloom, SR; Edwards, CM | 1 |
Cravello, L; Ferrari, E; Fioravanti, M; Giacchero, R; Lovati, E; Pontiggia, B; Rondanelli, M; Solerte, SB; Stabile, M; Vignati, G | 1 |
Ahrén, B; Larsson, H | 2 |
Abbott, DH; Dumesic, DA; Eisner, JR; Nair, KS; Nielsen, MF; Rizza, RA | 1 |
Freeman, DJ; Leclerc, I; Rutter, GA | 1 |
Ikegami, H; Miki, T; Ogihara, T; Yamada, K; Yoneda, H | 1 |
Ban, N; Fujimoto, S; Hashimoto, H; Ihara, Y; Jomori, T; Kajikawa, M; Kubota, A; Kuroe, A; Miyawaki, K; Miyazaki, J; Niwa, H; Seino, Y; Tashiro, F; Tsuda, K; Yamada, Y; Yamashita, T; Yano, H | 1 |
Fölsch, UR; Gallwitz, B; Schmidt, WE; Siegel, EG | 1 |
Dirlewanger, M; Jequier, E; Paquot, N; Rey, V; Schneiter, PH; Tappy, L | 1 |
Ishida, T | 1 |
Bosch, F; Casellas, A; Devedjian, JC; George, M; Gros, L; Pelegrín, M; Pujol, A; Visa, J | 1 |
Mokuda, O; Sakamoto, Y | 1 |
Bruining, HA; Buscher, HC; Jacobs, ML; Ong, GL; van Goor, H; Weber, RF | 1 |
Battezzati, A; Caumo, A; Di Carlo, V; Luzi, L; Perseghin, G; Terruzzi, I; Zerbi, A | 1 |
Fritsche, A; Hardt, E; Häring, H; Schützenauer, S; Stefan, N; Stumvoll, M | 1 |
Ipp, E | 1 |
Bashmakov, Y; Brown, MS; Goldstein, JL; Hammer, RE; Matsuda, M; Shimomura, I | 1 |
Abitbol, C; Berkovitz, G; Eidson, M; Leal, D; Seeherunvong, T; Seeherunvong, W | 1 |
Cherrington, AD; Hsieh, PS; Moore, MC; Neal, DW | 1 |
Daimon, M; Igarashi, M; Kato, T; Manaka, H; Ohnuma, H; Sasaki, H; Yamatani, K | 1 |
Boden, G; Chen, X; Stein, TP | 1 |
Adrian, TE; Herrington, M; Kazakoff, K; Permert, J; Pour, PM | 1 |
Choi, CS; Kim, SK; Koh, JJ; Lee, HK; Lee, KU; Park, DJ; Park, KS; Shin, CS; Song, JH | 1 |
Alford, FP; Barton, J; Boston, RC; Walters, JM; Ward, GM | 1 |
Basu, A; Basu, R; Jensen, MD; Rizza, RA; Shah, P; Vella, A | 1 |
Breslow, JL; Chen, Y; Fillmore, JJ; Goldberg, IJ; Kako, Y; Kim, JK; Lutz, EP; Moore, IK; Pypaert, M; Shulman, GI; Velez-Carrasco, W; Yu, C | 1 |
Ihse, I; Lundquist, I; Nilsson, C; Zoucas, E | 1 |
Clark, SJ; Croos, P; Miell, J; Seed, PT; Shojaee-Moradie, F; Umpleby, AM; Wendon, JA | 1 |
Stubbs, RS; Wickremesekera, SK | 1 |
Astrup, A; Buemann, B; Juul Holst, J; Lysgård Madsen, J; Toubro, S; Verdich, C | 1 |
Ahrén, B; Holst, JJ; Johnson, O; Olsson, T; Rask, E; Seckl, J; Söderberg, S | 1 |
Hodate, K; Itoh, T; Kushibiki, S; Mori, Y; Shingu, H; Shinoda, M; Ueda, Y; Yokomizo, Y | 1 |
Bizeau, ME; Commerford, SR; Jampolis, A; McRae, H; Pagliassotti, MJ; Thresher, JS | 1 |
Barazzoni, R; Kiwanuka, E; Tessari, P | 1 |
Anderwald, C; Bernroider, E; Brehm, A; Krebs, M; Krssak, M; Meyerspeer, M; Nowotny, P; Roden, M; Roth, E; Waldhäusl, W | 1 |
Burcelin, R; Crivelli, V; Dacosta, A; Roy-Tirelli, A; Thorens, B | 1 |
Dirlewanger, M; Lefèbvre, PJ; Paquot, N; Scheen, AJ; Tappy, L | 1 |
Ahren, B; Cederquist, K; Forsberg, H; Holst, JJ; Johansson, A; Olsson, T; Seckl, JR | 1 |
Ericsson, UB; Groop, L; Hallengren, B; Lethagen, AL; Tuomi, T | 1 |
Donnelly, R; Gray, S; Idris, I; Patiag, D | 1 |
Born, J; Fehm, HL; Fruehwald-Schultes, B; Kern, W; Oltmanns, KM; Peters, A; Sopke, S; Toschek, B | 1 |
Kieffer, TJ; Lam, NT | 1 |
Ahrén, B; Holst, JJ; Reimer, MK | 1 |
Titov, VN | 1 |
Banerji, MA | 1 |
Boden, G; Cheung, P; Kresge, K; Mozzoli, M; Stein, TP | 1 |
Alazia, M; Gouin, F; Pontier, R | 1 |
Alberti, KG | 2 |
Alberti, KG; Nattrass, M | 1 |
Pfeifer, MA; Samols, E; Winkler, CF; Wolter, CF | 1 |
Courtney, JW; Duckworth, WC; Paulsen, EP | 1 |
Bennett, PH; Bennion, LJ; Savage, PJ | 1 |
Gourley, DR | 1 |
Kasuga, M; Kodama, S; Matsuo, M; Matsuo, T; Morishita, Y; Ninomiya, M; Sakurai, T; Seki, A | 1 |
Blizzard, RM; Huseman, C; Johanson, A; Varma, M | 1 |
Covinsky, JO; Hamburger, SC; Kelley, K | 1 |
Hudson, AJ; Tevaarwerk, GJ | 1 |
Felig, P; Soman, V | 1 |
Lind, T | 1 |
Belfiore, F; Iannello, S; Rabuazzo, AM | 1 |
Ratzmann, KP; Witt, S | 1 |
Ginsberg, HN | 1 |
Exton-Smith, AN; Heard, CR; Soerjodibroto, WS | 1 |
Altomonte, L; Bertoli, A; Ghirlanda, G; Greco, AV; Manna, R; Rebuzzi, AG | 1 |
Hülsmann, WC | 1 |
Felig, P; Sherwin, R | 1 |
Allsop, JR; Burke, JF; Wolfe, RR | 1 |
Drost, H; Gries, FA; Grüneklee, D; Voegtle-Boehringer, M | 1 |
Charbonnel, B; Guillon, J | 1 |
Goto, A; Kawamura, K; Kawanishi, K; Nishina, Y; Okada, S | 1 |
Olefsky, JM; Reaven, GM; Sperling, MA | 1 |
Eaton, RP | 1 |
Gaspard, U; Gerard, J; Lefebvre, PJ; Luyckx, AS | 1 |
Borth, F; Bruce, R; Crook, D; Devenport, M; Ghatei, M; Godsland, I; Stevenson, J; Whitehead, M; Wynn, V | 1 |
Fürnsinn, C; Hollenstein, U; Liener, K; Nowotny, P; Roden, M; Vierhapper, H; Waldhäusl, W | 1 |
Arslanian, S; Becker, DJ; Drash, AL; Ohki, Y | 1 |
Kobayashi, K; Miyakoshi, H; Miyamoto, I; Nagai, Y; Nishimura, Y; Noto, Y; Ohsawa, K | 1 |
Li, A; Wang, S; Xie, W | 1 |
Finegood, DT; Lewis, JT; Rajotte, RV; Tobin, BL; Tobin, BW | 1 |
Caiola, S; Giaccari, A; Leonetti, F; Lostia, O; Morviducci, L; Sbraccia, P; Tamburrano, G; Zorretta, D | 1 |
Christensen, SE; Flyvbjerg, A; Frystyk, J; Harris, AG; Ledet, T; Møller, N; Orskov, H | 1 |
D'Onofrio, F; Gambardella, A; Paolisso, G; Pizza, G; Sgambato, S; Tesauro, P; Varricchio, M | 1 |
Akimoto, R; Endres, D; Kolterman, O; Moossa, AR; Wahlstrom, HE | 1 |
Kolácný, I; Weber, P | 1 |
Barrow, RE; Fleming, RY; Herndon, DN; Jahoor, F; Rutan, RL; Wolfe, RR | 1 |
Funahashi, M; Koons, J; Winter, WE | 1 |
Shumak, S; Steiner, G; Zinman, B; Zuniga-Guarjardo, S | 1 |
Fukushima, H; Hamaguchi, T; Ichinose, K; Kishikawa, H; Shichiri, M; Shirotani, T; Uehara, M; Wada, S; Yamaguchi, K | 1 |
Frayn, KN; Galasko, CS; Henderson, AA; Little, RA | 1 |
DeFronzo, RA; Groop, LC; Petrides, AS; Riely, CA | 1 |
Eeftinck Schattenkerk, JK; Endert, E; Hommes, MJ; Romijn, JA; Sauerwein, HP | 1 |
Ferré, P | 1 |
Beylot, M; Laville, M; Mornex, R; Riou, JP | 1 |
Kühl, C | 1 |
Cheng, KN; Ford, GC; Halliday, D; Pacy, PJ | 1 |
Komatsu, M; Saito, S | 1 |
Lager, I | 1 |
Aerts, L; Holemans, K; Van Assche, FA | 1 |
Andrews, GC; de Boer, SF; Frölich, M; Jansz, HS; Koopmans, SJ; Krans, HM; Kreutter, DK; Maassen, JA; Radder, JK; van Mansfeld, AD | 1 |
Krans, HM; Nijs, HG; Poorthuis, BJ; Radder, JK | 1 |
Akimoto, R; Endres, D; Kolterman, O; Lavelle-Jones, M; Moossa, AR; Wahlstrom, HE | 1 |
Frey-Hewitt, B; Galbo, H; Haskell, W; Hollenbeck, CB; Kjaer, M; Reaven, GM | 1 |
Attvall, S; Fowelin, J; Lager, I; Smith, U; von Schenck, H | 1 |
Bengmark, S; Magnússon, J; Tranberg, KG | 1 |
Beard, JC; Bergman, RN; Kahn, SE; Klaff, LJ; Porte, D; Schwartz, MW; Taborsky, GJ | 1 |
Battezzati, A; Castoldi, R; Di Carlo, V; Facchini, F; Ferrari, G; Luzi, L; Pozza, G; Secchi, A; Spotti, D; Staudacher, C | 1 |
Cherrington, AD; Friedman, A; McGuinness, OP | 1 |
Bonner-Weir, S; Leahy, JL; Weir, GC | 1 |
Hanley, RM; Steiner, AL | 1 |
Gawler, DJ; Houslay, MD; Milligan, G; Wilson, A | 1 |
Elahi, D; Meneilly, GS; Minaker, KL; Rowe, JW; Sclater, AL | 1 |
Alvestrand, A; Efendic, S; Mujagic, M; Wajngot, A | 1 |
Boström, M; Goertz, G; Henriksson, J; Nie, Z; Wallberg-Henriksson, H | 1 |
Haymond, MW; Horber, F; Rodriguez, N; Schwenk, WF; Zimmerman, T | 1 |
Andersen, DK; Goldstein, JA; Kirwin, JD; Rademaker, EA; Seymour, NE; Trachtenberg, JE | 1 |
Bonora, E; Cacciatori, V; Cigolini, M; Corgnati, A; Moghetti, P; Muggeo, M; Querena, M; Zancanaro, C | 1 |
Beard, JC; Bergman, RN; Ding, HL; Kahn, SE; Porte, D; Schwartz, MW; Taborsky, GJ; Ward, WK | 1 |
Cantell, K; Koivisto, VA; Pelkonen, R | 1 |
Andersen, DK; Laster, MK; Pochettino, A; Rademaker, EA; Rosenberg, HE; Seymour, NE; Tanaka, Y; Turk, JB | 1 |
Banerji, MA; Lebovitz, HE | 1 |
Dobrescu, C; Lang, CH | 1 |
Lager, I; Smith, U | 1 |
Antoniello, S; Auletta, M; Cacciatore, L; Cavalcanti, E; La Rocca, S; Salvatore, F | 1 |
Iochida, LC; Matsumoto, M; Sasaki, H; Sekikawa, A; Tominaga, M | 1 |
Baudon, MA; Castano, L; Ferré, P; Girard, J; Ktorza, A; Maulard, P; Pénicaud, L | 1 |
Binder, C; Bolli, GB; Cherrington, AD; Cryer, PE; Gale, EA; Gerich, JE; Sherwin, RS | 1 |
Best, JD; Halter, JB; Pfeifer, MA; Porte, D; Ward, WK | 1 |
Cavalie, G; Lachkar, H; Mirouze, J; Monnier, L; Orsetti, A; Richard, JL; Rodier, M | 1 |
Adamson, U; Kollind, M; Lins, PE | 2 |
Amsterdam, JD; Maislin, G; Phillips, JL; Winokur, A | 1 |
Schmitz, O | 1 |
Berger, W; Keller, U; Müller, R | 1 |
Cabezas-Cerrato, J; De la Fuente, A; García López, JM; Gaudiero, GJ; Mato Mato, JA; Odriozola, A; Tomé, MA | 1 |
Peters, EJ; Prince, MJ; Shangraw, RE; Stuart, CA; Wolfe, RR | 1 |
Iversen, J; Tygstrup, N; Vilstrup, H | 1 |
Beck, B; Debry, G; Dollet, JM; Max, JP | 1 |
Boine, L; Bruno, A; Cassader, M; Cavallo-Perin, P; Lenti, G; Pagano, G | 1 |
Koh, CS; Lee, HK; Lee, KU; Min, HK | 1 |
Drake, S; Shankar, TP; Solomon, SS | 1 |
Bergamini, E; Masiello, P | 1 |
Helderman, JH; Imamura, T; Koffler, M; Santeusanio, F | 1 |
Bajorunas, DR; Brennan, MF; Dresler, CM; Fortner, JG; Horowitz, GD; Jeevanandam, M; McDermott, K | 1 |
Duckworth, WC; Fredi, JL; Himmelstein, S; Shankar, TP; Solomon, SS | 1 |
Möring, J; Müller, MJ; Seitz, HJ | 1 |
Petrides, AS; Strohmeyer, G | 1 |
Elahi, D; Meneilly, GS; Minaker, KL; Rowe, JW | 1 |
Doeden, B; Rizza, R | 1 |
Efendić, S; Karlander, S; Vranić, M | 1 |
Blickle, JF; Bockel, R; Doffoël, M; Schlienger, JL; Vetter, D | 1 |
Eriksson, UJ; Hellerström, C; Swenne, I | 1 |
Andersen, O; Hornnes, PJ; Kühl, C | 1 |
Hornnes, PJ | 2 |
Beard, JC; Benedetti, TJ; Halter, JB; Johnston, CL; Porte, D; Ward, WK | 1 |
Campisi, R; Carducci Artenisio, A; Consolo, F; Forte, F; Lettina, G; Perrone, G; Ragonese, F; Saitta, G | 1 |
Raskin, P | 1 |
Basílico, MZ; Chicco, A; Gutman, R; Lombardo, YB; Mocchiutti, N | 1 |
Costin, G; Kogut, MD | 1 |
DeFronzo, RA; Smith, JD | 1 |
Buzzelli, G; Cotrozzi, G; Gentilini, P; Matassi, L; Orioli, S; Relli, P; Simondi, P | 1 |
Fyhrqvist, F; Groop, L; Groop, PH; Melander, A; Tolppanen, EM; Tötterman, KJ; Wåhlin-Boll, E | 1 |
Bratusch-Marrain, P; Waldhäusl, W | 1 |
Alberti, KG; Beck-Nielsen, H; Hjøllund, E; Orskov, H; Schmitz, O | 1 |
Kahn, CR; Neville, DM; Roth, J | 1 |
Bates, RW; Garrison, MM; Goldfine, ID; Kahn, CR; Neville, DM; Roth, J | 1 |
Dash, RJ; Gupta, PR; Rastogi, GK; Sinha, MK; Wahi, PL | 1 |
Yen, SS | 1 |
Danforth, E; Sims, EA | 1 |
Mosin, VI | 1 |
Späth, G | 1 |
Milner, RD | 1 |
Andreani, D; Fallucca, F; Iavicoli, M; Menzinger, G; Tamburrano, G | 1 |
Forsham, PH; Grodsky, GM; Karam, JH | 1 |
Brill, SJ; Chabner, BA; Felig, P | 1 |
Jungers, P; Kleinknecht, D; Laudat, MH; Laudat, P; Strauch, G | 1 |
Glasgow, AM | 1 |
Jordan, PH; Kahil, ME; McIlhaney, GR | 1 |
Kuroda, K; Matsuyama, T; Shima, K | 1 |
Bubnova, MM; Kniazev, IuA | 1 |
99 review(s) available for glucagon and Insulin Resistance
Article | Year |
---|---|
Pathways of Glucagon Secretion and Trafficking in the Pancreatic Alpha Cell: Novel Pathways, Proteins, and Targets for Hyperglucagonemia.
Topics: Biomarkers; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Secreting Cells; Humans; Hyperglycemia; Insulin Resistance; Signal Transduction | 2021 |
Physiological significance of bistable circuit design in metabolic homeostasis: role of integrated insulin-glucagon signalling network.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Glucagon; Homeostasis; Humans; Insulin; Insulin Resistance; Signal Transduction | 2022 |
Type 3 Diabetes and Its Role Implications in Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Blood Glucose; Brain; Diabetes Complications; Diabetes Mellitus; Disease Susceptibility; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Signal Transduction | 2020 |
Glucose effectiveness: Lessons from studies on insulin-independent glucose clearance in mice.
Topics: Administration, Intravenous; Adult; Aged; Animals; Biological Transport; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Homeostasis; Humans; Incretins; Insulin; Insulin Resistance; Insulin Secretion; Male; Mice; Middle Aged | 2021 |
Glucose-lowering action through targeting islet dysfunction in type 2 diabetes: Focus on dipeptidyl peptidase-4 inhibition.
Topics: Asia, Eastern; Asian People; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glucagon; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Metformin | 2021 |
The role of glucagon in weight loss-mediated metabolic improvement: a systematic review and meta-analysis.
Topics: Bariatric Surgery; Blood Glucose; Diet, Reducing; Fasting; Glucagon; Humans; Insulin Resistance; Obesity; Observational Studies as Topic; Weight Loss | 2018 |
[Role of Paradoxical Hypersecretion of Glucagon in the Pathogenesis of Type 2 Diabetes Mellitus].
Topics: Diabetes Mellitus, Type 2; Glucagon; Humans; Insulin; Insulin Resistance | 2018 |
The Liver-α-Cell Axis and Type 2 Diabetes.
Topics: Amino Acids; Animals; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Secreting Cells; Glucose; Humans; Insulin; Insulin Resistance; Liver | 2019 |
Cell Autonomous Dysfunction and Insulin Resistance in Pancreatic α Cells.
Topics: Diabetes Mellitus, Type 2; Glucagon; Glucagon-Secreting Cells; Glucose; Humans; Insulin; Insulin Resistance; Liver | 2019 |
Type 2 diabetes and the evolving paradigm in glucose regulation.
Topics: Adipocytes; Appetite; Brain; Diabetes Mellitus, Type 2; Fasting; Fatty Acids, Nonesterified; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose; Humans; Insulin Resistance; Insulin-Secreting Cells; Kidney; Liver; Muscle, Skeletal; Obesity; Sodium-Glucose Transport Proteins | 2013 |
Metabolic phenotyping guidelines: assessing glucose homeostasis in rodent models.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Models, Animal; Fasting; Female; Glucagon; Glucose; Glucose Tolerance Test; Guidelines as Topic; Homeostasis; Humans; Insulin; Insulin Resistance; Male; Mice; Phenotype; Pregnancy; Pregnancy in Diabetics; Rats; Somatostatin | 2014 |
[New therapies for type 2 diabetes mellitus].
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Anti-Obesity Agents; Diabetes Mellitus, Type 2; Diacylglycerol O-Acyltransferase; Dipeptidyl Peptidase 4; Drug Therapy, Combination; Drugs, Investigational; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucokinase; Gluconeogenesis; Glucose; Humans; Hypoglycemic Agents; Incretins; Insulin Resistance; Insulin, Long-Acting; Molecular Targeted Therapy; Obesity; Phosphofructokinase-2; Sodium-Glucose Transport Proteins; Weight Loss | 2015 |
Physiological mechanisms of action of incretin and insulin in regulating skeletal muscle metabolism.
Topics: Blood Flow Velocity; Blood Glucose; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Homeostasis; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Insulin Resistance; Microcirculation; Muscle, Skeletal | 2014 |
How to fight obesity with antidiabetic drugs: targeting gut or kidney?
Topics: Anti-Obesity Agents; Bariatric Surgery; Biological Transport; Clinical Trials as Topic; Comorbidity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glucose; Glycosuria; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Kidney Tubules, Proximal; Microvilli; Multicenter Studies as Topic; Obesity; Peptides; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Venoms; Weight Loss | 2015 |
Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Topics: Anastomosis, Roux-en-Y; Blood Glucose; Body Mass Index; Denmark; Female; Follow-Up Studies; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin Resistance; Insulin-Secreting Cells; Male; Obesity, Morbid; Quality of Life; Treatment Outcome; Weight Loss | 2015 |
Contribution of the distal small intestine to metabolic improvement after bariatric/metabolic surgery: Lessons from ileal transposition surgery.
Topics: Animals; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Eating; Endotoxemia; Enteroendocrine Cells; Gastric Bypass; Gastrointestinal Microbiome; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Ileum; Insulin; Insulin Resistance; Insulin Secretion; Rats | 2016 |
An overview of incretin hormones.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Glucagon; Humans; Incretins; Insulin Resistance; Insulin-Secreting Cells | 2008 |
Growth factor control of pancreatic islet regeneration and function.
Topics: Cell Division; Cellular Senescence; Glucagon; Growth Substances; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Islets of Langerhans; Regeneration | 2009 |
Current and emerging therapies: an overview of incretin-based therapy in the management of type 2 diabetes.
Topics: Administration, Oral; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Incretins; Insulin Resistance; Middle Aged; Nurse Practitioners; Patient Selection; Primary Health Care | 2008 |
Clinical review: Is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency?
Topics: Arginine; Glucagon; Growth Hormone-Releasing Hormone; Guidelines as Topic; Human Growth Hormone; Humans; Insulin Resistance; Recombinant Proteins | 2009 |
Pathophysiology of type 2 diabetes: targeting islet cell dysfunction.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Disease Progression; Endocrine Cells; Genetic Predisposition to Disease; Global Health; Glucagon; Glucose; Humans; Incidence; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Risk Assessment | 2010 |
Pro-insulin, C peptide, glucagon, adiponectin, TNF alpha, AMPK: neglected players in type 2 diabetes mellitus.
Topics: Adipocytes; Adiponectin; AMP-Activated Protein Kinases; Biomarkers; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Tumor Necrosis Factor-alpha | 2010 |
Pathophysiology of prediabetes.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Glucagon; Glucose; Humans; Insulin Resistance; Insulin-Secreting Cells; Lipids; Liver; Prediabetic State; Risk Factors | 2011 |
Type 2 diabetes across generations: from pathophysiology to prevention and management.
Topics: Adipose Tissue; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diabetes, Gestational; Diabetic Retinopathy; Epigenesis, Genetic; Female; Fetal Development; Genetic Predisposition to Disease; Glucagon; Glucagon-Like Peptide 1; Homeostasis; Humans; Incretins; Insulin Resistance; Insulin-Secreting Cells; Life Style; Liver; Muscle, Skeletal; Myocardium; Obesity; Prediabetic State; Pregnancy | 2011 |
[Central insulin action and resistance in regulating diverse functions].
Topics: Appetite Regulation; Brain; Glucagon; Gluconeogenesis; Humans; Insulin; Insulin Resistance; Learning; Liver | 2011 |
[Glucagon and glucagon-like peptides the role in control glucose homeostasis. Part I].
Topics: Blood Glucose; Energy Metabolism; Glucagon; Glucagon-Like Peptide 1; Glucose; Homeostasis; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans | 2011 |
Minireview: The role of the autonomic nervous system in mediating the glucagon response to hypoglycemia.
Topics: Animals; Autoimmunity; Autonomic Nervous System; Central Nervous System; Diabetes Mellitus; Diabetes Mellitus, Type 1; Gene Expression Regulation; Glucagon; Glucose; Humans; Hypoglycemia; Insulin Resistance; Islets of Langerhans; Models, Biological; Peripheral Nervous System | 2012 |
Glucagon and cyclic AMP: time to turn the page?
Topics: Adipose Tissue; Biological Transport; Cyclic AMP; Female; Glucagon; Humans; Insulin; Insulin Resistance; Liver; Male; Myocardium; Phosphoenolpyruvate Carboxykinase (ATP); Pyruvate Kinase; Signal Transduction | 2012 |
Insulin sensitivity and secretion modifications after bariatric surgery.
Topics: Animals; Bariatric Surgery; Body Mass Index; Diabetes Mellitus, Type 2; Gastric Mucosa; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Humans; Incretins; Insulin Resistance; Insulin-Secreting Cells; Intestinal Mucosa; Obesity, Morbid | 2012 |
Insulin resistance in type 2 diabetic youth.
Topics: Adolescent; Body Mass Index; C-Peptide; Child; Diabetes Mellitus, Type 2; Exercise Tolerance; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Metformin; Obesity; Phenotype; Young Adult | 2012 |
The combination of insulin and GLP-1 analogues in the treatment of type 2 diabetes.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Treatment Outcome | 2012 |
Dysglycaemia in the critically ill - significance and management.
Topics: Analysis of Variance; Biomarkers; Blood Glucose; Critical Illness; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Risk Factors | 2013 |
Preclinical developments in type 2 diabetes.
Topics: Acetyl-CoA Carboxylase; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Fatty Acids, Nonesterified; Glucagon; Glucagon-Like Peptide 1; I-kappa B Kinase; Insulin Resistance; Peptide Fragments; Protein Precursors; Protein Serine-Threonine Kinases | 2002 |
Aging and insulin secretion.
Topics: Adult; Aged; Aged, 80 and over; Aging; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Intolerance; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Middle Aged; Nutrition Surveys; Peptide Fragments | 2003 |
Insulin sensitisation in the treatment of Type 2 diabetes.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adrenergic beta-3 Receptor Agonists; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Humans; Hydroxysteroid Dehydrogenases; Hypoglycemic Agents; Insulin; Insulin Resistance; Islets of Langerhans; Metformin; Peptide Fragments; Protein Precursors; Randomized Controlled Trials as Topic; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Thiazoles; Transcription Factors | 2003 |
[Analogs of glucagon-like peptide-1 (GLP-1): an old concept as a new treatment of patients with diabetes mellitus type 2].
Topics: Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Enzyme Inhibitors; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin Resistance; Peptide Fragments; Protein Precursors | 2004 |
Islet adaptation to insulin resistance: mechanisms and implications for intervention.
Topics: Adaptation, Physiological; Animals; Blood Glucose; Cholinergic Agonists; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Metformin; Peptide Fragments; Protein Precursors; Sulfonylurea Compounds | 2005 |
[Impaired hepatic glucose metabolism].
Topics: Glucagon; Glucose; Glucose Intolerance; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Insulin Resistance; Lipid Metabolism; Liver; Obesity; Postprandial Period | 2005 |
The incretins: a link between nutrients and well-being.
Topics: Animals; Autonomic Nervous System; Blood Glucose; Dietary Fiber; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Homeostasis; Humans; Insulin; Insulin Resistance; Insulin Secretion; Intestinal Mucosa; Inulin; Mice; Peptide Fragments; Protein Precursors; Receptors, Gastrointestinal Hormone; Receptors, Glucagon | 2005 |
Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.
Topics: Biomarkers; Blood Glucose; Body Mass Index; Caloric Restriction; Diabetes Mellitus, Type 2; Energy Metabolism; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin Resistance; Male; Obesity, Morbid; Peptide Fragments; Peptide Hormones; Prognosis; Protein Precursors; Treatment Outcome; Weight Loss | 2005 |
Dipeptidyl peptidase IV inhibitors and diabetes therapy.
Topics: Animals; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Enzyme Inhibitors; Glucagon; Glucose; Homeostasis; Humans; Incretins; Insulin; Insulin Resistance; Models, Biological | 2008 |
Abnormalities in glucose metabolism in patients with schizophrenia treated with atypical antipsychotic medications.
Topics: Animals; Antipsychotic Agents; Cannabinoid Receptor Modulators; Diabetes Mellitus; Ghrelin; Glucagon; Glucose Metabolism Disorders; Humans; Insulin; Insulin Resistance; Leptin; Schizophrenia | 2008 |
Metabolic effects of sulfonylurea drugs. A review.
Topics: Animals; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Insulin Secretion; Liver; Somatostatin; Sulfonylurea Compounds | 1983 |
New pharmacologic approaches to the treatment of diabetes.
Topics: Carbohydrate Metabolism; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucagon; Gluconeogenesis; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Pyrrolidines; Somatostatin; Sulfonylurea Compounds | 1984 |
Advances in endocrine pharmacotherapeutics. Part--III.
Topics: Adult; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Glucagon; Humans; Hyperparathyroidism; Hyperthyroidism; Hypoparathyroidism; Hypothyroidism; Insulin; Insulin Resistance; Osteomalacia; Pregnancy; Rickets; Somatostatin; Vitamin D | 1984 |
Alterations of maternal metabolism in normal and diabetic pregnancies: differences in insulin-dependent, non-insulin-dependent, and gestational diabetes.
Topics: Blood Glucose; C-Peptide; Child; Circadian Rhythm; Female; Glucagon; Humans; Hydrocortisone; Insulin; Insulin Resistance; Lipoproteins, HDL; Maternal-Fetal Exchange; Placenta; Postpartum Period; Pregnancy; Pregnancy in Diabetics; Prolactin; Time Factors; Triglycerides; Uterus | 1983 |
[Anomalies of glycoregulation in alcoholic cirrhosis of the liver].
Topics: Adipose Tissue; Blood Glucose; Carbohydrate Metabolism; Glucagon; Gluconeogenesis; Glucose Tolerance Test; Homeostasis; Humans; Insulin; Insulin Resistance; Insulin Secretion; Liver; Liver Cirrhosis, Alcoholic; Monocytes; Receptor, Insulin | 1984 |
The relationship between the hyperplastic pancreatic islet and insulin insensitivity in obesity.
Topics: Adipose Tissue; Alloxan; Animals; Glucagon; Glucose; Humans; Hyperplasia; Insulin; Insulin Resistance; Islets of Langerhans; Liver; Mice; Mice, Obese; Microscopy, Electron; Muscles; Obesity; Receptor, Insulin; Streptozocin | 1981 |
[Endocrine changes in hepatic cirrhosis].
Topics: Adrenal Cortex Hormones; Carbohydrate Metabolism; Endocrine Glands; Gastrins; Glucagon; Glucose Tolerance Test; Gonadal Steroid Hormones; Growth Hormone; Hormones; Humans; Insulin; Insulin Resistance; Liver Cirrhosis; Prolactin; Thyroid Hormones | 1981 |
Uremia and the liver. III. Uremia and hepatic metabolism of carbohydrates, lipids, and proteins.
Topics: Amino Acids; Animals; Carbohydrate Metabolism; Cholesterol; Glucagon; Gluconeogenesis; Glucose Tolerance Test; Humans; Insulin Resistance; Lipid Metabolism; Lipoproteins, VLDL; Liver; Liver Glycogen; Protein Biosynthesis; Proteins; Triglycerides; Urea; Uremia | 1981 |
[Maternal glucose tolerance along pregnancy (author's transl)].
Topics: Amino Acids; Energy Metabolism; Estrogens; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Liver; Maternal-Fetal Exchange; Placental Lactogen; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Progesterone; Receptor, Insulin | 1982 |
[Active chronic hepatitis and insulin resistance: possible role of glucagon, GH and free fatty acids].
Topics: Adult; Arginine; Carbohydrate Metabolism; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Tolerance Test; Growth Hormone; Hepatitis; Humans; Insulin; Insulin Resistance; Male; Middle Aged | 1981 |
Metabolic effects of insulin-like growth factor-I: a focus on insulin sensitivity.
Topics: Animals; Diabetes Mellitus; Glucagon; Growth Hormone; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Like Growth Factor I; Metabolism | 1995 |
[Factors with insulin-like effects: IGF-I and GLP-1].
Topics: Blood Glucose; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Pancreatic Hormones; Peptide Fragments; Peptides; Protein Precursors | 1995 |
Glucose metabolism and liver cirrhosis.
Topics: Catecholamines; Chronic Disease; Diabetes Mellitus, Type 2; Fatty Acids; Glucagon; Glucose; Humans; Hyperglycemia; Hyperinsulinism; Insulin Resistance; Insulin-Like Growth Factor I; Liver Cirrhosis; Nutrition Disorders | 1995 |
The genetics of non-insulin-dependent diabetes mellitus.
Topics: Amyloid; Animals; Base Sequence; Carrier Proteins; Chromosome Mapping; Cloning, Molecular; Diabetes Mellitus, Type 2; DNA, Mitochondrial; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Glucagon; Glucagon-Like Peptide 1; Glucokinase; Glucose Transporter Type 4; Glycogen Synthase; Humans; Insulin; Insulin Resistance; Islet Amyloid Polypeptide; Molecular Sequence Data; Monosaccharide Transport Proteins; Muscle Proteins; Neoplasm Proteins; Peptide Fragments; Protein Precursors; Receptor, Insulin; Selection, Genetic; Tumor Suppressor Proteins | 1995 |
[Insulin resistance: role in type 2 diabetes].
Topics: Diabetes Mellitus, Type 2; Fatty Acids; Glucagon; Glucose; Humans; Insulin Resistance; Liver; Muscle, Skeletal; Oxidation-Reduction | 1994 |
Hormonal responses and future treatment of non-insulin-dependent diabetes mellitus (NIDDM).
Topics: Animals; Diabetes Mellitus, Type 2; Glucagon; Humans; Insulin; Insulin Resistance; Insulin Secretion; Pancreatic Hormones; Prediabetic State; Somatostatin | 1993 |
New treatments for patients with type 2 diabetes mellitus.
Topics: Amyloid; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islet Amyloid Polypeptide; Peptide Fragments; Protein Precursors; Sulfonylurea Compounds | 1996 |
New concepts in extracellular signaling for insulin action: the single gateway hypothesis.
Topics: Biological Transport; Endothelium, Vascular; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Signal Transduction | 1997 |
Glucagon-like peptide-1 structure, function and potential use for NIDDM.
Topics: Diabetes Mellitus, Type 2; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Peptide Fragments; Protein Precursors; Receptors, Glucagon | 1997 |
Metabolic abnormalities in impaired glucose tolerance.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Glucagon; Glucose; Glucose Intolerance; Humans; Hyperglycemia; Insulin; Insulin Resistance; Middle Aged; Prevalence; Risk Factors; United States | 1997 |
[Physiopathological fundamentals of type 2 diabetes].
Topics: Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucagon; Gluconeogenesis; Humans; Insulin; Insulin Resistance; Obesity | 1999 |
Aspects of secretion and actions of amylin: interplay between amylin and other hormones.
Topics: Amyloid; Gastric Emptying; Glucagon; Hormones; Human Growth Hormone; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islet Amyloid Polypeptide; Satiety Response | 1999 |
Present and potential future use of gene therapy for the treatment of non-insulin dependent diabetes mellitus (Review).
Topics: Adult; Animals; Antigens, Neoplasm; Biomarkers, Tumor; Blood Glucose; Cell Transplantation; Diabetes Mellitus, Type 2; Gene Expression Regulation; Genes, Synthetic; Genetic Therapy; Genetic Vectors; Glucagon; Glucagon-Like Peptide 1; Glucokinase; Glucose Transporter Type 2; Homeodomain Proteins; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Lectins, C-Type; Mice; Middle Aged; Monosaccharide Transport Proteins; Muscle Contraction; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Pancreatitis-Associated Proteins; Peptide Fragments; Promoter Regions, Genetic; Protein Precursors; Proteins; Rats; Trans-Activators | 1999 |
[Hepatogenic diabetes--the current concepts of its pathophysiology and therapy].
Topics: Diabetes Mellitus; Diabetes Mellitus, Type 2; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Humans; Hypoglycemic Agents; Insulin Resistance; Liver; Liver Diseases; Peptide Fragments; Receptor, Insulin | 1999 |
[Insulin resistance and liver].
Topics: Animals; Diabetes Mellitus; Glucagon; Glucose; Glycogen; Humans; Insulin; Insulin Resistance; Liver | 2000 |
Impaired glucose tolerance: the irrepressible alpha-cell?
Topics: Female; Glucagon; Glucose Intolerance; Humans; Insulin Resistance; Islets of Langerhans | 2000 |
The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent.
Topics: Animals; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Administration Routes; Gastric Emptying; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Intestine, Small; Islets of Langerhans; Peptide Fragments; Protein Precursors; Rats; Receptors, Glucagon; Satiety Response; Signal Transduction | 2002 |
[Isoglycemic blood interval and mechanism of its regulation: facts and hypotheses (a literature review)].
Topics: Adipocytes; Animals; Blood Glucose; Fatty Acids, Unsaturated; Glucagon; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 4; Humans; Insulin; Insulin Resistance; Monocytes; Monosaccharide Transport Proteins; Muscle Proteins; Receptor, Insulin | 2001 |
Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".
Topics: Adolescent; Adult; Black People; Body Mass Index; C-Peptide; Child; Diabetes Mellitus, Type 2; Food; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Puberty | 2002 |
The role of insulin in hypertriglyceridemia.
Topics: Dietary Carbohydrates; Dietary Fats; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hyperinsulinism; Hyperlipidemias; Insulin; Insulin Resistance; Lipoproteins, VLDL; Liver; Triglycerides | 1975 |
Isolation and characterization of membrane drug receptors.
Topics: Animals; Drug Tolerance; gamma-Aminobutyric Acid; Glucagon; Glycine; Humans; Insulin; Insulin Resistance; Membranes; Morphine; Receptor, Insulin; Receptors, Adrenergic, beta; Receptors, Cell Surface; Receptors, Cholinergic; Receptors, Drug; Receptors, Opioid; Sodium; Substance-Related Disorders; Toxins, Biological | 1976 |
Metabolic changes in pregnancy relevant to diabetes mellitus.
Topics: Adult; Blood Glucose; Carbohydrate Metabolism; Female; Glucagon; Glucose Tolerance Test; Hemoglobin A; Humans; Insulin; Insulin Resistance; Pregnancy; Pregnancy in Diabetics; Proinsulin | 1979 |
Insulin resistance in obesity: a critical analysis at enzyme level. A review.
Topics: Adipose Tissue; Animals; Diabetes Mellitus; Glucagon; Gluconeogenesis; Humans; Hyperglycemia; Hyperinsulinism; Insulin Resistance; Lipolysis; Liver; Mice; Muscles; Obesity; Proteins; Rats | 1979 |
[Methods for the characterization of glucose turnover and the peripheral insulin resistance in human prediabetic conditions].
Topics: C-Peptide; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerol; Growth Hormone; Humans; Insulin Resistance; Liver; Prediabetic State; Tritium | 1979 |
[Diabetes mellitus secondary to liver diseases. A review (author's transl)].
Topics: Diabetes Mellitus; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Humans; Hypertension, Portal; Hypokalemia; Insulin; Insulin Resistance; Liver Cirrhosis; Pancreatic Diseases | 1975 |
[Insulin resistance and diabetic ketoacidosis].
Topics: Blood Glucose; Diabetic Ketoacidosis; Fatty Acids, Nonesterified; Glucagon; Humans; Hydrocortisone; Hypothermia; Insulin; Insulin Antibodies; Insulin Resistance; Ketone Bodies | 1976 |
Evolving role of glucagon in human diabetes mellitus.
Topics: Diabetes Mellitus; Glucagon; Glucose; Humans; Hyperglycemia; Insulin Antagonists; Insulin Resistance; Ketone Bodies; Liver | 1975 |
Octreotide and diabetes: theoretical and experimental aspects.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucagon; Growth Hormone; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Octreotide; Vascular Diseases | 1992 |
[Hyperthyroidism and glucose metabolism].
Topics: Blood Glucose; Clinical Trials as Topic; Glucagon; Gluconeogenesis; Hyperthyroidism; Insulin; Insulin Resistance | 1991 |
Aetiology of gestational diabetes.
Topics: Diabetes, Gestational; Female; Glucagon; Humans; Insulin; Insulin Resistance; Islets of Langerhans; Pregnancy | 1991 |
The insulin-antagonistic effect of the counterregulatory hormones.
Topics: Animals; Catecholamines; Diabetes Mellitus, Type 1; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Insulin Resistance; Reference Values; Stress, Physiological | 1991 |
Experimental reduction of B-cell mass: implications for the pathogenesis of diabetes.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Animals, Newborn; Arginine; Blood Glucose; Cyclic AMP; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Synergism; Glucagon; Glucose; Glucose Tolerance Test; Histocytochemistry; Humans; Immunologic Techniques; In Vitro Techniques; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Pancreatectomy; Rats; Rats, Inbred Strains | 1986 |
Insulin-antagonistic effects of counterregulatory hormones: clinical and mechanistic aspects.
Topics: Animals; Catecholamines; Diabetes Mellitus; Glucagon; Homeostasis; Hormones; Humans; Insulin Antagonists; Insulin Resistance | 1989 |
Glucose regulation in non-insulin-dependent diabetes mellitus. Interaction between pancreatic islets and the liver.
Topics: Arginine; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Fatty Acids, Nonesterified; Feedback; Glucagon; Gluconeogenesis; Glucose; Glycogen; Homeostasis; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Liver; Somatostatin; Sulfonylurea Compounds | 1985 |
Insulin-dependent diabetes mellitus: pathophysiology.
Topics: Autoimmune Diseases; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Diagnosis, Differential; Glucagon; Humans; Insulin; Insulin Resistance | 1986 |
[Disturbances of glucose metabolism and its regulation in hepatopathies].
Topics: Glucagon; Glucose; Humans; Hyperinsulinism; Hypoglycemia; Insulin; Insulin Resistance; Insulin Secretion; Liver; Liver Diseases | 1985 |
Is there an animal model for gestational diabetes?
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Gestational Age; Glucagon; Glucose; Hydrocortisone; Insulin; Insulin Resistance; Islets of Langerhans; Mice; Pregnancy; Pregnancy in Diabetics; Progesterone; Rats | 1985 |
Etiology and pathophysiology of gestational diabetes mellitus.
Topics: Alanine; Amino Acids; Blood Glucose; Dietary Proteins; Female; Glucagon; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin; Insulin Resistance; Insulin Secretion; Monocytes; Pregnancy; Pregnancy in Diabetics; Proinsulin; Receptor, Insulin; Triglycerides | 1985 |
On the decrease of glucose tolerance in pregnancy: studies of gastro-entero-pancreatic hormones and cortisol.
Topics: Blood Glucose; Female; Gastric Inhibitory Polypeptide; Gastrins; Gastrointestinal Hormones; Glucagon; Humans; Hydrocortisone; Insulin; Insulin Resistance; Insulin Secretion; Pancreatic Polypeptide; Pregnancy; Pregnancy in Diabetics | 1985 |
Islet-cell abnormalities in non-insulin-dependent diabetes mellitus.
Topics: Alanine; Arginine; Blood Glucose; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dietary Proteins; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans | 1985 |
Is glucose intolerance harmful for the uremic patient?
Topics: Amino Acids, Branched-Chain; Arteriosclerosis; Diabetes Mellitus; Diabetic Angiopathies; Glomerular Filtration Rate; Glucagon; Glucose; Glycated Hemoglobin; Humans; Hyperglycemia; Hyperinsulinism; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Lipoproteins, VLDL; Renal Dialysis; Uremia | 1985 |
Endocrine regulation of metabolic homeostasis during pregnancy.
Topics: Adipose Tissue; Amino Acids; Animals; Catecholamines; Endocrine Glands; Fatty Acids, Nonesterified; Female; Gastrointestinal Hormones; Glucagon; Glucocorticoids; Gluconeogenesis; Glucose; Growth Hormone; Homeostasis; Humans; Insulin; Insulin Resistance; Insulin Secretion; Lipid Metabolism; Maternal-Fetal Exchange; Metabolism; Muscles; Pancreas; Placental Hormones; Pregnancy | 1973 |
Role of insulin in obesity.
Topics: Adipose Tissue; Animals; Dietary Carbohydrates; Dietary Fats; Eating; Fatty Acids; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypothalamus; Insulin; Insulin Resistance; Insulin Secretion; Obesity | 1974 |
[Carbohydrate metabolism in liver diseases].
Topics: Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitus; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Tolerance Test; Growth Hormone; Hepatitis; Humans; Hyperglycemia; Hypoglycemia; Insulin; Insulin Resistance; Insulin Secretion; Liver; Liver Cirrhosis; Liver Diseases; Pancreatitis; Tolbutamide | 1974 |
[Intensive medicine. Acute threatening metabolic disorders in diabetes mellitus].
Topics: Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Coma; Diabetic Ketoacidosis; Diagnosis, Differential; Electrolytes; Emergencies; Glucagon; Glucose; Glycosuria; Humans; Hyperglycemia; Hypoglycemia; Infusions, Parenteral; Insulin; Insulin Resistance; Lactates; Mental Disorders; Neurologic Manifestations; Osmosis; Prognosis; Shock | 1972 |
Insulin secretion in human protein-calorie deficiency.
Topics: Blood Glucose; Chromium; Fatty Acids, Nonesterified; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Infant; Infant Nutrition Disorders; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Kwashiorkor; Nutrition Disorders; Potassium Deficiency; Protein-Energy Malnutrition; Secretory Rate | 1972 |
Insulin secretion in obesity: pseudodiabetes?
Topics: Age Factors; Animals; Diabetes Mellitus; Glucagon; Glucose; Humans; Hyperplasia; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans | 1968 |
83 trial(s) available for glucagon and Insulin Resistance
Article | Year |
---|---|
The sodium-glucose cotransporter 2 inhibitor ipragliflozin improves liver function and insulin resistance in Japanese patients with type 2 diabetes.
Topics: Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucosides; Humans; Insulin; Insulin Resistance; Japan; Liver; Male; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Time Factors; Treatment Outcome | 2022 |
Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Insulins; Islets of Langerhans; Treatment Outcome | 2022 |
Metformin Lowers Body Weight But Fails to Increase Insulin Sensitivity in Chronic Heart Failure Patients without Diabetes: a Randomized, Double-Blind, Placebo-Controlled Study.
Topics: Aged; Body Composition; Body Weight; Calorimetry, Indirect; Double-Blind Method; Female; Glucagon; Glycated Hemoglobin; Heart Failure; Humans; Insulin Resistance; Male; Metformin; Middle Aged; Mitochondria; Muscle, Skeletal; Oxygen Consumption; Stroke Volume | 2021 |
Exercise Increases Insulin Sensitivity and Skeletal Muscle AMPK Expression in Systemic Lupus Erythematosus: A Randomized Controlled Trial.
Topics: Adult; AMP-Activated Protein Kinases; Biopsy; Blood Glucose; Exercise; Female; Glucagon; Glucose Transporter Type 4; Humans; Insulin; Insulin Resistance; Lupus Erythematosus, Systemic; Male; Muscle, Skeletal; Phosphorylation; Signal Transduction | 2018 |
Alpha cell function interacts with diet to modulate prediabetes and Type 2 diabetes.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Diet, Mediterranean; Disease-Free Survival; Female; Glucagon; Glucagon-Secreting Cells; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged; Prediabetic State | 2018 |
Basal glucagon hypersecretion and response to oral glucose load in prediabetes and mild type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin Resistance; Male; Middle Aged; Prediabetic State; Severity of Illness Index; Young Adult | 2019 |
Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.
Topics: Adult; Blood Glucose; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Male; Obesity, Morbid; Pancreas; Peptide Fragments; Postprandial Period; Treatment Outcome | 2013 |
Comparison of vildagliptin and glimepiride: effects on glycaemic control, fat tolerance and inflammatory markers in people with type 2 diabetes.
Topics: Adamantane; Adiponectin; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dietary Fats; Double-Blind Method; Drug Therapy, Combination; Female; Glucagon; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipid Metabolism; Male; Metformin; Middle Aged; Nitriles; Proinsulin; Pyrrolidines; Sulfonylurea Compounds; Treatment Outcome; Triglycerides; Tumor Necrosis Factor-alpha; Vildagliptin | 2014 |
Impaired incretin secretion and pancreatic dysfunction with older age and diabetes.
Topics: Adiponectin; Adipose Tissue; Adult; Aged; Aging; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Down-Regulation; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Pancreas; Postprandial Period; Up-Regulation | 2014 |
Effect of a test meal on meal responses of satiation hormones and their association to insulin resistance in obese adolescents.
Topics: Adolescent; Body Mass Index; Child; Female; Gastrointestinal Hormones; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Islet Amyloid Polypeptide; Male; Meals; Metabolic Syndrome; Pediatric Obesity; Postprandial Period; Satiation | 2014 |
Saxagliptin improves glycemic control by modulating postprandial glucagon and C-peptide levels in Chinese patients with type 2 diabetes.
Topics: Adamantane; Asian People; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Fasting; Female; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Metformin; Middle Aged; Postprandial Period | 2014 |
Glucose counterregulation in advanced type 2 diabetes: effect of β-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; C-Peptide; Case-Control Studies; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged; Single-Blind Method | 2014 |
Imeglimin increases glucose-dependent insulin secretion and improves β-cell function in patients with type 2 diabetes.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucagon; Glucose Clamp Technique; Hepatobiliary Elimination; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Triazines | 2015 |
Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
Topics: Adiponectin; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Obesity; Treatment Outcome; Weight Loss | 2015 |
Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Limosilactobacillus reuteri; Male; Middle Aged; Obesity; Oxidative Stress; Pilot Projects; Probiotics; Prospective Studies; Protein Precursors | 2015 |
The structure of wheat bread influences the postprandial metabolic response in healthy men.
Topics: Bile Acids and Salts; Blood Glucose; Body Mass Index; Bread; Breath Tests; Carbon Dioxide; Cross-Over Studies; Gastric Inhibitory Polypeptide; Glucagon; Humans; Incretins; Insulin; Insulin Resistance; Male; Portion Size; Postprandial Period; Triticum; Young Adult | 2015 |
Effect of meal composition on postprandial glucagon-like peptide-1, insulin, glucagon, C-peptide, and glucose responses in overweight/obese subjects.
Topics: Adolescent; Adult; Aged; Appetite; Blood Glucose; Body Mass Index; C-Peptide; Cross-Over Studies; Exercise; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Male; Meals; Mental Recall; Middle Aged; Obesity; Overweight; Postprandial Period; Young Adult | 2017 |
Mechanisms of Action of Liraglutide in Patients With Type 2 Diabetes Treated With High-Dose Insulin.
Topics: Adipose Tissue; Adult; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Liraglutide; Magnetic Resonance Imaging; Male; Middle Aged | 2016 |
Mechanisms Regulating Insulin Response to Intragastric Glucose in Lean and Non-Diabetic Obese Subjects: A Randomized, Double-Blind, Parallel-Group Trial.
Topics: Adult; Blood Glucose; Body Mass Index; Body Weight; C-Peptide; Case-Control Studies; Diabetes Mellitus; Double-Blind Method; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Incretins; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Young Adult | 2016 |
Ghrelin Impairs Prandial Glucose Tolerance and Insulin Secretion in Healthy Humans Despite Increasing GLP-1.
Topics: Adult; Blood Glucose; Female; Gastric Inhibitory Polypeptide; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Male; Peptide YY; Postprandial Period; Young Adult | 2016 |
Exercise-Induced Secretion of FGF21 and Follistatin Are Blocked by Pancreatic Clamp and Impaired in Type 2 Diabetes.
Topics: Adult; Cross-Over Studies; Diabetes Mellitus, Type 2; Exercise; Fibroblast Growth Factors; Follistatin; Glucagon; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Male; Pancreas; Young Adult | 2016 |
Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Blood Glucose; Calorimetry, Indirect; Creatinine; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme Inhibitors; Glucagon; Glucosides; Humans; Insulin; Insulin Resistance; Ketones; Lipid Metabolism; Middle Aged; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Young Adult | 2016 |
Ghrelin, leptin, and glycemic control after sleeve gastrectomy versus Roux-en-Y gastric bypass-results of a randomized clinical trial.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Female; Gastrectomy; Gastric Bypass; Ghrelin; Glucagon; Glycated Hemoglobin; Homeostasis; Humans; Insulin Resistance; Laparoscopy; Leptin; Male; Middle Aged; Obesity, Morbid; Operative Time; Prospective Studies; Weight Loss; Young Adult | 2017 |
Third Exposure to a Reduced Carbohydrate Meal Lowers Evening Postprandial Insulin and GIP Responses and HOMA-IR Estimate of Insulin Resistance.
Topics: 3-Hydroxybutyric Acid; Aged; Blood Glucose; Dietary Carbohydrates; Energy Intake; Energy Metabolism; Fatty Acids, Nonesterified; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Homeostasis; Humans; Insulin; Insulin Resistance; Middle Aged; Postprandial Period; Sedentary Behavior | 2016 |
Effects of gemigliptin, a dipeptidyl peptidase-4 inhibitor, on lipid metabolism and endotoxemia after a high-fat meal in patients with type 2 diabetes.
Topics: Adiponectin; Adult; Aged; Apolipoprotein B-100; Apolipoprotein B-48; Blood Glucose; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Cytokines; Diabetes Mellitus, Type 2; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Endotoxemia; Endotoxins; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Interleukin-6; Lipid Metabolism; Male; Middle Aged; Piperidones; Postprandial Period; Pyrimidines; RNA, Messenger; Subcutaneous Fat, Abdominal; Transcriptome; Triglycerides; Tumor Necrosis Factor-alpha | 2017 |
Effect of exenatide on postprandial glucose fluxes, lipolysis, and ß-cell function in non-diabetic, morbidly obese patients.
Topics: Adipose Tissue; Adult; Blood Glucose; Exenatide; Fasting; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Lipolysis; Liver; Male; Middle Aged; Obesity, Morbid; Peptides; Postprandial Period; Venoms | 2017 |
KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Infusion Pumps; Insulin; Insulin Resistance; Ion Channel Gating; KATP Channels; Male; Middle Aged; Sulfonylurea Compounds | 2009 |
Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.
Topics: Adult; Aged; Biomarkers; Body Composition; C-Peptide; Calorimetry, Indirect; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet; Dinoprost; Double-Blind Method; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Fatty Acids, Omega-3; Female; Glucagon; Glucose Clamp Technique; Humans; Infusions, Intravenous; Insulin; Insulin Resistance; Isoprostanes; Male; Middle Aged; Oxidative Stress | 2009 |
The impact of exercise training compared to caloric restriction on hepatic and peripheral insulin resistance in obesity.
Topics: Aged; Aged, 80 and over; Body Weight; Caloric Restriction; Exercise; Gas Chromatography-Mass Spectrometry; Glucagon; Humans; Insulin; Insulin Resistance; Liver; Middle Aged; Obesity; Overweight; Patient Selection; Weight Loss | 2009 |
Early improvement in glycemic control after bariatric surgery and its relationships with insulin, GLP-1, and glucagon secretion in type 2 diabetic patients.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Prospective Studies; Treatment Outcome; Weight Loss | 2011 |
Acute peripheral metabolic effects of intraarterial leg infusion of somatostatin in healthy young men.
Topics: Adult; Biopsy; Blood Glucose; C-Peptide; Gene Expression; Glucagon; Glucose Clamp Technique; GTPase-Activating Proteins; Human Growth Hormone; Humans; Hyperinsulinism; Infusions, Intra-Arterial; Insulin Resistance; Insulin-Like Growth Factor I; Leg; Lipids; Male; Muscle, Skeletal; Somatostatin; STAT5 Transcription Factor; Suppressor of Cytokine Signaling Proteins; Young Adult | 2011 |
Effects of dietary protein on lipid metabolism in high fructose fed humans.
Topics: Blood Glucose; Calorimetry, Indirect; Cross-Over Studies; Diet; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Energy Metabolism; Fatty Acids, Nonesterified; Fructose; Glucagon; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Male; Postprandial Period; Triglycerides; Young Adult | 2012 |
Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.
Topics: Adult; Blood Glucose; C-Peptide; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Humans; Incretins; Infusions, Intravenous; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Kinetics; Male; Severity of Illness Index; Young Adult | 2012 |
Metabolic effects of short-term GLP-1 treatment in insulin resistant heart failure patients.
Topics: Blood Glucose; Calorimetry, Indirect; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Fatty Acids, Nonesterified; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Glucose Tolerance Test; Heart Failure; Humans; Insulin; Insulin Resistance; Male; Middle Aged | 2012 |
Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
Topics: Adult; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hyperglycemia; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged; Obesity; Obesity, Morbid; Postprandial Period; Time Factors | 2012 |
Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin resistance in type 2 diabetic patients.
Topics: Blood Glucose; C-Peptide; C-Reactive Protein; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Exercise; Fasting; Female; Glucagon; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Insulin-Secreting Cells; Italy; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2012 |
The effect of a bile acid sequestrant on glucose metabolism in subjects with type 2 diabetes.
Topics: Allylamine; Anticholesteremic Agents; Blood Glucose; C-Peptide; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Postprandial Period | 2013 |
Fibroblast growth factor 21 mediates specific glucagon actions.
Topics: Adult; Animals; Anti-Obesity Agents; Cells, Cultured; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibroblast Growth Factors; Glucagon; HEK293 Cells; Hepatocytes; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Mice; Mice, Knockout; Mice, Mutant Strains; Molecular Targeted Therapy; Obesity; Peptides; Rats; Receptors, Glucagon; Recombinant Proteins | 2013 |
Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fatty Acids, Nonesterified; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Obesity; Peptide Fragments; Protein Precursors | 2002 |
Preferential stimulation of abdominal subcutaneous lipolysis after prednisolone exposure in humans.
Topics: Abdomen; Adipose Tissue; Adult; Blood Glucose; C-Peptide; Calorimetry, Indirect; Cross-Over Studies; Double-Blind Method; Energy Metabolism; Fasting; Fatty Acids, Nonesterified; Femur; Glucagon; Glycerol; Human Growth Hormone; Humans; Insulin; Insulin Resistance; Lipolysis; Male; Microdialysis; Placebos; Prednisolone | 2002 |
Effects of 1-mo bolus subcutaneous administration of exendin-4 in type 2 diabetes.
Topics: Aged; Blood Glucose; Body Composition; C-Peptide; Diabetes Mellitus, Type 2; Exenatide; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Insulin Resistance; Islets of Langerhans; Male; Middle Aged; Peptides; Venoms | 2003 |
Insulin secretion and cellular glucose metabolism after prolonged low-grade intralipid infusion in young men.
Topics: Adult; Area Under Curve; Blood Glucose; C-Peptide; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male; Oxidation-Reduction | 2003 |
Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Analysis of Variance; Blood Glucose; Contraceptive Agents; Cyproterone Acetate; Drug Combinations; Estradiol; Female; Glucagon; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Polycystic Ovary Syndrome | 2004 |
One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.
Topics: Circadian Rhythm; Cross-Over Studies; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Female; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glucose; Hormones; Humans; Hypoglycemic Agents; Insulin Resistance; Islets of Langerhans; Liraglutide; Male; Middle Aged | 2004 |
Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of beta-cells.
Topics: Adipose Tissue; Adult; Alanine; Anthropometry; Blood Glucose; Body Composition; Body Mass Index; C-Peptide; Feedback; Glucagon; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Triglycerides | 2004 |
Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men.
Topics: Adult; Blood Glucose; Cross-Over Studies; Double-Blind Method; Drinking; Glomerular Filtration Rate; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Kidney Tubules, Proximal; Male; Natriuresis; Obesity; Peptide Fragments; Protein Precursors; Protons; Renin; Renin-Angiotensin System; Sodium; Thirst; Urine | 2004 |
Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Blood Glucose; Body Composition; Bone Density; C-Peptide; Cyclopropanes; Drug Therapy, Combination; Female; Glucagon; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Insulin; Insulin Resistance; Lipids; Lipoproteins; Male; Nevirapine; Oxazines; Pilot Projects; RNA, Viral; Viral Load | 2004 |
Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia.
Topics: Adult; Blood Glucose; C-Peptide; Cross-Over Studies; Exenatide; Fatty Acids, Nonesterified; Glucagon; Humans; Hydrocortisone; Hypoglycemia; Infusions, Intravenous; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Peptides; Venoms | 2004 |
Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome.
Topics: Adolescent; Blood Glucose; Body Composition; Bone Density; Case-Control Studies; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Estradiol; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Lipids; Turner Syndrome | 2005 |
Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1beta and -1alpha mutations.
Topics: Adult; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Clamp Technique; Hepatocyte Nuclear Factor 1-alpha; Hepatocyte Nuclear Factor 1-beta; Humans; Insulin; Insulin Resistance; Male; Mutation | 2006 |
Metabolic effects of parenteral nutrition enriched with n-3 polyunsaturated fatty acids in critically ill patients.
Topics: Adult; Aged; Blood Glucose; Critical Care; Critical Illness; Energy Metabolism; Fat Emulsions, Intravenous; Fatty Acids, Omega-3; Female; Food, Fortified; Glucagon; Gluconeogenesis; Humans; Hydrocortisone; Insulin Resistance; Intensive Care Units; Lipid Metabolism; Liver; Male; Middle Aged; Parenteral Nutrition, Total | 2006 |
Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes.
Topics: Adiponectin; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose Tolerance Test; Glycated Hemoglobin; Glycolysis; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Lactates; Male; Middle Aged; Pioglitazone; Thiazolidinediones | 2007 |
Insulin counter-regulatory factors, fibrinogen and C-reactive protein during olanzapine administration: effects of the antidiabetic metformin.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; C-Reactive Protein; Double-Blind Method; Female; Fibrinogen; Glucagon; Human Growth Hormone; Humans; Hydrocortisone; Hypoglycemic Agents; Insulin; Insulin Resistance; Leptin; Male; Metabolic Syndrome; Metformin; Middle Aged; Olanzapine; Schizophrenia; Sex Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |
Effects of a 3-day fast on regional lipid and glucose metabolism in human skeletal muscle and adipose tissue.
Topics: Adipose Tissue; Adult; Arm; Calorimetry, Indirect; Fasting; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerol; Growth Hormone; Humans; Hydrocortisone; Hypoglycemic Agents; Insulin; Insulin Resistance; Isotope Labeling; Leg; Lipid Metabolism; Lipolysis; Male; Microdialysis; Muscle, Skeletal; Palmitates; Subcutaneous Fat; Subcutaneous Fat, Abdominal; Weight Loss | 2007 |
Weight loss therapy improves pancreatic endocrine function in obese older adults.
Topics: Aged; Aging; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Diet, Reducing; Exercise; Female; Glucagon; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Male; Obesity; Risk Factors; Weight Loss | 2008 |
[The somatostatin infusion test for the evaluation of glucose utilization in bezafibrate medication].
Topics: Adult; Bezafibrate; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Humans; Insulin; Insulin Resistance; Somatostatin; Time Factors | 1984 |
Alcohol-potentiated reactive hypoglycaemia depends on the nature of the carbohydrate ingested at the same time.
Topics: Adult; Alcohol Drinking; Alcoholic Beverages; Blood Glucose; Dietary Carbohydrates; Drug Synergism; Ethanol; Glucagon; Humans; Hypoglycemia; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Social Behavior; Starch; Sucrose | 1984 |
Effects of potassium supplementation on insulin binding and insulin action in human obesity: protein-modified fast and refeeding.
Topics: Adult; Blood Glucose; Combined Modality Therapy; Dietary Proteins; Fasting; Female; Glucagon; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Monocytes; Obesity; Potassium; Potassium Chloride; Receptor, Insulin | 1984 |
Glycemic response to stress is altered in euglycemic Pima Indians.
Topics: Adolescent; Adult; Blood Glucose; Catecholamines; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Tolerance Test; Humans; Hydrocortisone; Indians, North American; Insulin; Insulin Resistance; Male; Mathematics; Obesity; Prevalence; Radioimmunoassay; Risk Factors; Software; Stress, Psychological; White People | 1994 |
Regulation of glucose homeostasis in humans with denervated livers.
Topics: Adult; Biomarkers; Blood Glucose; C-Peptide; Central Nervous System; Denervation; Glucagon; Glucose Clamp Technique; Growth Hormone; Homeostasis; Humans; Hydrocortisone; Hyperglycemia; Hyperinsulinism; Hypoglycemia; Insulin; Insulin Resistance; Liver; Liver Transplantation; Middle Aged; Models, Biological; Somatostatin; Time Factors | 1997 |
The effect of norepinephrine on insulin secretion and glucose effectiveness in non-insulin-dependent diabetes.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Catecholamines; Computer Simulation; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Models, Biological; Neurotransmitter Agents; Norepinephrine; Time Factors | 1997 |
The effect of oral terbutaline on maternal glucose metabolism and energy expenditure in pregnancy.
Topics: Adrenergic beta-Agonists; Adult; Blood Glucose; Calorimetry, Indirect; Energy Metabolism; Female; Gestational Age; Glucagon; Glucose; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Lactic Acid; Liver; Pregnancy; Terbutaline; Tocolytic Agents | 1998 |
Preoperative oral carbohydrate administration reduces postoperative insulin resistance.
Topics: Adolescent; Adult; Aged; Beverages; Blood Glucose; Carbohydrates; Fasting; Female; Glucagon; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Kinetics; Male; Middle Aged; Postoperative Complications; Preoperative Care | 1998 |
Effect of hemipancreatectomy and of pancreatic diversion on the tolerance to a glucose load in humans.
Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Feedback; Female; Glucagon; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hydrocortisone; Hyperglycemia; Immunosuppression Therapy; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Pancreas Transplantation; Pancreatectomy | 2000 |
A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glucose Clamp Technique; Humans; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Peptide Fragments; Protein Precursors; Reproducibility of Results | 2000 |
Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus.
Topics: Aged; Blood Glucose; Deuterium; Diabetes Mellitus, Type 2; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose; Glycolysis; Human Growth Hormone; Humans; Hydrocortisone; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Ketone Bodies; Male; Middle Aged; Tritium | 2001 |
Physiologic modeling of the intravenous glucose tolerance test in type 2 diabetes: a new approach to the insulin compartment.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Infusions, Intravenous; Insulin; Insulin Resistance; Kinetics; Male; Middle Aged; Models, Biological | 2001 |
Systemic and regional free fatty acid metabolism in type 2 diabetes.
Topics: Abdomen; Adipose Tissue; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Hormones; Human Growth Hormone; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipolysis; Male; Middle Aged; Obesity; Palmitates; Protein Synthesis Inhibitors; Somatostatin; Tritium | 2001 |
Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men.
Topics: Adult; Biomarkers; Blood Glucose; Blood Pressure; Body Weight; Eating; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Peptide Fragments; Postprandial Period; Protein Precursors; Regression Analysis | 2001 |
Mechanism of amino acid-induced skeletal muscle insulin resistance in humans.
Topics: Adenosine Diphosphate; Adult; Amino Acids; Blood Glucose; Deuterium; Epinephrine; Fasting; Glucagon; Glucose Clamp Technique; Glucose-6-Phosphate; Glycogen; Human Growth Hormone; Humans; Hydrocortisone; Hydrogen-Ion Concentration; Insulin; Insulin Resistance; Kinetics; Magnetic Resonance Spectroscopy; Male; Muscle, Skeletal; Phosphates; Phosphocreatine; Phosphorylation; Somatostatin | 2002 |
Short-term treatment with metformin decreases serum leptin concentration without affecting body weight and body fat content in normal-weight healthy men.
Topics: Adipose Tissue; Adult; Blood Pressure; Body Weight; C-Peptide; Diabetes Mellitus; Glucagon; Humans; Hydrocortisone; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Leptin; Male; Metformin; Obesity; Reference Values | 2002 |
FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.
Topics: Adult; Blood Glucose; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose; Glucose Clamp Technique; Glycogen; Humans; Hydrocortisone; Infusions, Intravenous; Insulin; Insulin Resistance; Liver; Male; Reference Values; Somatostatin | 2002 |
Danazol induces resistance to both insulin and glucagon in young women.
Topics: Adult; Blood Glucose; C-Peptide; Cholesterol; Danazol; Endometriosis; Female; Glucagon; Humans; Insulin; Insulin Resistance; Models, Biological | 1992 |
Daily magnesium supplements improve glucose handling in elderly subjects.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Blood Viscosity; Body Mass Index; C-Peptide; Double-Blind Method; Erythrocytes; Female; Glucagon; Homeostasis; Humans; Insulin; Insulin Resistance; Lactates; Magnesium; Male; Pyruvates | 1992 |
Effect of recombinant human growth hormone on catabolic hormones and free fatty acids following thermal injury.
Topics: Burns; Catecholamines; Child; Double-Blind Method; Energy Metabolism; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Heart Rate; Humans; Hydrocortisone; Injections, Intramuscular; Injury Severity Score; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Respiration; Skin Transplantation; Wound Healing | 1992 |
Dose-response relationships for the effects of insulin on glucose and fat metabolism in injured patients and control subjects.
Topics: Adolescent; Adult; Basal Metabolism; Blood Flow Velocity; Blood Glucose; Dose-Response Relationship, Drug; Epinephrine; Female; Forearm; Fractures, Bone; Glucagon; Glucose Clamp Technique; Humans; Hydrocortisone; Insulin; Insulin Resistance; Lipid Metabolism; Male; Oxidation-Reduction | 1991 |
Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients.
Topics: Adult; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glycated Hemoglobin; Humans; Insulin; Insulin Infusion Systems; Insulin Resistance; Kidney Failure, Chronic; Kidney Transplantation; Male; Pancreas Transplantation; Reference Values | 1990 |
Impairment of noninsulin-mediated glucose disposal in the elderly.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Animals; Blood Glucose; Fasting; Glucagon; Glucose; Humans; Hyperglycemia; Infusions, Intravenous; Insulin; Insulin Resistance; Middle Aged; Somatostatin | 1989 |
[Comparison of biosynthetic human insulin and purified pork insulin. Studies in insulin-resistant obese patients using the insulin suppression test].
Topics: Adult; Aged; Animals; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Insulin, Regular, Pork; Male; Middle Aged; Obesity; Recombinant Proteins; Somatostatin; Swine | 1986 |
Insulin resistance following nocturnal hypoglycaemia in insulin-dependent diabetes mellitus.
Topics: Adult; Circadian Rhythm; Diabetes Mellitus, Type 1; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Insulin; Insulin Resistance; Male; Somatostatin | 1987 |
Insulin resistance in Graves' disease: a quantitative in-vivo evaluation.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Graves Disease; Humans; Insulin; Insulin Resistance; Insulin Secretion; Liver; Male; Middle Aged | 1988 |
Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.
Topics: Aged; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Erythrocytes; Female; Gastric Inhibitory Polypeptide; Glipizide; Glucagon; Glyburide; Glycosuria; Humans; Insulin; Insulin Resistance; Kinetics; Male; Middle Aged; Random Allocation; Sulfonylurea Compounds | 1985 |
Insulin, free fatty acids, and glucose response to intravenous glucagon following myocardial infarction.
Topics: Acute Disease; Adult; Blood Glucose; Clinical Trials as Topic; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Myocardial Infarction; Secretory Rate | 1974 |
512 other study(ies) available for glucagon and Insulin Resistance
Article | Year |
---|---|
Response to Letter to the Editor from Roy et al: "Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function".
Topics: Glucagon; Glucose Tolerance Test; Humans; Insulin Resistance; Obesity | 2022 |
Letter to the Editor From Roy et al: "Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-cell Function".
Topics: Glucagon; Glucose Tolerance Test; Humans; Insulin Resistance; Obesity | 2022 |
Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Pancreatitis, Chronic; Peptide YY | 2022 |
Timing of Meals and Exercise Affects Hormonal Control of Glucoregulation, Insulin Resistance, Substrate Metabolism, and Gastrointestinal Hormones, but Has Little Effect on Appetite in Postmenopausal Women.
Topics: Aged; Aged, 80 and over; Appetite; Cholecystokinin; Eating; Exercise; Feeding Behavior; Female; Gastrointestinal Hormones; Ghrelin; Glucagon; Humans; Hunger; Insulin Resistance; Intestines; Middle Aged; Postmenopause; Satiation | 2021 |
Pancreatic cancer-associated diabetes mellitus is characterized by reduced β-cell secretory capacity, rather than insulin resistance.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Pancreatic Neoplasms | 2022 |
Hyperglucagonemia in Pediatric Adiposity Associates With Cardiometabolic Risk Factors but Not Hyperglycemia.
Topics: Adiposity; Adolescent; Blood Glucose; Body Mass Index; Cardiometabolic Risk Factors; Cardiovascular Diseases; Child; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Glucagon; Glucose; Humans; Hyperglycemia; Insulin; Insulin Resistance; Overweight; Pediatric Obesity; Risk Factors; Young Adult | 2022 |
The alpha-7 nicotinic acetylcholine receptor agonist GTS-21 engages the glucagon-like peptide-1 incretin hormone axis to lower levels of blood glucose in db/db mice.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Resistance; Male; Mice; Mice, Knockout; Nicotinic Agonists; Pyridines; Sitagliptin Phosphate; Tyrosine | 2022 |
A Study of Correlation of Glucagon-Insulin Ratio with Hba1c in Diabetic Patients in a Tertiary Care Hospital.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucagon; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Middle Aged; Prospective Studies; Tertiary Care Centers | 2022 |
2'-O-Methylperlatolic Acid Enhances Insulin-Regulated Blood Glucose-Lowering Effect through Insulin Receptor Signaling Pathway.
Topics: Animals; Benzoates; Blood Glucose; Depsides; Diabetes Mellitus, Experimental; Glucagon; Glucose; Insulin; Insulin Resistance; Mice; Proto-Oncogene Proteins c-akt; Receptor, Insulin; Salicylates; Signal Transduction; Streptozocin | 2022 |
Incretin Response to Mixed Meal Challenge in Active Cushing's Disease and after Pasireotide Therapy.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Incretins; Insulin; Insulin Resistance; Meals; Pituitary ACTH Hypersecretion; Somatostatin | 2022 |
Reduced insulin signaling and high glucagon in early insulin resistance impaired fast-fed regulation of renal gluconeogenesis via insulin receptor substrate.
Topics: Glucagon; Gluconeogenesis; Humans; Insulin; Insulin Resistance; Kidney; Liver; Phosphoenolpyruvate Carboxykinase (ATP); Receptor, Insulin; RNA, Messenger | 2022 |
The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Glucose Intolerance; Humans; Insulin; Insulin Resistance; Kinetics; Male; Prediabetic State; Receptor, Melatonin, MT2 | 2022 |
Endocrine-metabolic adaptations in Dorper ewes: comparison between single and twin pregnancies during gestation, parturition, and postpartum.
Topics: Animals; Blood Glucose; Female; Glucagon; Hydrocortisone; Insulin; Insulin Resistance; Parturition; Postpartum Period; Pregnancy; Sheep; Sheep Diseases; Thyroid Hormones | 2022 |
Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease.
Topics: Adolescent; Child; Glucagon; Glucose; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Non-alcoholic Fatty Liver Disease; Obesity; Triglycerides; Uric Acid | 2022 |
The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model.
Topics: Adiponectin; Animals; Anti-Inflammatory Agents; Arachidonic Acids; Cytokines; Diabetes Mellitus, Type 2; Fatty Acids; Fatty Acids, Monounsaturated; Fatty Acids, Nonesterified; Glucagon; Glucose; Inflammation; Insulin; Insulin Resistance; Lipoprotein Lipase; Oleic Acid; Prediabetic State; Rats | 2022 |
Lipid droplet accumulation in β cells in patients with type 2 diabetes is associated with insulin resistance, hyperglycemia and β cell dysfunction involving decreased insulin granules.
Topics: Blood Glucose; Boron Compounds; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Insulin; Insulin Resistance; Lipid Droplets | 2022 |
Surfactin Mitigates a High-Fat Diet and Streptozotocin-Induced Type 2 Diabetes through Improving Pancreatic Dysfunction and Inhibiting Inflammatory Response.
Topics: Animals; Blood Glucose; Claudin-1; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucagon; Glucose; Inflammation; Insulin Resistance; Mice; Occludin; Pancreas; Pancreatic Hormones; Phosphatidylinositol 3-Kinases; Phosphatidylinositols; Proto-Oncogene Proteins c-akt; Streptozocin | 2022 |
Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cell Cycle Proteins; Cyclic AMP Response Element-Binding Protein; Diabetes Mellitus, Type 2; Gene Expression; Glucagon; Gluconeogenesis; Glucose; Hepatocytes; Homeostasis; Hyperglycemia; Insulin; Insulin Resistance; Liver; Mice; RNA-Binding Proteins; src-Family Kinases; Transcription Factors | 2022 |
Predictors of acarbose therapeutic efficacy in newly diagnosed type 2 diabetes mellitus patients in China.
Topics: Acarbose; Blood Glucose; China; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Insulins | 2022 |
Chronic physiologic hyperglycemia impairs insulin-mediated suppression of plasma glucagon concentration in healthy humans.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Glucagon; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Insulin Resistance | 2023 |
Hypoglycemia in children and young adults with cystic fibrosis during oral glucose tolerance testing vs. continuous glucose monitoring.
Topics: Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; Child; Cystic Fibrosis; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hypoglycemia; Insulin; Insulin Resistance; Young Adult | 2023 |
Blocking IL-6 signaling improves glucose tolerance via SLC39A5-mediated suppression of glucagon secretion.
Topics: Animals; Blood Glucose; Cation Transport Proteins; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Secreting Cells; Glucose; Humans; Inflammation; Insulin; Insulin Resistance; Interleukin-6; Macaca mulatta; Mice; Obesity | 2023 |
Lower serum zinc level is associated with higher fasting insulin in type 2 diabetes mellitus (T2DM) and relates with disturbed glucagon suppression response in male patients.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glycated Hemoglobin; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Male | 2023 |
Adipose tissue-derived FABP4 mediates glucagon-stimulated hepatic glucose production in gestational diabetes.
Topics: Adipokines; Adipose Tissue; Animals; Diabetes, Gestational; Fatty Acid-Binding Proteins; Female; Glucagon; Glucose; Humans; Infant, Newborn; Insulin Resistance; Liver; Mice; Pregnancy | 2023 |
Hepatic sialic acid synthesis modulates glucose homeostasis in both liver and skeletal muscle.
Topics: Animals; Glucagon; Glucose; Homeostasis; Insulin; Insulin Resistance; Liver; Mice; Muscle, Skeletal; N-Acetylneuraminic Acid; Polysaccharides | 2023 |
PAHSAs enhance hepatic and systemic insulin sensitivity through direct and indirect mechanisms.
Topics: Adipose Tissue, White; Animals; Cyclic AMP; Diet, High-Fat; Glucagon; In Vitro Techniques; Insulin Resistance; Lipolysis; Liver; Male; Mice; Mice, Inbred C57BL; Models, Biological; Receptors, G-Protein-Coupled; Signal Transduction; Stearates | 2019 |
Obesity dysregulates fasting-induced changes in glucagon secretion.
Topics: Adult; Animals; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Humans; Hyperglycemia; Insulin; Insulin Resistance; Male; Mice, Inbred C57BL; Middle Aged; Obesity; Pancreas | 2019 |
Impaired glucagon suppression and reduced insulin sensitivity in subjects with prediabetes undergoing atorvastatin therapy.
Topics: Adult; Aged; Atorvastatin; Blood Glucose; Blotting, Western; Cell Line; Female; Glucagon; Glucose Tolerance Test; Humans; Immunoprecipitation; Insulin Resistance; Male; Middle Aged; Multivariate Analysis; Prediabetic State | 2019 |
Antidiabetic effects and sustained metabolic benefits of sub-chronic co-administration of exendin-4/gastrin and xenin-8-Gln in high fat fed mice.
Topics: Animals; Body Weight; Diet, High-Fat; Drug Interactions; Energy Metabolism; Exenatide; Gastrins; Glucagon; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Metabolism; Mice; Pancreas; Peptide Fragments; Time Factors | 2019 |
The glutamate receptor GluK2 contributes to the regulation of glucose homeostasis and its deterioration during aging.
Topics: Animals; Blood Glucose; Female; Glucagon; Glucagon-Secreting Cells; Glucose; GluK2 Kainate Receptor; Homeostasis; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Glucagon; Receptors, Kainic Acid | 2019 |
Modelling the effects of glucagon during glucose tolerance testing.
Topics: Blood Glucose; Computer Simulation; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemia; Insulin Resistance; Linear Models; Models, Biological; Reproducibility of Results | 2019 |
Childhood trauma and glucose metabolism in patients with first-episode psychosis.
Topics: Adult; Adverse Childhood Experiences; Antipsychotic Agents; Biomarkers; C-Peptide; Female; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Insulin Resistance; Leptin; Male; Middle Aged; Nicotinamide Phosphoribosyltransferase; Plasminogen Activator Inhibitor 1; Psychotic Disorders; Resistin | 2020 |
Incretin hormones, insulin, glucagon and advanced glycation end products in relation to cognitive function in older people with and without diabetes, a population-based study.
Topics: Aged; Blood Glucose; Case-Control Studies; Cognition; Cross-Sectional Studies; Diabetes Mellitus; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glycation End Products, Advanced; Humans; Insulin; Insulin Resistance; Male; Mental Status and Dementia Tests; Optical Imaging; Sweden | 2020 |
Stress adaptation is associated with insulin resistance in women with gestational diabetes mellitus.
Topics: Adult; Blood Glucose; Diabetes, Gestational; Epinephrine; Female; Glucagon; Glutathione; Hormones; Humans; Hydrocortisone; Insulin Resistance; Malondialdehyde; Norepinephrine; Oxidative Stress; Pregnancy; Stress, Physiological; Stress, Psychological; Superoxide Dismutase | 2020 |
Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities.
Topics: Amino Acid Sequence; Animals; Anti-Obesity Agents; Apoptosis; Blood Glucose; Body Weight; Cell Proliferation; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose Transporter Type 2; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Male; Mice; Neoplasm Proteins; Obesity; Receptors, Glucagon; Structure-Activity Relationship | 2020 |
Dapagliflozin exerts positive effects on beta cells, decreases glucagon and does not alter beta- to alpha-cell transdifferentiation in mouse models of diabetes and insulin resistance.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Body Weight; Cell Transdifferentiation; Diabetes Mellitus, Experimental; Diet, High-Fat; Energy Intake; Glucagon; Glucagon-Secreting Cells; Glucosides; Homeodomain Proteins; Hydrocortisone; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Male; Mice, Transgenic; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin; Trans-Activators | 2020 |
Plasma glucagon levels measured by sandwich ELISA are correlated with impaired glucose tolerance in type 2 diabetes.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male; Middle Aged | 2020 |
Inhibition of prolyl hydroxylases increases hepatic insulin and decreases glucagon sensitivity by an HIF-2α-dependent mechanism.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Glucagon; Glucose; Hepatocytes; Humans; Insulin; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Prolyl Hydroxylases; Prolyl-Hydroxylase Inhibitors; Signal Transduction | 2020 |
The effect of the ghrelin-receptor agonist capromorelin on glucose metabolism in healthy cats.
Topics: Animals; Blood Glucose; Cats; Glucagon; Glucose; Glucose Tolerance Test; Insulin; Insulin Resistance; Male; Piperidines; Pyrazoles; Receptors, Ghrelin | 2021 |
Fasting serum total bile acid levels are associated with insulin sensitivity, islet β-cell function and glucagon levels in response to glucose challenge in patients with type 2 diabetes.
Topics: Adult; Bile Acids and Salts; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged | 2020 |
Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis.
Topics: Adult; Amino Acids; Animals; Blood Glucose; Fatty Liver; Female; Glucagon; Glucagon-Secreting Cells; Glucose; Hepatocytes; Humans; Insulin; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Middle Aged; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Receptors, Glucagon; Urea | 2020 |
Direct Effects of D-Chiro-Inositol on Insulin Signaling and Glucagon Secretion of Pancreatic Alpha Cells.
Topics: Animals; Cell Line, Tumor; Glucagon; Glucagon-Secreting Cells; Inositol; Insulin; Insulin Resistance; Mice; Palmitic Acid; Signal Transduction | 2020 |
The liver-alpha cell axis associates with liver fat and insulin resistance: a validation study in women with non-steatotic liver fat levels.
Topics: Adiposity; Adult; Alanine; Biomarkers; Blood Chemical Analysis; Cross-Sectional Studies; Female; Glucagon; Glucagon-Secreting Cells; Humans; Insulin Resistance; Liver; Magnetic Resonance Imaging; Non-alcoholic Fatty Liver Disease; Predictive Value of Tests; Prognosis; Prospective Studies | 2021 |
Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice.
Topics: Animals; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Energy Intake; Female; Glucagon; Half-Life; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Mice; Obesity; Oligopeptides; Oxytocin; Protein Stability; Triglycerides | 2021 |
Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Hispanic or Latino; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Obesity; Prediabetic State; United States; Veterans | 2021 |
The effects of an alpha-2-adrenoceptor agonist, antagonist, and their combination on the blood insulin, glucose, and glucagon concentrations in insulin sensitive and dysregulated horses.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Blood Glucose; Drug Interactions; Female; Glucagon; Horses; Hypnotics and Sedatives; Imidazoles; Insulin; Insulin Resistance; Male; Quinolizines | 2021 |
Low-Density Lipoprotein Cholesterol Is Associated With Insulin Secretion.
Topics: Adult; Blood Glucose; Cholesterol, LDL; Cohort Studies; Diabetes Mellitus, Type 2; Fasting; Female; Germany; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Pancreas | 2021 |
Bihormonal dysregulation of insulin and glucagon contributes to glucose intolerance development at one year post-delivery in women with gestational diabetes: a prospective cohort study using an early postpartum 75-g glucose tolerance test.
Topics: Adult; Blood Glucose; Body Mass Index; Diabetes, Gestational; Fasting; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Pregnancy; Prospective Studies | 2021 |
Mathematical Model of Glucagon Kinetics for the Assessment of Insulin-Mediated Glucagon Inhibition During an Oral Glucose Tolerance Test.
Topics: Blood Glucose; Glucagon; Glucagon-Secreting Cells; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Kinetics; Models, Theoretical | 2021 |
Metabolic effects of 1-week binge drinking and fast food intake during Roskilde Festival in young healthy male adults.
Topics: Adult; Aspartate Aminotransferases; Binge Drinking; Blood Glucose; C-Peptide; C-Reactive Protein; Denmark; Diet; Elasticity Imaging Techniques; Fast Foods; Fatty Liver; Fibroblast Growth Factors; Glucagon; Glucose Tolerance Test; Growth Differentiation Factor 15; Holidays; Humans; Insulin Resistance; Liver; Male; Young Adult | 2021 |
Lack of Improvement in Insulin Sensitivity After Pancreas Transplantation in Recipients With a High Level of Calcineurin Inhibitors.
Topics: Adult; Blood Glucose; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Kaplan-Meier Estimate; Male; Middle Aged; Pancreas Transplantation; Tacrolimus | 2021 |
Acute pancreatitis-induced islet dysfunction in ferrets.
Topics: Acute Disease; Amylases; Animals; Blood Glucose; Ceruletide; Ferrets; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Insulin; Insulin Resistance; Interleukin-6; Lipase; Pancreatitis; Tumor Necrosis Factor-alpha | 2021 |
Sam68 promotes hepatic gluconeogenesis via CRTC2.
Topics: Adaptor Proteins, Signal Transducing; Animals; Blood Glucose; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Gene Expression Regulation; Glucagon; Gluconeogenesis; Glucose; Hepatocytes; Homeostasis; Humans; Hyperglycemia; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; RNA-Binding Proteins; Transcription Factors; Up-Regulation | 2021 |
Activation of PI3K/Akt Signaling Pathway in Rat Hypothalamus Induced by an Acute Oral Administration of D-Pinitol.
Topics: Administration, Oral; Animals; Blood Glucose; Enzyme Activation; Glucagon; Homeostasis; Hypothalamus; Inositol; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Male; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Wistar; Signal Transduction | 2021 |
O-GlcNAcylated p53 in the liver modulates hepatic glucose production.
Topics: Acetylglucosamine; Animals; Base Sequence; Caloric Restriction; Cell Line; Colforsin; Diabetes Mellitus, Type 2; Epinephrine; Glucagon; Glucocorticoids; Gluconeogenesis; Glucose; Glycosylation; Hepatocytes; Humans; Hydrocortisone; Hyperglycemia; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Liver; Mice, Inbred C57BL; Mice, Knockout; Obesity; Phosphoenolpyruvate Carboxykinase (GTP); Promoter Regions, Genetic; Protein Binding; Protein Stability; Pyruvic Acid; RNA, Messenger; Transcription, Genetic; Tumor Suppressor Protein p53 | 2021 |
Increased Insulin Resistance and Glucagon Levels in Mild/Inactive Systemic Lupus Erythematosus Patients Despite Normal Glucose Tolerance.
Topics: Adult; Biomarkers; Blood Glucose; Case-Control Studies; Cross-Sectional Studies; Fasting; Female; Glucagon; Glucose Tolerance Test; Glucose Transporter Type 4; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Lupus Erythematosus, Systemic; Muscle, Skeletal; Postprandial Period; Severity of Illness Index | 2018 |
Tributyltin in male mice disrupts glucose homeostasis as well as recovery after exposure: mechanism analysis.
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Glucagon; Glucose; Homeostasis; Hormones; Insulin; Insulin Resistance; Liver; Male; Mice; Muscle, Skeletal; Signal Transduction; Trialkyltin Compounds | 2017 |
Curcumin reverses the depressive-like behavior and insulin resistance induced by chronic mild stress.
Topics: Animals; Behavior, Animal; Blood Glucose; Corticosterone; Curcumin; Depression; Disease Models, Animal; Glucagon; Glucose Tolerance Test; Insulin; Insulin Resistance; Leptin; Male; Pioglitazone; Rats; Rats, Sprague-Dawley; Stress, Psychological; Thiazolidinediones | 2017 |
How Should We Think About the Role of the Brain in Glucose Homeostasis and Diabetes?
Topics: Blood Glucose; Brain; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucagon; Glucose; Homeostasis; Humans; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans | 2017 |
Short-Term Moderate Sleep Restriction Decreases Insulin Sensitivity in Young Healthy Adults.
Topics: Adolescent; Adult; Blood Glucose; Fasting; Female; Glucagon; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin; Insulin Resistance; Male; Sleep Deprivation; Young Adult | 2016 |
Higher glucagon-to-insulin ratio is associated with elevated glycated hemoglobin levels in type 2 diabetes patients.
Topics: Adult; Aged; Biomarkers; Body Mass Index; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Postprandial Period | 2019 |
Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes.
Topics: Adult; Aged; Amino Acids; Biomarkers; Body Mass Index; Case-Control Studies; Cholesterol; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucagon-Secreting Cells; Glycated Hemoglobin; Humans; Insulin Resistance; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Up-Regulation | 2018 |
Acute activation of GLP-1-expressing neurons promotes glucose homeostasis and insulin sensitivity.
Topics: Animals; Blood Glucose; Energy Metabolism; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Glucose Tolerance Test; Homeostasis; Insulin; Insulin Resistance; Mice; Mice, Transgenic; Neurons; Proglucagon; Receptors, Glucagon | 2017 |
Differential associations of lower cardiac vagal tone with insulin resistance and insulin secretion in recently diagnosed type 1 and type 2 diabetes.
Topics: Adolescent; Adult; Aged; C-Peptide; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Clamp Technique; Heart; Heart Rate; Humans; Insulin; Insulin Resistance; Lipids; Male; Middle Aged; Vagus Nerve; Young Adult | 2018 |
Impaired Insulin Action Is Associated With Increased Glucagon Concentrations in Nondiabetic Humans.
Topics: Biomarkers; Blood Glucose; C-Peptide; Cross-Sectional Studies; Female; Follow-Up Studies; Glucagon; Glucagon-Secreting Cells; Glucose Tolerance Test; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Prediabetic State; Prognosis | 2018 |
Honokiol protects pancreatic β cell against high glucose and intermittent hypoxia-induced injury by activating Nrf2/ARE pathway in vitro and in vivo.
Topics: Animals; Apoptosis; Biphenyl Compounds; Blood Glucose; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Free Radical Scavengers; Glucagon; Hypoxia; Insulin; Insulin Resistance; Insulin-Secreting Cells; Lignans; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sleep Apnea, Obstructive | 2018 |
The influence of adiposity and acute exercise on circulating hepatokines in normal-weight and overweight/obese men.
Topics: Adiposity; Adult; alpha-2-HS-Glycoprotein; Biomarkers; Blood Glucose; Body Composition; Body Mass Index; Body Weight; Case-Control Studies; Exercise; Exercise Test; Fibroblast Growth Factors; Follistatin; Glucagon; Humans; Insulin; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Life Style; Male; Middle Aged; Obesity; Overweight; Selenoprotein P; Young Adult | 2018 |
Evidence of a liver-alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids.
Topics: Aged; Alanine; Amino Acids; Cross-Sectional Studies; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin Resistance; Liver; Magnetic Resonance Spectroscopy; Male; Middle Aged | 2018 |
Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study.
Topics: Adipose Tissue; Animals; Blood Glucose; Blood Pressure; Body Weight; Brain; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Hypertension; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Obesity; Prolactin-Releasing Hormone; Rats, Inbred SHR | 2018 |
Immunohistochemical expression of insulin, glucagon, and somatostatin in pancreatic islets of horses with and without insulin resistance.
Topics: Animals; Female; Glucagon; Horse Diseases; Horses; Immunohistochemistry; Insulin; Insulin Resistance; Islets of Langerhans; Male; Somatostatin | 2018 |
5-aminolevulinic acid (ALA) deficiency causes impaired glucose tolerance and insulin resistance coincident with an attenuation of mitochondrial function in aged mice.
Topics: 5-Aminolevulinate Synthetase; Aminolevulinic Acid; Animals; Blood Glucose; Glucagon; Gluconeogenesis; Glucose Intolerance; Insulin; Insulin Resistance; Levulinic Acids; Mice; Mice, Transgenic; Mitochondria; Signal Transduction | 2018 |
Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
Topics: Blood Glucose; Caloric Restriction; Diabetes Mellitus, Type 2; Fasting; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Liver; Male; Middle Aged; Obesity; Peptide YY; Postprandial Period; Remission Induction | 2018 |
Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Cell Line; Cyclic AMP; Diabetes Mellitus; Dideoxyadenosine; Diet, High-Fat; Exenatide; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucose; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Islets of Langerhans; Mice; Mice, Obese; Peptides; Venoms | 2018 |
Dendrobium Officinale Kimura et Migo Ameliorates Insulin Resistance in Rats with Diabetic Nephropathy.
Topics: Animals; C-Reactive Protein; Cytokines; Dendrobium; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glucagon; Insulin; Insulin Resistance; Interleukin-6; Rats; Rats, Sprague-Dawley; Toll-Like Receptors; Tumor Necrosis Factor-alpha | 2018 |
p8 deficiency leads to elevated pancreatic beta cell mass but does not contribute to insulin resistance in mice fed with high-fat diet.
Topics: Animals; Diet, High-Fat; Dietary Fats; DNA-Binding Proteins; Energy Metabolism; Female; Glucagon; Glucose; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Proteins | 2018 |
Contribution of systemic inflammation to permanence of K
Topics: Animals; Blood Glucose; Cytokines; Diabetes Mellitus; Glucagon; Glucagon-Like Peptide 1; Glyburide; Inflammation; Insulin; Insulin Resistance; Leptin; Mice; Mice, Transgenic; Mutation; Potassium Channels, Inwardly Rectifying | 2018 |
Glucose intolerance in monosodium glutamate obesity is linked to hyperglucagonemia and insulin resistance in α cells.
Topics: Adipose Tissue, White; Animals; Biomarkers; Blood Glucose; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Glucagon; Glucagon-Secreting Cells; Glucose Intolerance; Insulin; Insulin Resistance; Liver; Male; Mice; Obesity; Phosphoenolpyruvate Carboxykinase (ATP); Phosphorylation; Sodium Glutamate; TOR Serine-Threonine Kinases | 2019 |
Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Topics: Adiposity; Adult; Aged; Biomarkers; Body Mass Index; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Prevalence; Prognosis; Republic of Korea; Risk Assessment; Risk Factors; Time Factors; Ultrasonography | 2019 |
Chronic Exposure to Palmitate Impairs Insulin Signaling in an Intestinal L-cell Line: A Possible Shift from GLP-1 to Glucagon Production.
Topics: Cell Line; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin Resistance; Palmitates; Proprotein Convertase 2; Signal Transduction | 2018 |
PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin.
Topics: Animals; Cyclic AMP Response Element-Binding Protein; Diabetes Mellitus, Type 2; Fasting; Female; Gene Expression Regulation; Glucagon; Gluconeogenesis; Glucose; Hepatocytes; Homeostasis; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Liver Diseases; Male; Mice; Models, Animal; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Proto-Oncogene Proteins c-akt; Signal Transduction | 2019 |
Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose-Tolerant Participants.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Gluconeogenesis; Glucose; Glucose Clamp Technique; Glycogenolysis; Healthy Volunteers; Humans; Hyperglycemia; Insulin; Insulin Resistance; Liver; Male; Middle Aged; Tritium | 2019 |
Timing Modulates the Effect of Sleep Loss on Glucose Homeostasis.
Topics: Adult; Blood Glucose; Cross-Over Studies; Glucagon; Glucagon-Secreting Cells; Glucose Clamp Technique; Healthy Volunteers; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Pituitary-Adrenal System; Random Allocation; Sleep Deprivation; Time Factors; Young Adult | 2019 |
A novel measure of glucose homeostasis (or loss thereof) comprising the joint dynamics of glucose, insulin, glucagon, and cortisol.
Topics: Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Glucagon; Homeostasis; Humans; Hydrocortisone; Insulin; Insulin Resistance; Insulin Secretion; Prediabetic State | 2019 |
Glucose-dependent Insulinotropic Polypeptide (GIP) Resistance and β-cell Dysfunction Contribute to Hyperglycaemia in Acromegaly.
Topics: Acromegaly; Adult; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Humans; Hyperglycemia; Incretins; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Prospective Studies; Receptors, Gastrointestinal Hormone | 2019 |
Phosphorylation of Forkhead Protein FoxO1 at S253 Regulates Glucose Homeostasis in Mice.
Topics: Alanine; Animals; Blood Glucose; Forkhead Box Protein O1; Glucagon; Glucose; Homeostasis; Insulin; Insulin Resistance; Islets of Langerhans; Liver; Mice, Inbred C57BL; Mice, Transgenic; Phosphorylation; Serine | 2019 |
The short-chain fatty acid propionate increases glucagon and FABP4 production, impairing insulin action in mice and humans.
Topics: Animals; Fatty Acid-Binding Proteins; Female; Glucagon; Glycogen; Humans; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Propionates; Weight Gain | 2019 |
Proinsulin associates with poor β-cell function, glucose-dependent insulinotropic peptide, and insulin resistance in persistent type 2 diabetes after Roux-en-Y gastric bypass in humans.
Topics: Adult; Blood Glucose; Body Weight; C-Peptide; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged; Recurrence | 2020 |
Biomarkers of insulin action during single soccer sessions before and after a 12-week training period in type 2 diabetes patients on a caloric-restricted diet.
Topics: Aged; Biomarkers; Blood Glucose; Body Composition; Diabetes Mellitus, Type 2; Diet, Reducing; Exercise Therapy; Female; Glucagon; Humans; Insulin; Insulin Resistance; Lactic Acid; Leptin; Male; Middle Aged; Physical Conditioning, Human; Soccer; Treatment Outcome | 2019 |
Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
Topics: Adult; Area Under Curve; Blood Glucose; C-Peptide; Fasting; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Obesity | 2013 |
Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus.
Topics: Adult; Area Under Curve; Biomarkers; Blood Glucose; Body Mass Index; C-Peptide; Diabetes, Gestational; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glycated Hemoglobin; Homeostasis; Humans; Insulin; Insulin Resistance; Insulin Secretion; Postpartum Period; Postprandial Period; Pregnancy | 2013 |
X-box binding protein 1 is essential for insulin regulation of pancreatic α-cell function.
Topics: Animals; DNA-Binding Proteins; Glucagon; Glucagon-Secreting Cells; Glucose Intolerance; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Knockout; Phosphorylation; Proto-Oncogene Proteins c-akt; Regulatory Factor X Transcription Factors; Signal Transduction; Transcription Factors; X-Box Binding Protein 1 | 2013 |
Glucose homeostasis, obesity and diabetes.
Topics: Aging; Body Mass Index; Diabetes Mellitus, Type 2; Glucagon; Glucose; Glucose Intolerance; Glucose Transport Proteins, Facilitative; Glycogen; Homeostasis; Humans; Inflammation Mediators; Insulin; Insulin Resistance; Metabolic Syndrome; Obesity; Obesity, Abdominal; Sodium-Glucose Transport Proteins | 2013 |
Postnatal development of the endocrine pancreas in mice lacking functional GABAB receptors.
Topics: Animals; Animals, Newborn; Body Weight; Female; Gene Expression Regulation; Glucagon; Glutamate Decarboxylase; Insulin; Insulin Resistance; Islets of Langerhans; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Organ Size; Proliferating Cell Nuclear Antigen; Real-Time Polymerase Chain Reaction; Receptors, GABA-B; RNA | 2013 |
Circulating glucagon to ghrelin ratio as a determinant of insulin resistance in hyperthyroidism.
Topics: Adipose Tissue; Adult; Aged; Body Composition; Fasting; Female; Ghrelin; Glucagon; Graves Disease; Humans; Hyperthyroidism; Insulin Resistance; Male; Middle Aged | 2014 |
GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.
Topics: Absorptiometry, Photon; Aged; Biomarkers; Blood Glucose; Body Composition; C-Peptide; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Obesity, Morbid; Treatment Outcome | 2013 |
Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Gastric Bypass; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged; Peptide Fragments; Receptors, Glucagon | 2013 |
Impairment of pancreatic β-cell function by chronic intermittent hypoxia.
Topics: Animals; Blood Glucose; Cell Proliferation; Diabetes Mellitus, Type 2; Glucagon; Homeostasis; Humans; Hypoxia; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Mitochondria; Models, Biological; Proinsulin; Reactive Oxygen Species; Sleep Apnea Syndromes | 2013 |
Increasing glucagon secretion could antagonize the action of exogenous insulin for glycemic control in streptozocin-induced diabetic rhesus monkeys.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Glucagon; Glucagon-Secreting Cells; Hypoglycemic Agents; Insulin; Insulin Resistance; Longitudinal Studies; Macaca mulatta; Streptozocin; Time Factors; Treatment Outcome; Triglycerides | 2013 |
Postprandial glucose fluxes and insulin sensitivity during exercise: a study in healthy individuals.
Topics: Activities of Daily Living; Adult; Algorithms; Blood Glucose; C-Peptide; Carbon Radioisotopes; Deuterium; Feasibility Studies; Female; Glucagon; Gluconeogenesis; Glucose; Humans; Infusions, Intravenous; Insulin; Insulin Resistance; Male; Middle Aged; Models, Biological; Motor Activity; Postprandial Period; Tritium; Young Adult | 2013 |
Long-term effects of bariatric surgery on meal disposal and β-cell function in diabetic and nondiabetic patients.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Gastric Bypass; Glucagon; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Obesity; Obesity, Morbid; Weight Loss | 2013 |
TAK-875, a GPR40/FFAR1 agonist, in combination with metformin prevents progression of diabetes and β-cell dysfunction in Zucker diabetic fatty rats.
Topics: Animals; Benzofurans; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Glucagon; Glycated Hemoglobin; Homeodomain Proteins; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Metformin; Proliferating Cell Nuclear Antigen; Rats; Rats, Zucker; Receptors, G-Protein-Coupled; Sulfones; Time Factors; Trans-Activators | 2013 |
Fgf21 impairs adipocyte insulin sensitivity in mice fed a low-carbohydrate, high-fat ketogenic diet.
Topics: 3-Hydroxybutyric Acid; Adipocytes; Animals; Blood Glucose; Body Weight; Diet, Carbohydrate-Restricted; Diet, High-Fat; Fibroblast Growth Factors; Glucagon; Gluconeogenesis; Glucose Intolerance; Insulin; Insulin Resistance; Ketone Bodies; Liver; Male; Mice; Mice, Knockout; Phenotype; Phosphorylation; Proto-Oncogene Proteins c-akt | 2013 |
Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet.
Topics: Animals; Blood Glucose; Body Weight; Cell Dedifferentiation; Densitometry; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dietary Sucrose; Disease Models, Animal; Fluorescent Antibody Technique; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose Tolerance Test; Glycated Hemoglobin; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Macaca mulatta; Nuclear Proteins; Protective Agents; Resveratrol; Sirtuin 1; Stilbenes; Transcription Factors | 2013 |
Glucagon regulates gluconeogenesis through KAT2B- and WDR5-mediated epigenetic effects.
Topics: Acetylation; Amino Acid Sequence; Anacardic Acids; Animals; Cells, Cultured; Conserved Sequence; Epigenesis, Genetic; Glucagon; Gluconeogenesis; Glucose; HEK293 Cells; Hepatocytes; Histones; Humans; Hypoglycemic Agents; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Liver; Male; Methylation; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Molecular Sequence Data; p300-CBP Transcription Factors; Protein Processing, Post-Translational; Proteins | 2013 |
Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
Topics: Adult; Diabetes Mellitus, Type 2; Female; Gastrectomy; Gastric Bypass; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glycemic Index; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Male; Middle Aged; Obesity, Morbid; Pancreatic Polypeptide; Peptide YY; Remission Induction | 2013 |
A novel glucagon-like peptide-1 (GLP-1)/glucagon hybrid peptide with triple-acting agonist activity at glucose-dependent insulinotropic polypeptide, GLP-1, and glucagon receptors and therapeutic potential in high fat-fed mice.
Topics: Amino Acid Sequence; Animals; Blood Glucose; Cyclic AMP; Diet, High-Fat; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Insulin; Insulin Resistance; Insulin Secretion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Molecular Sequence Data; Obesity; Receptors, Gastrointestinal Hormone; Receptors, Glucagon; Recombinant Fusion Proteins | 2013 |
Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis.
Topics: Animals; Appetite Depressants; Body Weight; Dietary Fats; Dietary Sucrose; Drug Resistance; Energy Metabolism; Feeding Behavior; Female; Glucagon; Glucose; Homeostasis; Hyperglycemia; Hyperinsulinism; Hyperphagia; Insulin; Insulin Resistance; Insulin Secretion; Male; Mice; Mice, Knockout; Neurons; Obesity; Pro-Opiomelanocortin; Receptor, Serotonin, 5-HT2C; Recombinant Fusion Proteins; Serotonin; Serotonin Receptor Agonists | 2013 |
Glucagon and insulin cord blood levels in very preterm, late preterm and full-term infants.
Topics: Apgar Score; Cesarean Section; Female; Fetal Blood; Glucagon; Humans; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Insulin; Insulin Resistance; Male | 2014 |
Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 mice.
Topics: Animals; Appetite; Body Weight; Cholesterol; Cholesterol, LDL; Diet; Eating; Fibroblast Growth Factors; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Gluconeogenesis; Insulin Resistance; Leptin; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Receptors, Glucagon; Triglycerides | 2013 |
Low and high dietary protein:carbohydrate ratios during pregnancy affect materno-fetal glucose metabolism in pigs.
Topics: Adaptation, Physiological; Animals; Area Under Curve; Blood Glucose; Brain; Diet; Diet, Carbohydrate-Restricted; Diet, Protein-Restricted; Dietary Carbohydrates; Dietary Proteins; Female; Fetal Development; Fetal Growth Retardation; Fetus; Glucagon; Gluconeogenesis; Glucose; Glucose Tolerance Test; Inositol; Insulin; Insulin Resistance; Lactic Acid; Liver; Placenta; Pregnancy; Pregnancy Complications; Prenatal Nutritional Physiological Phenomena; Protein Deficiency; Swine; Umbilicus | 2014 |
Glucagon/insulin ratio in preoperative screening before pancreatic surgery: correlation with hemoglobin A1C in subjects with and without pancreatic cancer.
Topics: Aged; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Pancreas; Pancreatic Neoplasms; Preoperative Period | 2014 |
Effects of AMPK activation on insulin sensitivity and metabolism in leptin-deficient ob/ob mice.
Topics: Acetyl-CoA Carboxylase; Adenylate Kinase; Animals; Female; Glucagon; Insulin; Insulin Resistance; Leptin; Lipid Metabolism; Male; Mice; Mice, Obese; Muscle, Skeletal; Obesity; Phosphorylation | 2014 |
Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease.
Topics: Case-Control Studies; Fatty Liver; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Non-alcoholic Fatty Liver Disease | 2014 |
Incretin effect and glucagon responses to oral and intravenous glucose in patients with maturity-onset diabetes of the young--type 2 and type 3.
Topics: Administration, Intravenous; Administration, Oral; Adult; Diabetes Mellitus, Type 2; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide 1; Glucokinase; Glucose; Hepatocyte Nuclear Factor 1-alpha; Humans; Incretins; Insulin Resistance; Male; Middle Aged | 2014 |
Differential AMPK phosphorylation by glucagon and metformin regulates insulin signaling in human hepatic cells.
Topics: AMP-Activated Protein Kinases; Cell Line; Cyclic AMP-Dependent Protein Kinases; Gene Knockdown Techniques; Glucagon; Hepatocytes; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Phosphorylation; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Signal Transduction | 2014 |
Alteration of the glucagon axis in GPR120 (FFAR4) knockout mice: a role for GPR120 in glucagon secretion.
Topics: Animals; Calcium; Cells, Cultured; Fatty Acids; Fatty Acids, Unsaturated; Female; Glucagon; Glucagon-Secreting Cells; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, G-Protein-Coupled | 2014 |
Clozapine directly increases insulin and glucagon secretion from islets: implications for impairment of glucose tolerance.
Topics: Animals; Antipsychotic Agents; Clozapine; Cyclobutanes; Epinephrine; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucose; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Liver; Male; Pancreas; Rats, Sprague-Dawley; Receptors, Glucagon; Sympathomimetics; Tissue Culture Techniques | 2014 |
[Changes of plasma glucagon level in individuals with different glucose metabolism].
Topics: Diabetes Mellitus, Type 2; Glucagon; Glucose; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance | 2014 |
Role of endogenous GLP-1 and GIP in beta cell compensatory responses to insulin resistance and cellular stress.
Topics: Animals; Apoptosis; Cell Proliferation; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Hormones; Hydrocortisone; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Lymphocytes; Male; Mice; Mice, Knockout; Pancreas; Protein Transport; Streptozocin | 2014 |
Effects of delayed gastric emptying on postprandial glucose kinetics, insulin sensitivity, and β-cell function.
Topics: Adolescent; Adult; Algorithms; Blood Glucose; C-Peptide; Female; Food; Gastric Emptying; Glucagon; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Kinetics; Male; Middle Aged; Young Adult | 2014 |
PTEN deletion in pancreatic α-cells protects against high-fat diet-induced hyperglucagonemia and insulin resistance.
Topics: Animals; Arginine; Diabetes Mellitus, Type 2; Diet, High-Fat; Female; Glucagon; Glucagon-Secreting Cells; Hyperglycemia; Insulin Resistance; Insulin-Secreting Cells; Male; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Transgenic; Phosphatidylinositol 3-Kinases; PTEN Phosphohydrolase; RNA, Small Interfering; Signal Transduction | 2015 |
Resveratrol ameliorates mitochondrial dysfunction but increases the risk of hypoglycemia following hemorrhagic shock.
Topics: Animals; Blood Glucose; Corticosterone; Glucagon; Glucagon-Like Peptide 1; Hypoglycemia; Insulin; Insulin Resistance; Kidney; Male; Mitochondria; Mitochondria, Liver; Rats, Long-Evans; Reactive Oxygen Species; Resuscitation; Resveratrol; Shock, Hemorrhagic; Stilbenes | 2014 |
Maternal insulin resistance and transient hyperglycemia impact the metabolic and endocrine phenotypes of offspring.
Topics: Animals; Animals, Newborn; Blood Glucose; Cell Proliferation; Diabetes, Gestational; Disease Models, Animal; Female; Glucagon; Glucagon-Like Peptide 1; Hyperglycemia; Hyperinsulinism; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Leptin; Mice; Organ Size; Phenotype; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Weight Gain | 2014 |
Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
Topics: Aged; Blood Glucose; Combined Modality Therapy; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Japan; Middle Aged; Monitoring, Ambulatory; Postprandial Period; Pyrazoles; Thiazolidines | 2015 |
Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.
Topics: Animals; Anti-Obesity Agents; Blood Glucose; Body Weight; Diet, High-Fat; Drug Synergism; Eating; Exenatide; Glucagon; Glucagon-Like Peptide 1; Insulin Resistance; Male; Mice, Inbred C57BL; Mice, Obese; Obesity; Peptides; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Venoms | 2014 |
Over-expression of Follistatin-like 3 attenuates fat accumulation and improves insulin sensitivity in mice.
Topics: Activins; Adiposity; Animals; Diet, High-Fat; Female; Follistatin-Related Proteins; Glucagon; Glucose Intolerance; Insulin; Insulin Resistance; Islets of Langerhans; Liver; Mice, Inbred C57BL; Muscle Development; Muscle, Skeletal; Myostatin; Proteins; Random Allocation; Recombinant Proteins; Signal Transduction; Subcutaneous Fat; Up-Regulation | 2015 |
Peripheral insulin resistance and impaired insulin signaling contribute to abnormal glucose metabolism in preterm baboons.
Topics: Animals; Blood Glucose; Female; Gene Expression Regulation; Glucagon; Glucose; Glucose Clamp Technique; Insulin Resistance; Muscle, Skeletal; Papio; Pregnancy; Premature Birth; Proto-Oncogene Proteins c-akt; Receptor, Insulin; Signal Transduction; Vertebrobasilar Insufficiency | 2015 |
Patients with psoriasis are insulin resistant.
Topics: Adult; Anthropometry; Blood Glucose; C-Peptide; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Glucagon; Gluconeogenesis; Glucose Clamp Technique; Glucose Intolerance; Humans; Hyperinsulinism; Inflammation; Insulin; Insulin Resistance; Male; Middle Aged; Prediabetic State; Psoriasis; Risk | 2015 |
Functional GIP receptors play a major role in islet compensatory response to high fat feeding in mice.
Topics: Adaptation, Physiological; Adiposity; Animals; Apoptosis; Blood Glucose; Cell Proliferation; Diet, High-Fat; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Insulin; Insulin Resistance; Intestinal Mucosa; Islets of Langerhans; Male; Mice, Inbred C57BL; Mice, Knockout; Receptors, Gastrointestinal Hormone; Time Factors | 2015 |
Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area.
Topics: Aged; Blood Glucose; C-Peptide; Cell Count; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged | 2015 |
Islet adaptation to obesity and insulin resistance in WNIN/GR-Ob rats.
Topics: Adaptation, Physiological; Age Factors; Animals; Body Weight; Female; Gene Expression; Glucagon; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Microscopy, Electron, Scanning; Obesity; Organ Size; Oxidative Stress; Rats; Rats, Mutant Strains; Somatostatin | 2014 |
Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.
Topics: Administration, Oral; Adult; Animals; Benzhydryl Compounds; Blood Glucose; Cell Separation; Female; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation; Gene Silencing; Glucagon; Glucagon-Secreting Cells; Gluconeogenesis; Glucosides; Hepatocyte Nuclear Factor 4; Humans; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; RNA, Small Interfering; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2 | 2015 |
Incretin secretion in obese Korean children and adolescents with newly diagnosed type 2 diabetes.
Topics: Adolescent; Analysis of Variance; Asian People; Blood Glucose; Body Mass Index; C-Peptide; Case-Control Studies; Child; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Resistance; Male; Obesity; Republic of Korea | 2016 |
Relationship between circadian blood pressure variability and function of islet α and β cell in type 2 diabetes with dyssomnia.
Topics: Administration, Oral; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Diabetes Mellitus, Type 2; Dyssomnias; Female; Glucagon; Glucagon-Secreting Cells; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Prehypertension; Retrospective Studies | 2015 |
Acute glucagon induces postprandial peripheral insulin resistance.
Topics: Adenylyl Cyclases; Animals; Blood Glucose; Bucladesine; Cyclic AMP; Dose-Response Relationship, Drug; Glucagon; Glucose Clamp Technique; Glutathione; Injections, Intravenous; Insulin; Insulin Resistance; Liver; Male; Nitric Oxide; omega-N-Methylarginine; Portal Vein; Postprandial Period; Rats; Rats, Sprague-Dawley | 2015 |
Hydrolysis enhances bioavailability of proanthocyanidin-derived metabolites and improves β-cell function in glucose intolerant rats.
Topics: Animals; Biological Availability; Blood Glucose; Body Composition; Diet, Fat-Restricted; Diet, High-Fat; Dietary Supplements; Glucagon; Glucose Tolerance Test; Hydrolysis; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Proanthocyanidins; Rats; Rats, Sprague-Dawley | 2015 |
KBP-042 improves bodyweight and glucose homeostasis with indices of increased insulin sensitivity irrespective of route of administration.
Topics: Adiposity; Animals; Blood Glucose; Body Weight; Calcitonin; Diet, High-Fat; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Homeostasis; Insulin Resistance; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Leptin; Male; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Calcitonin | 2015 |
[Association between sleep disorders and dawn phenomenon in patients with type 2 diabetes mellitus].
Topics: Diabetes Mellitus, Type 2; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Sleep Wake Disorders | 2015 |
Sustained treatment with a stable long-acting oxyntomodulin analogue improves metabolic control and islet morphology in an experimental model of type 1 diabetes.
Topics: Animals; Apoptosis; Blood Glucose; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Eating; Gastrointestinal Hormones; Glucagon; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Islets of Langerhans; Mice; Oxyntomodulin; Pancreas | 2015 |
The frog skin host-defense peptide CPF-SE1 improves glucose tolerance, insulin sensitivity and islet function and decreases plasma lipids in high-fat fed mice.
Topics: Amino Acid Sequence; Animals; Anura; Blood Glucose; Body Composition; Body Weight; Diet, High-Fat; Energy Intake; Glucagon; Glucose Tolerance Test; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Lipids; Male; Mice; Molecular Sequence Data; Peptides; Skin | 2015 |
[I10W]tigerinin-1R enhances both insulin sensitivity and pancreatic beta cell function and decreases adiposity and plasma triglycerides in high-fat mice.
Topics: Adiposity; Animals; Antimicrobial Cationic Peptides; Blood Glucose; Body Composition; Diet, High-Fat; Glucagon; Glucose Tolerance Test; Hypoglycemic Agents; Insulin Resistance; Insulin-Secreting Cells; Lipids; Male; Mice; Obesity; Peptides; Triglycerides | 2016 |
The Zinc Transporter Slc30a8/ZnT8 Is Required in a Subpopulation of Pancreatic α-Cells for Hypoglycemia-induced Glucagon Secretion.
Topics: Animals; Cation Transport Proteins; Cells, Cultured; Female; Gene Deletion; Glucagon; Glucagon-Secreting Cells; Glucose; Hypoglycemia; Insulin Resistance; Mice, Inbred C57BL; Zinc; Zinc Transporter 8 | 2015 |
Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21.
Topics: Animals; Blood Glucose; Energy Metabolism; Fibroblast Growth Factors; Glucagon; Gluconeogenesis; Glucose; Glycogen; Insulin Resistance; Lipids; Liver; Male; Mice; Mice, Knockout | 2015 |
Cross-sectional and Longitudinal Analyses of Factors Contributing to the Progressive Loss of the β-cell Function in Type 2 Diabetes.
Topics: Adult; Aged; Body Mass Index; C-Peptide; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Disease Progression; Female; Glucagon; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Longitudinal Studies; Male; Middle Aged; Overweight; Regression Analysis; Thinness; Triglycerides | 2015 |
Ileal Transposition Decreases Plasma Lipopolysaccharide Levels in Association with Increased L Cell Secretion in Non-obese Non-diabetic Rats.
Topics: Animals; Blood Glucose; Body Weight; Drinking; Eating; Enteroendocrine Cells; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucose Tolerance Test; Ileum; Insulin Resistance; Lipopolysaccharides; Male; Obesity, Morbid; Peptide YY; Rats, Sprague-Dawley | 2016 |
Postprandial glucose, insulin, and glucagon-like peptide-1 responses of different equine breeds adapted to meals containing micronized maize.
Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Blood Glucose; Breeding; Diet; Food Handling; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Horses; Insulin; Insulin Resistance; Postprandial Period; Zea mays | 2015 |
Prediabetes linked to excess glucagon in transgenic mice with pancreatic active AKT1.
Topics: Animals; Blood Glucose; Diabetes Mellitus; Enzyme Activation; Fasting; Genotype; Glucagon; Glucose; Glucose Intolerance; Homeostasis; Hyperglycemia; Insulin; Insulin Resistance; Mice; Mice, Transgenic; Myristic Acids; Pancreas; Prediabetic State; Proto-Oncogene Proteins c-akt | 2016 |
TCF7L2 Genotype and α-Cell Function in Humans Without Diabetes.
Topics: Adult; Aged; Alleles; Cohort Studies; Diabetes Mellitus; Emulsions; Fatty Acids, Nonesterified; Female; Genetic Variation; Genotype; Glucagon; Glucagon-Secreting Cells; Glucose Tolerance Test; Glycerol; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Phospholipids; Soybean Oil; Transcription Factor 7-Like 2 Protein | 2016 |
Enhanced insulin sensitivity mediated by adipose tissue browning perturbs islet morphology and hormone secretion in response to autonomic nervous activation in female mice.
Topics: Adipose Tissue, Brown; Animals; Autonomic Nervous System; Cell Shape; Cell Transdifferentiation; Female; Forkhead Transcription Factors; Glucagon; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic | 2016 |
Comparison of gut hormones and adipokines stimulated by glucagon test among patients with type II diabetes mellitus after metabolic surgery.
Topics: Adipokines; Adult; Aged; Bariatric Surgery; Blood Glucose; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Gastrointestinal Hormones; Glucagon; Humans; Insulin Resistance; Male; Middle Aged; Obesity, Morbid | 2016 |
The effect of 8 days of strict bed rest on the incretin effect in healthy volunteers.
Topics: Adolescent; Adult; Bed Rest; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucose; Glucose Tolerance Test; Healthy Volunteers; Humans; Incretins; Insulin; Insulin Resistance; Male; Young Adult | 2016 |
[Association between retinopathy and sleep disorder in patients with type 2 diabetes mellitus].
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Postprandial Period; Sleep Wake Disorders | 2015 |
A Transient Metabolic Recovery from Early Life Glucose Intolerance in Cystic Fibrosis Ferrets Occurs During Pancreatic Remodeling.
Topics: Animals; Blood Glucose; Cystic Fibrosis; Cytokines; Female; Ferrets; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Hyperglycemia; Insulin; Insulin Resistance; Male; Pancreas | 2016 |
Differential effects of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide and metformin on pancreatic β-cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes.
Topics: Adult; Aged; Area Under Curve; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Immunoglobulin Fc Fragments; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Metformin; Middle Aged; Postprandial Period; Recombinant Fusion Proteins; Treatment Outcome | 2016 |
Glucagon receptor antagonist and GIP agonist combination for diet-induced obese mice.
Topics: Animals; Cell Line; Cyclic AMP; Diabetes Mellitus, Type 2; Diet, High-Fat; Energy Metabolism; Gastric Inhibitory Polypeptide; Glucagon; Insulin; Insulin Resistance; Insulin Secretion; Male; Mice; Mice, Obese; Motor Activity; Obesity; Rats; Receptors, Glucagon | 2016 |
Relationship between pancreatic hormones and glucose metabolism: A cross-sectional study in patients after acute pancreatitis.
Topics: Acute Disease; Adult; Aged; Biomarkers; Blood Glucose; Chi-Square Distribution; Cross-Sectional Studies; Fasting; Female; Glucagon; Glycated Hemoglobin; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Islet Amyloid Polypeptide; Linear Models; Male; Middle Aged; Multivariate Analysis; Pancreatic Hormones; Pancreatic Polypeptide; Pancreatitis; Somatostatin | 2016 |
Utility of C-peptide for a reliable estimate of insulin secretion in children with growth hormone deficiency.
Topics: Area Under Curve; C-Peptide; Case-Control Studies; Child; Child, Preschool; Fasting; Female; Glucagon; Glucose Tolerance Test; Hormones; Human Growth Hormone; Humans; Hypopituitarism; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Like Growth Factor I; Insulin-Secreting Cells; Male; Prospective Studies | 2016 |
Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production.
Topics: Adipose Tissue; Animals; Diet; Efferent Pathways; Fatty Acids, Nonesterified; Forkhead Box Protein O1; Gene Deletion; Gene Expression Regulation; Glucagon; Glucokinase; Gluconeogenesis; Glucose; Glucose Tolerance Test; Heparin; Hepatocytes; Insulin; Insulin Resistance; Lipogenesis; Liver; Male; Mechanistic Target of Rapamycin Complex 1; Mice, Knockout; Multiprotein Complexes; Postprandial Period; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Vagus Nerve | 2016 |
Effects of flavonoid-rich Chinese bayberry (Morella rubra Sieb. et Zucc.) fruit extract on regulating glucose and lipid metabolism in diabetic KK-A(y) mice.
Topics: Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Flavonoids; Fruit; Glucagon; Glucose-6-Phosphatase; Glutathione Peroxidase; Hep G2 Cells; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Leptin; Lipid Metabolism; Lipids; Liver; Mice; Myrica; Organ Size; Plant Extracts; Transcription Factors | 2016 |
Dogfish glucagon analogues counter hyperglycaemia and enhance both insulin secretion and action in diet-induced obese diabetic mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diet, High-Fat; Dogfish; Glucagon; Glucose Tolerance Test; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Obese; Obesity | 2016 |
Exenatide Treatment Alone Improves β-Cell Function in a Canine Model of Pre-Diabetes.
Topics: Animals; Blood Glucose; Body Composition; Disease Models, Animal; Dogs; Eating; Energy Metabolism; Exenatide; Fasting; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Liver; Male; Peptides; Prediabetic State; Venoms | 2016 |
Male Men1 heterozygous mice exhibit fasting hyperglycemia in the early stage of MEN1.
Topics: Animals; Fasting; Glucagon; Gluconeogenesis; Heterozygote; Hyperglycemia; Insulin Resistance; Islets of Langerhans; Liver; Male; Mice; Mice, Mutant Strains; Multiple Endocrine Neoplasia Type 1 | 2016 |
Influence of a HTR2B Stop Codon on Glucagon Homeostasis and Glucose Excursion in Non-Diabetic Men.
Topics: Adult; Blood Glucose; Cohort Studies; Finland; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male; Receptor, Serotonin, 5-HT2B | 2016 |
Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation.
Topics: Aged; Blood Glucose; Cohort Studies; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Prediabetic State | 2016 |
Insulin resistance, glucagon-like peptide-1 and factors influencing glucose homeostasis in neonates.
Topics: Blood Glucose; C-Peptide; Female; Glucagon; Glucagon-Like Peptide 1; Homeostasis; Humans; Infant, Newborn; Infant, Premature; Insulin; Insulin Resistance; Intensive Care Units, Neonatal; Male; New Zealand | 2017 |
TSC1-mTOR signaling determines the differentiation of islet cells.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Blood Glucose; Cell Differentiation; Diet, High-Fat; Glucagon; Glucose Clamp Technique; Glucose Intolerance; Insulin; Insulin Resistance; Islets of Langerhans; Mice; Mice, Knockout; Nerve Tissue Proteins; Signal Transduction; Somatostatin; Telomerase; TOR Serine-Threonine Kinases | 2017 |
Brain GLUT4 Knockout Mice Have Impaired Glucose Tolerance, Decreased Insulin Sensitivity, and Impaired Hypoglycemic Counterregulation.
Topics: Animals; Blood Glucose; Blotting, Western; Brain; Diet, High-Fat; Epinephrine; Glucagon; Glucose; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Glucose Transporter Type 4; Homeostasis; Hypoglycemia; Hypothalamus; In Vitro Techniques; Indinavir; Insulin Resistance; Male; Mice; Mice, Knockout; Neurons; Paraventricular Hypothalamic Nucleus; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley | 2017 |
Improvement in insulin sensitivity following intensive insulin therapy and association of glucagon with long-term diabetes remission.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Remission Induction | 2016 |
Nonsuppressed Glucagon After Glucose Challenge as a Potential Predictor for Glucose Tolerance.
Topics: Adult; Aged; Cohort Studies; Diabetes Mellitus, Type 2; Diet Therapy; Exercise; Female; Finland; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin Resistance; Life Style; Longitudinal Studies; Male; Middle Aged | 2017 |
The impact of kidney transplantation on insulin sensitivity.
Topics: Adult; Blood Glucose; Body Composition; Case-Control Studies; Female; Glucagon; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Kidney Transplantation; Lipolysis; Living Donors; Male; Middle Aged; Time Factors; Young Adult | 2017 |
Glucagon receptor inhibition normalizes blood glucose in severe insulin-resistant mice.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucagon; Glucagon-Secreting Cells; Humans; Hyperglycemia; Insulin; Insulin Resistance; Insulin-Secreting Cells; Ketosis; Mice; Mutation; Peptides; Receptor, Insulin; Receptors, Glucagon | 2017 |
Effects of a Novel Glucokinase Activator, HMS5552, on Glucose Metabolism in a Rat Model of Type 2 Diabetes Mellitus.
Topics: Animals; Blood Glucose; Carbohydrate Metabolism; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucagon; Glucokinase; Glucose Tolerance Test; Insulin; Insulin Resistance; Male; Rats; Rats, Sprague-Dawley; Triglycerides | 2017 |
Gastric bypass in the pig increases GIP levels and decreases active GLP-1 levels.
Topics: Animals; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Obesity; Sus scrofa | 2017 |
β-Cell Inactivation of
Topics: Adipokines; Animals; Apoptosis; Blood Glucose; Diabetes Mellitus, Experimental; Diet, High-Fat; Gene Expression Profiling; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Incretins; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Mice, Knockout; Oxadiazoles; Pyrimidines; Receptors, G-Protein-Coupled | 2017 |
The Characteristics of Hepatic Gsα-cAMP Axis in HSHF Diet-Fed Obese Insulin Resistance Rats and Genetic Diabetic Mice.
Topics: Animals; Blood Glucose; Cyclic AMP; Diabetes Mellitus; Diet, High-Fat; Dietary Sugars; Disease Models, Animal; Glucagon; GTP-Binding Protein alpha Subunits; Insulin; Insulin Resistance; Liver; Male; Mice, Inbred C57BL; Obesity; Rats, Wistar | 2017 |
Spontaneous diabetes in hemizygous human amylin transgenic mice that developed neither islet amyloid nor peripheral insulin resistance.
Topics: Amyloid; Animals; Apoptosis; Blood Glucose; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Glucagon; Glucose; Glucose Tolerance Test; Humans; Immunohistochemistry; Insulin Resistance; Islet Amyloid Polypeptide; Islets of Langerhans; Mice; Mice, Inbred Strains; Mice, Transgenic; Microscopy, Electron, Transmission; Somatostatin | 2008 |
Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes.
Topics: Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose; Glucose Clamp Technique; Glycerol; Heparin; Humans; Insulin; Insulin Resistance; Male; Metformin; Middle Aged; Pioglitazone; Thiazolidinediones | 2008 |
Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat.
Topics: Adipokines; Adiposity; Age Factors; Aging; Animals; Blood Glucose; Crosses, Genetic; Diabetes Mellitus, Type 2; Disease Models, Animal; Disease Progression; Female; Fertility; Ghrelin; Glucagon; Glucose Intolerance; Insulin; Insulin Resistance; Insulin-Secreting Cells; Intra-Abdominal Fat; Lipids; Male; Obesity; Rats; Rats, Sprague-Dawley; Rats, Zucker; Triglycerides | 2008 |
A lipid-parameter-based index for estimating insulin sensitivity and identifying insulin resistance in a healthy population.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Glucose; Body Mass Index; Fasting; Fatty Acids, Nonesterified; Glucagon; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Lipids; Middle Aged; Proinsulin; Reference Values; Waist-Hip Ratio | 2008 |
Hepatic glucose production and insulin resistance.
Topics: Adipokines; Animals; Blood Glucose; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Gluconeogenesis; Glycogenolysis; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Leptin; Liver; Male; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Signal Transduction; Triglycerides | 2008 |
Visceral fat and adiponectin: associations with insulin resistance are tissue-specific in women.
Topics: Absorptiometry, Photon; Adiponectin; Adiposity; Blood Glucose; Body Mass Index; Enzyme-Linked Immunosorbent Assay; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Intra-Abdominal Fat; Liver; Middle Aged; Muscle, Skeletal; Obesity; Octreotide; Postmenopause; Time Factors; Tomography, X-Ray Computed | 2009 |
Transgenic expression of insulin-response element binding protein-1 in beta-cells reproduces type 2 diabetes.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucagon; Glucagon-Secreting Cells; Glucose; Hyperinsulinism; Insulin; Insulin Resistance; Insulin-Secreting Cells; Iron Regulatory Protein 1; Mice; Mice, Transgenic; Obesity; Phenotype; Rats; Rats, Zucker; Somatostatin-Secreting Cells | 2009 |
Effects of insulin on ketogenesis following fasting in lean and obese men.
Topics: Adolescent; Adult; Blood Glucose; Body Mass Index; Body Weight; Energy Metabolism; Epinephrine; Fasting; Fatty Acids, Nonesterified; Glucagon; Humans; Hydrocortisone; Insulin; Insulin Resistance; Ketone Bodies; Male; Middle Aged; Obesity; Thinness; Young Adult | 2009 |
Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity.
Topics: Animals; Blood Glucose; Fasting; Fibroblast Growth Factors; Glucagon; Insulin Resistance; Liver; Liver Glycogen; Male; Mice; Mice, Obese | 2009 |
Mechanisms to conserve glucose in lactating women during a 42-h fast.
Topics: Adult; Algorithms; Blood Glucose; C-Peptide; Calorimetry, Indirect; Diet; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose; Hexoses; Humans; Insulin; Insulin Resistance; Isotope Labeling; Ketone Bodies; Kinetics; Lactates; Lactation; Milk, Human; Oxidation-Reduction | 2009 |
Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: implications for glucose metabolism and food choice behaviour.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Body Composition; Body Weight; Clozapine; Dibenzothiazepines; Dietary Fats; Disease Models, Animal; Eating; Exenatide; Food Preferences; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Hypoglycemic Agents; Insulin Resistance; Male; Obesity; Peptides; Pyrazines; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Sitagliptin Phosphate; Triazoles; Venoms | 2009 |
On the diagnosis and investigation of adrenal insufficiency in adults.
Topics: Adrenal Insufficiency; Adult; Diagnostic Techniques, Endocrine; Glucagon; Humans; Hypothalamic Diseases; Insulin Resistance; Metyrapone; Pituitary Diseases; Prognosis; Reference Values | 2010 |
Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.
Topics: Acute-Phase Proteins; Adiposity; Adult; Australia; Biomarkers; Blood Glucose; Case-Control Studies; China; Cross-Sectional Studies; England; Genotype; Glucagon; Glucose Clamp Technique; Hepacivirus; Hepatitis C, Chronic; Humans; Insulin; Insulin Resistance; Intra-Abdominal Fat; Lipocalin-2; Lipocalins; Liver; Magnetic Resonance Spectroscopy; Male; Middle Aged; Muscle, Skeletal; Proto-Oncogene Proteins; Receptors, Tumor Necrosis Factor, Type II; RNA, Viral; Subcutaneous Fat; Time Factors; Viral Load | 2010 |
Metabolic effects of free fatty acids during endotoxaemia in a porcine model--free fatty acid inhibition of growth hormone secretion as a potential catabolic feedback mechanism.
Topics: Animals; Endotoxemia; Endotoxins; Epinephrine; Fatty Acids, Nonesterified; Feedback, Physiological; Female; Glucagon; Glucose; Growth Hormone; Hydrocortisone; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipopolysaccharides; Norepinephrine; Swine | 2010 |
[Expression of glucagon in gestational and diet-induced hyperlipidemic gestational rats].
Topics: Animals; Blood Glucose; Diet; Female; Gene Expression Regulation; Glucagon; Glucose Tolerance Test; Hyperlipidemias; Insulin; Insulin Resistance; Pancreas; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications; Rats; RNA, Messenger | 2010 |
Hyperinsulinemic euglycemic step clamping with tracer glucose infusion and labeled glucose infusate for assessment of acute insulin resistance in pigs.
Topics: Animals; C-Peptide; Chromatography, Liquid; Dose-Response Relationship, Drug; Glucagon; Glucose; Glucose Clamp Technique; Hydrocortisone; Insulin; Insulin Resistance; Kinetics; Liver; Male; Swine; Tandem Mass Spectrometry | 2010 |
Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.
Topics: Adult; Area Under Curve; Blood Glucose; Body Weight; C-Peptide; Diet; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Resistance; Male; Motor Activity; Prednisolone | 2010 |
Insulin sensitivity and body composition in cirrhosis: changes after TIPS.
Topics: Body Composition; C-Peptide; Diabetes Mellitus; Energy Metabolism; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin Resistance; Liver; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Predictive Value of Tests; Rest | 2010 |
Increased beta-cell mass by islet transplantation and PLAG1 overexpression causes hyperinsulinemic normoglycemia and hepatic insulin resistance in mice.
Topics: Animals; Blood Glucose; Cell Division; DNA-Binding Proteins; Gene Expression Regulation; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Homeostasis; Hyperinsulinism; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans Transplantation; Mice; Mice, Inbred C57BL; Mice, Transgenic | 2010 |
Combination peroxisome proliferator-activated receptor gamma and alpha agonist treatment in Type 2 diabetes prevents the beneficial pioglitazone effect on liver fat content.
Topics: Abdominal Muscles; Adult; Aged; Bezafibrate; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Insulin Resistance; Liver; Middle Aged; Pioglitazone; PPAR alpha; PPAR gamma; Thiazolidinediones; Triglycerides | 2010 |
Glucose homeostasis in pre-diabetic NOD and lymphocyte-deficient NOD/SCID mice during gestation.
Topics: Animals; Blood Glucose; Corticosterone; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose Tolerance Test; Homeostasis; Insulin; Insulin Resistance; Islets of Langerhans; Lymphocytes; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Pancreas; Prediabetic State; Pregnancy; Pregnancy in Diabetics | 2010 |
Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Glucagon; Gluconeogenesis; Glucose; Glycosuria; Humans; Hyperglycemia; Insulin Resistance; Intestinal Absorption; Liver; Postprandial Period; Reference Values; Uridine Diphosphate Glucose | 2010 |
Systemic energy homeostasis in Huntington's disease patients.
Topics: Adult; Blood Glucose; Calorimetry, Indirect; Energy Metabolism; Female; Glucagon; Glucose Clamp Technique; Homeostasis; Humans; Huntingtin Protein; Huntington Disease; Insulin; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; Nerve Tissue Proteins; Nuclear Proteins; Signal Transduction; Trinucleotide Repeats | 2010 |
Distinguishing among incretin-based therapies. Glucose-lowering effects of incretin-based therapies.
Topics: Adamantane; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incretins; Insulin; Insulin Resistance; Liraglutide; Male; Metformin; Middle Aged; Peptides; Pyrazines; Receptors, Glucagon; Sitagliptin Phosphate; Triazoles; Venoms | 2010 |
Distinguishing among incretin-based therapies. Patient education and self-management.
Topics: Adamantane; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incretins; Insulin; Insulin Resistance; Liraglutide; Male; Metformin; Middle Aged; Patient Education as Topic; Peptides; Pyrazines; Receptors, Glucagon; Self Care; Sitagliptin Phosphate; Triazoles; Venoms | 2010 |
Basal alpha-cell up-regulation in obese insulin-resistant adolescents.
Topics: Adolescent; Analysis of Variance; Area Under Curve; Blood Glucose; C-Peptide; Glucagon; Glucagon-Secreting Cells; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Obesity; Regression Analysis; Up-Regulation; Young Adult | 2011 |
Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.
Topics: Adult; Area Under Curve; Blood Glucose; C-Peptide; Diet; Energy Intake; Fasting; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Motor Activity; Postprandial Period; Prednisolone; Young Adult | 2011 |
Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Cardiotonic Agents; Dipeptidyl-Peptidase IV Inhibitors; Glucagon; Glucagon-Like Peptide 1; Insulin; Insulin Resistance; Male; Myocardial Reperfusion Injury; Myocytes, Cardiac; Obesity; Pancreas; Phosphotransferases; Prediabetic State; Rats; Rats, Wistar | 2011 |
Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults.
Topics: Adolescent; Adult; Biomarkers; C-Peptide; Diabetes Mellitus, Type 1; Disease Progression; Fasting; Female; Glucagon; Glycated Hemoglobin; Humans; Insulin Resistance; Male; Proinsulin; Prospective Studies; Reference Values; Remission Induction; Young Adult | 2011 |
Evaluation of beta-cell sensitivity to glucose and first-phase insulin secretion in obese dogs.
Topics: Animals; Blood Glucose; Dog Diseases; Dogs; Glucagon; Glucose Tolerance Test; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Obesity | 2011 |
Dual modulation of GIP and glucagon action by the low molecular weight compound 4-hydroxybenzoic acid 2-bromobenzylidene hydrazide.
Topics: Adipokines; Animals; Benzene Derivatives; Gastric Inhibitory Polypeptide; Glucagon; Hydrocarbons, Brominated; Insulin Resistance; Male; Mice; Obesity; Parabens; Receptors, Gastrointestinal Hormone | 2011 |
Divergent effects of GLP-1 analogs exendin-4 and exendin-9 on the expression of myosin heavy chain isoforms in C2C12 myotubes.
Topics: Animals; Blotting, Western; Calcineurin; Calcium; Cell Differentiation; Cell Line; Cytosol; Exenatide; Gene Expression; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Hypoglycemic Agents; Insulin; Insulin Resistance; Mice; Muscle Fibers, Skeletal; Myoblasts; Myosin Heavy Chains; Peptide Fragments; Peptides; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Protein Isoforms; Receptors, Glucagon; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Trans-Activators; Transcription Factors; Venoms | 2011 |
Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women.
Topics: Alanine Transaminase; Diabetes Mellitus, Type 2; Female; gamma-Glutamyltransferase; Glucagon; Humans; Insulin; Insulin Resistance; Insulin Secretion; Liver; Male | 2011 |
Serum prolactin concentrations determine whether they improve or impair β-cell function and insulin sensitivity in diabetic rats.
Topics: Adiponectin; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Hydrocortisone; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Pancreatectomy; Prolactin; Rats; Rats, Sprague-Dawley; Testosterone | 2011 |
Effects of biotin deficiency on pancreatic islet morphology, insulin sensitivity and glucose homeostasis.
Topics: Animals; Biotin; Blood Glucose; Body Weight; Glucagon; Glucose Tolerance Test; Homeostasis; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred BALB C | 2012 |
Olanzapine effects on body composition, food preference, glucose metabolism and insulin sensitivity in the rat.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Body Composition; Body Weight; Diet, High-Fat; Food Preferences; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Liver; Male; Obesity; Olanzapine; Rats; Schizophrenia; Weight Gain | 2011 |
Circulating glucagon is associated with inflammatory mediators in metabolically compromised subjects.
Topics: Adult; Aged; Anthropometry; Body Mass Index; Cohort Studies; Complement Factor B; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Inflammation Mediators; Insulin Resistance; Interleukin-6; Lipid Metabolism; Male; Metabolic Diseases; Middle Aged; Obesity; Triglycerides; Weight Loss | 2011 |
Homozygous carriers of the G allele of rs4664447 of the glucagon gene (GCG) are characterised by decreased fasting and stimulated levels of insulin, glucagon and glucagon-like peptide (GLP)-1.
Topics: Adolescent; Adult; Age of Onset; Aged; Case-Control Studies; Child; Child, Preschool; Czechoslovakia; Denmark; Diabetes Mellitus, Type 2; Europe; Female; Genetic Association Studies; Glucagon; Glucagon-Like Peptide 1; Homozygote; Humans; Infant; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Obesity; Polymorphism, Single Nucleotide | 2011 |
Glucotoxicity and α cell dysfunction: involvement of the PI3K/Akt pathway in glucose-induced insulin resistance in rat islets and clonal αTC1-6 cells.
Topics: Animals; Cells, Cultured; Glucagon; Glucagon-Secreting Cells; Glucose; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction | 2012 |
Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Cardiotonic Agents; Glucagon; Glucagon-Like Peptide 1; Glucose; Glycolysis; Heart; Heart Rate; HEK293 Cells; Humans; Insulin Resistance; Male; Oxidation-Reduction; Palmitates; Peptides; Rats | 2012 |
Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states.
Topics: Adipose Tissue; Animals; Biological Transport; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Exenatide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Transporter Type 2; Glucose Transporter Type 4; Glycogen Synthase; Insulin Resistance; Liver; Male; Mitogen-Activated Protein Kinases; Muscle, Skeletal; Peptides; Phosphatidylinositol 3-Kinases; Rats; Rats, Wistar; Venoms | 2012 |
Effect of transjugular intrahepatic portosystemic shunt on glycometabolism in cirrhosis patients.
Topics: Adult; Aged; Algorithms; Cardiac Output; Case-Control Studies; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Hormones; Humans; Hyperinsulinism; Hypertension, Portal; Insulin Resistance; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Postoperative Care; Prediabetic State; Predictive Value of Tests; Preoperative Care; Sensitivity and Specificity; Treatment Outcome | 2012 |
Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses.
Topics: Animals; Glucagon; Gluconeogenesis; Glucose; Hepatocytes; Insulin Resistance; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; TNF Receptor-Associated Factor 2 | 2012 |
Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Body Weight; Energy Metabolism; Female; Glucagon; Glucose; Homeostasis; Homozygote; Hypothalamus; Insulin; Insulin Resistance; Leptin; Male; Mice; Mice, Inbred C57BL; Neurons; Pro-Opiomelanocortin; Receptors, Leptin | 2012 |
Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
Topics: Adult; Appetite; C-Peptide; Cholecystokinin; Confounding Factors, Epidemiologic; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Gastrins; Gastrointestinal Hormones; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Leptin; Male; Middle Aged; Obesity, Morbid; Pancreatic Polypeptide; Peptide YY; Postprandial Period; Somatostatin; Time Factors; Weight Loss | 2012 |
Melatonin can improve insulin resistance and aging-induced pancreas alterations in senescence-accelerated prone male mice (SAMP8).
Topics: Aging; Animals; Antioxidants; Follow-Up Studies; Gene Expression Regulation, Developmental; Glucagon; Glucose Transporter Type 2; Insulin; Insulin Resistance; Male; Melatonin; Mice; Oxidative Stress; Pancreas; Real-Time Polymerase Chain Reaction; RNA, Messenger | 2013 |
[Important therapy goal in diabetics. Intercept hypoglycemias!].
Topics: Aged; Autonomic Nervous System; Awareness; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Epinephrine; Glucagon; Glycated Hemoglobin; Humans; Hydrocortisone; Hypoglycemia; Hypoglycemic Agents; Insulin Resistance; Risk Factors | 2012 |
Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes.
Topics: Animals; Blood Glucose; Calcineurin; Calcium; Calcium Signaling; Cells, Cultured; Cyclic AMP; Diabetes Mellitus; Fasting; Gene Expression Regulation; Glucagon; Gluconeogenesis; HEK293 Cells; Hepatocytes; Humans; Inositol 1,4,5-Trisphosphate Receptors; Insulin Resistance; Liver; Mice; Phosphorylation; Trans-Activators; Transcription Factors | 2012 |
Improved blood glucose disposal and altered insulin secretion patterns in adenosine A(1) receptor knockout mice.
Topics: Animals; Blood Glucose; Diet, High-Fat; Eating; Glucagon; Glucose; Glucose Tolerance Test; Insulin; Insulin Resistance; Insulin Secretion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Adenosine A1; Weight Gain | 2012 |
Serum bile acids and leptin interact with glucose metabolism in patients with liver cirrhosis.
Topics: Adipose Tissue, White; Adult; Bile Acids and Salts; Female; Glucagon; Glucose; Humans; Hyperglycemia; Insulin Resistance; Intestinal Mucosa; Leptin; Liver; Liver Cirrhosis; Male; Middle Aged; Parenteral Nutrition; Postprandial Period | 2013 |
Major liver resection results in early exacerbation of insulin resistance, and may be a risk factor of developing overt diabetes in the future.
Topics: Adiponectin; Aged; Blood Glucose; Cohort Studies; Diabetes Mellitus; Disease Progression; Female; Glucagon; Glucose Tolerance Test; Hepatectomy; Homeostasis; Humans; Insulin; Insulin Resistance; Interleukin-6; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Risk; Time Factors; Tumor Necrosis Factor-alpha | 2013 |
Omeprazole improves the anti-obesity and antidiabetic effects of exendin-4 in db/db mice (-4 db/db)*.
Topics: Animals; Anti-Obesity Agents; Body Weight; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; Gastrins; Glucagon; Hypoglycemic Agents; Insulin Resistance; Leptin; Male; Mice; Mice, Inbred Strains; Mice, Obese; Obesity; Omeprazole; Peptides; Venoms | 2013 |
Measurement of glucose homeostasis in vivo: combination of tracers and clamp techniques.
Topics: Animals; Blood Glucose; Catheterization; Catheters, Indwelling; Equipment Design; Glucagon; Glucose; Glucose Clamp Technique; Glycogen; Homeostasis; Insulin; Insulin Resistance; Mice; Pancreas; Rats; Vascular Surgical Procedures | 2012 |
In vivo hyperpolarized carbon-13 magnetic resonance spectroscopy reveals increased pyruvate carboxylase flux in an insulin-resistant mouse model.
Topics: Animals; Aspartic Acid; Carbon Isotopes; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucagon; Gluconeogenesis; Insulin Resistance; Liver; Magnetic Resonance Spectroscopy; Malates; Male; Mice; Mice, Inbred C57BL; Pyruvate Carboxylase; Pyruvic Acid | 2013 |
Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling.
Topics: Adipose Tissue, Brown; Animals; Central Nervous System; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Insulin Resistance; Ion Channels; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondrial Proteins; Nerve Tissue Proteins; Neurons; Oxyntomodulin; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Receptors, Glucagon; Scapula; Signal Transduction; Sympathetic Nervous System; Thermogenesis; Trans-Activators; Transcription Factors; Uncoupling Protein 1; Up-Regulation | 2012 |
Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women.
Topics: Adult; Alcohol Drinking; Blood Pressure; Fasting; Female; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Middle Aged; Surveys and Questionnaires; Women's Health | 2012 |
Kinetic modeling of human hepatic glucose metabolism in type 2 diabetes mellitus predicts higher risk of hypoglycemic events in rigorous insulin therapy.
Topics: Algorithms; Blood Glucose; Carbohydrate Metabolism; Computer Simulation; Diabetes Mellitus, Type 2; Epinephrine; Glucagon; Glucose; Glycogen; Hepatocytes; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Kinetics; Liver; Models, Biological; Phosphorylation; Postprandial Period; Protein Processing, Post-Translational | 2012 |
Chronic activation of cannabinoid receptors in vitro does not compromise mouse islet function.
Topics: Animals; Cannabinoid Receptor Agonists; Glucagon; Indoles; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Mice; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2013 |
Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dietary Fats; Eating; Glucagon; Glucose Tolerance Test; Insulin; Insulin Resistance; Lipids; Mice; Mice, Obese; Obesity; Pancreas; Receptors, Cholecystokinin; Sincalide | 2013 |
Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy.
Topics: Adiponectin; Age Factors; Aged; Blood Pressure; Body Mass Index; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Clamp Technique; Homeostasis; Humans; Insulin; Insulin Resistance; Intra-Abdominal Fat; Male; Middle Aged; Models, Biological; Reproducibility of Results; Triglycerides; Waist Circumference | 2013 |
Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor.
Topics: Animals; Blood Glucose; Female; Glucagon; Glucagon-Secreting Cells; Glucose; Hepatocytes; Hyperplasia; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Islets of Langerhans; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Glucagon; Signal Transduction | 2013 |
Sex differences in insulin resistance in GABAB1 knockout mice.
Topics: Animals; Eating; Female; Gene Expression Regulation; Glucagon; Hypothalamus; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Insulin Secretion; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Muscle, Skeletal; Neuropeptide Y; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, Insulin; Receptors, GABA-B; Sex Characteristics | 2013 |
Choline supplementation promotes hepatic insulin resistance in phosphatidylethanolamine N-methyltransferase-deficient mice via increased glucagon action.
Topics: Animals; Base Sequence; Choline; DNA Primers; Glucagon; Gluconeogenesis; Glucose Tolerance Test; Insulin Resistance; Liver; Mice; Mice, Inbred C57BL; Phosphatidylethanolamine N-Methyltransferase | 2013 |
A preliminary investigation of the mechanisms underlying the effect of berberine in preventing high-fat diet-induced insulin resistance in rats.
Topics: Animals; Berberine; Cells, Cultured; Diet, High-Fat; Fatty Acids, Nonesterified; Glucagon; Glucagon-Secreting Cells; Glucose Tolerance Test; Hepatocytes; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Insulin-Secreting Cells; Male; Rats; Rats, Wistar; Receptor, Insulin; Triglycerides | 2012 |
Increased amino acid supply potentiates glucose-stimulated insulin secretion but does not increase β-cell mass in fetal sheep.
Topics: Amino Acids; Amino Acids, Branched-Chain; Animals; Animals, Inbred Strains; Arginine; Electrolytes; Female; Fetal Weight; Glucagon; Glucagon-Secreting Cells; Glucose; Infusions, Intravenous; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Organ Size; Pancreas; Pregnancy; Random Allocation; Sheep, Domestic; Solutions | 2013 |
Insulin sensitively controls the glucagon response to mild hypoglycemia in the dog.
Topics: Alanine; Animals; Blood Glucose; Consciousness; Dihydropyridines; Dogs; Fasting; Fatty Acids, Nonesterified; Female; Furans; Glucagon; Gluconeogenesis; Glycerol; Glycogen; Hypoglycemia; Insulin; Insulin Resistance; Islets of Langerhans; Ketones; Lactic Acid; Liver; Liver Circulation; Male | 2002 |
Reduction of hepatic glycogen synthesis and breakdown in patients with agenesis of the dorsal pancreas.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose Tolerance Test; Glycogen; Human Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Resistance; Insulin Secretion; Kinetics; Leptin; Liver; Magnetic Resonance Spectroscopy; Male; Middle Aged; Norepinephrine; Pancreas | 2002 |
Elevated glucagon-like peptide-1-(7-36)-amide, but not glucose, associated with hyperinsulinemic compensation for fat feeding.
Topics: Animals; Blood Glucose; Blotting, Northern; Dietary Fats; Dogs; Fasting; Fatty Acids, Nonesterified; Gene Expression; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Glucose; Glucose Tolerance Test; Hyperinsulinism; Insulin; Insulin Resistance; Islets of Langerhans; Kinetics; Magnetic Resonance Imaging; Male; Obesity; Peptide Fragments; Receptors, Glucagon; Reverse Transcriptase Polymerase Chain Reaction | 2002 |
An inadequate glycaemic response to glucagon is linked to insulin resistance in preterm infants?
Topics: Blood Glucose; Fasting; Glucagon; Humans; Infant, Newborn; Infant, Premature; Injections, Intravenous; Insulin; Insulin Resistance; Predictive Value of Tests | 2003 |
Combined pancreas and kidney transplantation in a lean type 2 diabetic patient. Effects on insulin secretion and sensitivity.
Topics: Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Kidney Function Tests; Kidney Transplantation; Middle Aged; Pancreas Transplantation | 2002 |
Residual C-peptide secretion and endothelial function in patients with Type II diabetes.
Topics: Aged; Analysis of Variance; Area Under Curve; Brachial Artery; C-Peptide; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Glucagon; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Nitroglycerin; Oxidative Stress; Regional Blood Flow; Thiobarbituric Acid Reactive Substances; Ultrasonography; Vasodilator Agents | 2003 |
Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens.
Topics: Adipose Tissue; Adult; Blood Glucose; Body Composition; Body Constitution; C-Peptide; CD4 Lymphocyte Count; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Glucose Intolerance; Glycated Hemoglobin; Glycerol; HIV Infections; HIV Protease Inhibitors; Homeostasis; Humans; Insulin; Insulin Resistance; Islets of Langerhans; Lipids; Liver; Male; Middle Aged; Muscle, Skeletal; Proinsulin; Viral Load | 2003 |
PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance.
Topics: Aging; Animals; Carrier Proteins; Female; Gene Deletion; Glucagon; Glucose; Glycogen; Glycogen Synthase; Homeostasis; Humans; Insulin; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Liver; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Phosphoprotein Phosphatases; Signal Transduction; Triglycerides | 2003 |
Metabolic adaptations to dexamethasone-induced insulin resistance in healthy volunteers.
Topics: Adult; Blood Glucose; Dexamethasone; Fatty Acids, Nonesterified; Female; Glucagon; Glucocorticoids; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Triglycerides | 2003 |
Interferon-alpha reduces insulin resistance and beta-cell secretion in responders among patients with chronic hepatitis B and C.
Topics: Adult; Alanine Transaminase; Analysis of Variance; Autoantibodies; Blood Glucose; C-Peptide; Chi-Square Distribution; Diabetes Mellitus, Type 1; DNA, Viral; Female; Glucagon; Glucose Tolerance Test; Hepatitis B e Antigens; Hepatitis B, Chronic; Hepatitis C, Chronic; Homeostasis; Humans; Insulin; Insulin Resistance; Insulin Secretion; Interferon-alpha; Islets of Langerhans; Male; Middle Aged | 2003 |
Studies with glucagon in patients with insulin sensitivity.
Topics: Blood Glucose; Diabetes Mellitus; Glucagon; Hormones; Humans; Insulin; Insulin Resistance; Pancreas; Pancreatic Hormones | 1955 |
Influence of adrenal extirpation, adrenal cortex hormones and glucagon on the insulin-sensitivity of eviscerated rats
Topics: Adrenal Cortex Hormones; Adrenalectomy; Animals; Glucagon; Insulin; Insulin Resistance; Rats | 1962 |
[CLINICAL SIGNIFICANCE OF INSULIN RESISTANCE].
Topics: Acidosis; Acromegaly; Adrenal Gland Diseases; Drug Hypersensitivity; Endopeptidases; Glucagon; Humans; Hyperthyroidism; Insulin; Insulin Antibodies; Insulin Resistance; Peptide Hydrolases; Surgical Procedures, Operative; Toxicology; Trypsin | 1964 |
LIPOATROPHIC DIABETES. I. STUDIES CONCERNING ENDOCRINE FUNCTION AND CARBOHYDRATE METABOLISM.
Topics: Adolescent; Carbohydrate Metabolism; Diabetes Mellitus, Lipoatrophic; Diabetes Mellitus, Type 1; Drug Tolerance; Epinephrine; Fatty Acids; Glucagon; Glucose Tolerance Test; Hepatomegaly; Humans; Infant; Insulin; Insulin Resistance; L-Lactate Dehydrogenase; Leucine; Lipids; Lipodystrophy; Liver; Liver Cirrhosis; Liver Function Tests; Metyrapone; Pharmacology; Pituitary-Adrenal Function Tests; Radiography; Tolbutamide; Transaminases; Urine | 1965 |
[THE EFFECT OF GLUCAGON IN PATIENTS WITH INSULIN RESISTANCE OR INSULIN ALLERGY].
Topics: Diabetes Mellitus; Drug Hypersensitivity; Geriatrics; Glucagon; Humans; Insulin; Insulin Resistance; Pharmacology; Skin Tests; Toxicology | 1965 |
Impaired glucose homeostasis in mice lacking the alpha1b-adrenergic receptor subtype.
Topics: Animals; Blood Glucose; Body Weight; Glucagon; Glucose; Glycogen; Homeostasis; Hyperinsulinism; Insulin Resistance; Leptin; Liver; Male; Mice; Mice, Mutant Strains; Mice, Obese; Receptors, Adrenergic; Receptors, Adrenergic, alpha-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2004 |
Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region.
Topics: Animals; Blood Glucose; Dogs; Dose-Response Relationship, Drug; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Infusions, Intravenous; Insulin; Insulin Resistance; Liver; Male; Metabolic Clearance Rate; Peptide Fragments; Portal System; Protein Precursors | 2004 |
Loss-of-function mutation of the galanin gene is associated with perturbed islet function in mice.
Topics: Animals; Antimetabolites; Body Weight; Deoxyglucose; Galanin; Glucagon; Glucose; Glucose Clamp Technique; Hyperinsulinism; Hypoglycemic Agents; Immunohistochemistry; Insulin; Insulin Resistance; Islets of Langerhans; Mice; Mice, Inbred Strains; Mice, Knockout; Sympathetic Nervous System | 2004 |
Elevated fasting plasma ghrelin in prader-willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance.
Topics: Adipose Tissue; Adult; Case-Control Studies; Fasting; Female; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin Resistance; Male; Middle Aged; Peptide Fragments; Peptide Hormones; Prader-Willi Syndrome; Protein Precursors; Regression Analysis; Viscera | 2004 |
Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
Topics: Administration, Oral; Area Under Curve; Blood Glucose; Body Weight; C-Peptide; Case-Control Studies; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Liver; Middle Aged; Peptide Fragments; Protein Precursors; Regression Analysis; Time Factors | 2004 |
Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting.
Topics: Adult; Amino Acids; Blood Flow Velocity; Blood Glucose; Calorimetry, Indirect; Fasting; Fatty Acids, Nonesterified; Forearm; Glucagon; Glucose Clamp Technique; Glycerol; Human Growth Hormone; Humans; Insulin; Insulin Resistance; Lactic Acid; Lipolysis; Male; Microdialysis; Plethysmography; Pyrazines; Somatostatin | 2004 |
Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.
Topics: Animals; Blood Glucose; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Consciousness; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Energy Metabolism; Fatty Acids; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Clamp Technique; Heart Failure; Hemodynamics; Hyperinsulinism; Infusions, Intravenous; Insulin Resistance; Male; Myocardium; Oxygen Consumption; Peptide Fragments; Protein Precursors; Recombinant Proteins; Ventricular Dysfunction, Left | 2004 |
Cardiac metabolism as a target for the treatment of heart failure.
Topics: Acetanilides; Animals; Dogs; Energy Metabolism; Epoxy Compounds; Fatty Acids; Forecasting; Glucagon; Glucagon-Like Peptide 1; Glucose; Heart Failure; Humans; Insulin Resistance; Myocardium; Peptide Fragments; Piperazines; Protein Precursors; Ranolazine; Recombinant Proteins | 2004 |
Beta-cell dysfunction in classic transient neonatal diabetes is characterized by impaired insulin response to glucose but normal response to glucagon.
Topics: Chromosome Aberrations; Chromosomes, Human, Pair 6; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Humans; Infant, Newborn; Insulin; Insulin Resistance; Islets of Langerhans; Male; Pedigree; Rare Diseases; Remission, Spontaneous; Risk Assessment; Sampling Studies; Siblings | 2004 |
Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Diet; Energy Intake; Family; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Glucose Intolerance; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Linear Models; Male; Models, Biological; Multivariate Analysis; Peptide Fragments; Protein Precursors | 2005 |
Insulin resistance and abomasal motility disorders in cows detected by use of abomasoduodenal electromyography after surgical correction of left displaced abomasum.
Topics: 3-Hydroxybutyric Acid; Abomasum; Animals; Blood Glucose; Cattle; Cattle Diseases; Electromyography; Fatty Acids, Nonesterified; Female; Gastrointestinal Motility; Glucagon; Hydrocortisone; Insulin; Insulin Resistance; Stomach Diseases | 2004 |
[The role of incretins. Type 2 diabetes with new beginnings].
Topics: Diabetes Mellitus, Type 2; Disease Progression; Exenatide; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Peptide Fragments; Peptides; Protein Precursors; Venoms | 2005 |
Increased glucose tolerance in N-type Ca2+ channel alpha(1B)-subunit gene-deficient mice.
Topics: Animals; Blood Glucose; Body Weight; Calcium Channels, N-Type; Crosses, Genetic; Dietary Fats; Eating; Fasting; Glucagon; Glucose; Glucose Tolerance Test; Heterozygote; Homeostasis; Homozygote; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Obesity; Polymerase Chain Reaction; Protein Subunits | 2005 |
Diabetogenic effects and pancreatic oxidative damage in rats subchronically exposed to arsenite.
Topics: Animals; Arsenites; Blood Glucose; Enzyme Inhibitors; Glucagon; Glutathione; Immunohistochemistry; Insulin Resistance; Lipid Peroxidation; Male; Models, Animal; Oxidative Stress; Pancreas; Rats; Rats, Wistar; Sodium Compounds; Thioredoxin-Disulfide Reductase | 2006 |
Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats.
Topics: Acetylcholine; Adenoviridae; Adiponectin; Animals; Aorta; Blood Glucose; Body Weight; Cardiovascular Physiological Phenomena; Diabetes Mellitus, Experimental; Erythrocytes; Genetic Therapy; Glucagon; Hemoglobins; Humans; In Vitro Techniques; Injections, Intravenous; Insulin; Insulin Resistance; Leptin; Lipids; Liver; Male; Nitric Oxide Synthase; Nitroprusside; Peptide Hormones; Rats; Rats, Sprague-Dawley; Vasodilation | 2006 |
FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
Topics: Animals; Benzimidazoles; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Dogs; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Clamp Technique; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin, Isophane; Liver; Male; PPAR gamma; Tritium | 2005 |
[Novel therapy in type 2 diabetes: to regulate glucose metabolism naturally].
Topics: Animals; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Exenatide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemic Agents; Infant, Newborn; Insulin Resistance; Lizards; Peptide Fragments; Peptides; Protein Precursors; Time Factors; Venoms | 2005 |
VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity.
Topics: Adipose Tissue; Animals; Diet; Disease Models, Animal; Disease Susceptibility; Energy Intake; Glucagon; Glucose; Homeostasis; Hyperglycemia; Hyperinsulinism; Hypoglycemia; Injections, Intraperitoneal; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Growth Factors; Neuropeptides; Obesity; Proteins; Receptor, Melanocortin, Type 4 | 2005 |
Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during thyroid hormone replacement therapy.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Female; Glucagon; Glucose Clamp Technique; Hormones; Human Growth Hormone; Humans; Hydrocortisone; Hypothyroidism; Insulin; Insulin Resistance; Insulin Secretion; Thyroid Hormones | 2005 |
Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Biopsy; Diabetes Mellitus, Type 2; Duodenum; Enteroendocrine Cells; Enzyme-Linked Immunosorbent Assay; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glucose Tolerance Test; Humans; Immunohistochemistry; Insulin; Insulin Resistance; Male; Middle Aged; Peptide Fragments; Reverse Transcriptase Polymerase Chain Reaction | 2006 |
Increased glucose tolerance and reduced adiposity in the absence of fasting hypoglycemia in mice with liver-specific Gs alpha deficiency.
Topics: Adiposity; Animals; Eating; Fasting; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; GTP-Binding Protein alpha Subunits, Gs; Hypoglycemia; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Lipid Metabolism; Liver; Male; Mice; Mice, Knockout; Mice, Transgenic; Oxygen Consumption; Signal Transduction | 2005 |
[A study on the mechanism of islet cell insulin resistance in high-fat-diet obese rats].
Topics: Animals; Diet, High-Fat; Glucagon; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Obesity; Rats; Rats, Wistar; Receptor, Insulin; Signal Transduction | 2005 |
Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes.
Topics: Adiponectin; Adult; Anthropometry; Blood Glucose; Calorimetry, Indirect; Case-Control Studies; Diabetes Mellitus, Type 1; Energy Metabolism; Female; Glucagon; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Lipids; Liver; Magnetic Resonance Spectroscopy; Male; Oxidation-Reduction | 2005 |
Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes.
Topics: Animals; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Type 2; Dietary Sucrose; Disease Models, Animal; Glucagon; Glucose; Homeostasis; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Mice; Mice, Inbred Strains; Receptor, Insulin | 2006 |
Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system.
Topics: Animals; Female; GABA-A Receptor Antagonists; Glucagon; Glucagon-Secreting Cells; Guinea Pigs; Humans; Insulin; Insulin Resistance; Islets of Langerhans; Male; Models, Biological; Rats; Rats, Sprague-Dawley; Receptors, GABA-A | 2006 |
Taiwanese vegetarians have higher insulin sensitivity than omnivores.
Topics: Adult; Blood Glucose; Body Mass Index; Body Size; Diet, Vegetarian; Energy Intake; Feeding Behavior; Female; Glucagon; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Middle Aged; Taiwan | 2006 |
Glucose-stimulated prehepatic insulin secretion is associated with circulating alanine, triglyceride, glucagon, lactate and TNF-alpha in patients with HIV-lipodystrophy.
Topics: Adult; Alanine; C-Peptide; Case-Control Studies; Glucagon; Glucose; Glucose Clamp Technique; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Infusions, Intravenous; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Lactates; Male; Middle Aged; Stimulation, Chemical; Triglycerides; Tumor Necrosis Factor-alpha | 2006 |
Sexual dimorphism in insulin sensitivity and susceptibility to develop diabetes in rats.
Topics: Animals; Biomarkers; Blood Glucose; Body Composition; Diabetes Mellitus, Experimental; Disease Susceptibility; Female; Glucagon; Glucose Tolerance Test; Immunohistochemistry; Insulin; Insulin Resistance; Islets of Langerhans; Male; Microscopy, Confocal; Niacinamide; Rats; Rats, Wistar; Sex Characteristics | 2006 |
Distinct endocrine effects of chronic haloperidol or risperidone administration in male rats.
Topics: Adipose Tissue; Animals; Antipsychotic Agents; Appetite; Body Weight; Corticosterone; Diabetes Mellitus, Type 2; Endocrine System; Energy Intake; Glucagon; Haloperidol; Hyperinsulinism; Insulin; Insulin Resistance; Insulin Secretion; Lipid Metabolism; Male; Obesity; Rats; Rats, Sprague-Dawley; Risperidone; Species Specificity; Testosterone; Weight Gain | 2006 |
[Study of relationship between stress hyperglycemia and insulin-resistance related factors].
Topics: Adult; Aged; C-Peptide; Critical Illness; Female; Glucagon; Humans; Hydrocortisone; Hyperglycemia; Insulin; Insulin Resistance; Intensive Care Units; Male; Middle Aged; Stress, Physiological; Tumor Necrosis Factor-alpha; Young Adult | 2006 |
Restructuring of pancreatic islets and insulin secretion in a postnatal critical window.
Topics: Age Factors; Animals; Blood Glucose; Cell Aggregation; Cell Count; Cells, Cultured; Diet; Glucagon; Glucagon-Secreting Cells; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Islets of Langerhans; Male; Rats; Rats, Wistar; Weaning | 2006 |
[The expression of insulin signal transduction molecules and islet alpha cell insulin resistance].
Topics: Adaptor Proteins, Signal Transducing; Animals; Blood Glucose; Fatty Acids, Nonesterified; Gene Expression; Glucagon; Glucose Clamp Technique; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Islets of Langerhans; Male; Phosphatidylinositol 3-Kinases; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Insulin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Triglycerides | 2006 |
Awareness of pathophysiological concepts of type 2 diabetes: a survey in 847 physicians.
Topics: Clinical Competence; Diabetes Mellitus, Type 2; Family Practice; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose; Humans; Insulin Resistance; Insulin-Secreting Cells; Liver; Online Systems; Primary Health Care; Surveys and Questionnaires | 2007 |
Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis.
Topics: Adipose Tissue; Blood Glucose; Body Mass Index; C-Peptide; Fasting; Female; Glucagon; Gluconeogenesis; Glucose Intolerance; Humans; Hyperglycemia; Insulin Resistance; Liver; Male; Middle Aged; Reference Values | 2007 |
Glucagon as a determinant of fibrinolytic activity in men with different stages of glucose tolerance: impact of glucagon on fibrinolysis.
Topics: Aged; Area Under Curve; Diabetes Mellitus, Type 2; Fibrinolysis; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin Resistance; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator | 2007 |
Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet.
Topics: Animal Feed; Animals; Blood Glucose; Diet; Female; Glucagon; Glucose Tolerance Test; Insulin; Insulin Resistance; Islets of Langerhans; Mice; Mice, Inbred C57BL; Oxygen; Receptors, Glucagon; Time Factors | 2007 |
Pancreatic insulin secretion in rats fed a soy protein high fat diet depends on the interaction between the amino acid pattern and isoflavones.
Topics: Amino Acids; Animals; Blood Glucose; Caseins; Cells, Cultured; Dietary Fats; Dietary Proteins; Gene Expression Regulation; Glucagon; Glucose Clamp Technique; Glucose Transporter Type 2; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Isoflavones; Leptin; Obesity; PPAR gamma; Rats; Rats, Sprague-Dawley; Soybean Proteins; Sterol Regulatory Element Binding Protein 1 | 2007 |
The common C49620T polymorphism in the sulfonylurea receptor gene (ABCC8), pancreatic beta cell function and long-term diabetic complications in obese patients with long-lasting type 2 diabetes mellitus.
Topics: Aged; ATP-Binding Cassette Transporters; Chronic Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Injections, Intravenous; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged; Obesity; Polymorphism, Single Nucleotide; Potassium Channels; Potassium Channels, Inwardly Rectifying; Prevalence; Receptors, Drug; Stroke; Sulfonylurea Receptors; Time Factors | 2007 |
Contributions of glucokinase and phosphofructokinase-2/fructose bisphosphatase-2 to the elevated glycolysis in hepatocytes from Zucker fa/fa rats.
Topics: Animals; Cells, Cultured; Gene Expression Regulation, Enzymologic; Glucagon; Glucokinase; Glucose; Glycolysis; Hepatocytes; Insulin Resistance; Male; Phosphofructokinase-2; Rats; Rats, Zucker; Recombinant Proteins | 2007 |
Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets.
Topics: Adiponectin; Animals; Blood Glucose; Body Weight; Corticosterone; Dietary Fats; Eating; Gastric Inhibitory Polypeptide; Glucagon; Glucose Intolerance; Glycated Hemoglobin; Insulin; Insulin Resistance; Lipids; Locomotion; Male; Mice; Mice, Obese; Obesity; Receptors, Gastrointestinal Hormone | 2007 |
Possible role of alpha-cell insulin resistance in exaggerated glucagon responses to arginine in type 2 diabetes.
Topics: Adult; Aged; Area Under Curve; Arginine; Body Mass Index; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin Resistance; Insulin-Secreting Cells; Japan; Male; Middle Aged; Reference Values | 2007 |
Susceptibility to oxidative stress, insulin resistance, and insulin secretory response in the development of diabetes from obesity.
Topics: Adult; Antioxidants; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin; Insulin Resistance; Insulin Secretion; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Obesity; Oxidative Stress | 2007 |
Association of fasting glucagon and proinsulin concentrations with insulin resistance.
Topics: Adolescent; Adult; Analysis of Variance; Body Mass Index; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin Resistance; Male; Multivariate Analysis; Proinsulin | 2007 |
GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
Topics: Adipokines; Adipose Tissue; Animals; Anti-Obesity Agents; Blood Glucose; Body Weight; Corticosterone; Dietary Fats; Eating; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Incretins; Insulin; Insulin Resistance; Lipids; Liver; Male; Mice; Motor Activity; Muscle, Skeletal; Obesity; Pancreas; Receptors, Gastrointestinal Hormone | 2007 |
Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; C-Peptide; Eating; Female; Food; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemia; Incretins; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Obesity, Morbid; Postoperative Complications | 2007 |
[The relationship between islet alpha cell insulin resistance and inflammatory pathway activation and its mechanism].
Topics: Animals; Fatty Acids, Nonesterified; Glucagon; Hypoglycemic Agents; Inflammation; Insulin; Insulin Resistance; Islets of Langerhans; Male; Pioglitazone; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiazolidinediones | 2007 |
Hepatic insulin resistance in antipsychotic naive schizophrenic patients: stable isotope studies of glucose metabolism.
Topics: Absorptiometry, Photon; Adult; Blood Glucose; Body Composition; Calorimetry, Indirect; Case-Control Studies; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glucose Clamp Technique; Humans; Hydrocortisone; Insulin; Insulin Resistance; Liver; Male; Norepinephrine; Oxygen Consumption; Schizophrenia; Statistics, Nonparametric | 2008 |
Independent measures of insulin secretion and insulin sensitivity during the same test: the glucagon-insulin tolerance test.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Hormones; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Reproducibility of Results | 2008 |
Increased pancreatic islet mass is accompanied by activation of the insulin receptor substrate-2/serine-threonine kinase pathway and augmented cyclin D2 protein levels in insulin-resistant rats.
Topics: Animals; Cell Cycle Proteins; Cell Proliferation; Cyclin D2; Cyclins; Dexamethasone; Glucagon; Immunoenzyme Techniques; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Islets of Langerhans; Male; Microscopy, Electron, Transmission; Models, Animal; Phosphoproteins; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Signal Transduction | 2008 |
Diabetes mellitus: customizing management.
Topics: Adult; Aging; Biguanides; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dietary Fats; Dietary Fiber; Female; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Male; Monitoring, Physiologic; Pregnancy; Pregnancy in Diabetics; Sulfonylurea Compounds | 1984 |
Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in non-obese subjects with impaired glucose tolerance.
Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Glucagon; Glucose Tolerance Test; Glycerol; Humans; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Male; Reference Values; Somatostatin | 1981 |
[Measurement of insulin sensitivity using the somatostatin-insulin-glucose test. Importance of the determination of plasma free fatty acids and insulin clearance].
Topics: Adult; Aged; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Male; Perfusion; Somatostatin | 1983 |
Insulin and glucagon binding to isolated hepatocytes of Egyptian sand rats (Psammomys obesus): evidence for an insulin receptor defect.
Topics: Animals; Arvicolinae; Binding Sites; Female; Glucagon; Insulin; Insulin Resistance; Liver; Male; Rats; Rats, Inbred Strains; Receptor, Insulin | 1984 |
The binding of pancreatic hormones to isolated chicken hepatocytes.
Topics: Animals; Cell Separation; Chickens; Glucagon; Insulin; Insulin Resistance; Kinetics; Liver; Male; Pancreatic Hormones; Pancreatic Polypeptide; Receptors, Cell Surface | 1982 |
[Insulin and glucagon receptors in the liver. Their regulation].
Topics: Animals; Binding, Competitive; Cyclic AMP; Glucagon; Humans; Insulin Resistance; Liver; Rats; Rats, Zucker; Receptor, Insulin; Receptors, Cell Surface; Receptors, Glucagon | 1981 |
Glucose intolerance in spinal cord injury.
Topics: Adult; Blood Glucose; Glucagon; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Middle Aged; Spinal Cord Injuries | 1983 |
[The role of insulin-dependent cytoplasmic regulator in carbohydrate metabolism during immobilization].
Topics: Animals; Cytoplasm; Diaphragm; Glucagon; Gluconeogenesis; Immobilization; Insulin; Insulin Resistance; Liver; Liver Glycogen; Male; Mitochondria, Liver; Myocardium; Rats; Stress, Physiological | 1983 |
Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids in acquired total lipodystrophy: effects on hyperlipoproteinemia and endogenous insulin resistance.
Topics: Adolescent; Chylomicrons; Dietary Fats; Fatty Acids; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Lipids; Lipodystrophy; Lipoproteins; Male; Triglycerides; Xanthomatosis | 1983 |
Epinephrine acutely mediates skeletal muscle insulin resistance.
Topics: Adult; Epinephrine; Fatty Acids, Nonesterified; Female; Forearm; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Lactates; Male; Muscles; Pyruvates | 1983 |
Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels.
Topics: Administration, Oral; Adolescent; Adult; Arginine; Blood Glucose; Contraceptives, Oral, Combined; Drug Combinations; Female; Glucagon; Glucose Tolerance Test; Humans; Infusions, Parenteral; Insulin; Insulin Resistance; Mestranol; Norethindrone | 1983 |
Normal insulin sensitivity of the islets of Langerhans in obese subjects with resistance to its glucoregulatory actions.
Topics: Adult; Blood Glucose; C-Peptide; Glucagon; Humans; Insulin; Insulin Infusion Systems; Insulin Resistance; Islets of Langerhans; Male; Obesity | 1984 |
Induction of insulin resistance in normal adipose tissue by uremic human serum.
Topics: Adipose Tissue; Adult; Aged; Animals; Blood Urea Nitrogen; Creatinine; Culture Techniques; Female; Glucagon; Glucose; Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Resistance; Lipolysis; Male; Middle Aged; Parathyroid Hormone; Rats; Rats, Inbred Strains; Uremia | 1984 |
Insulin resistance in a young man with cystic fibrosis.
Topics: Adolescent; Cystic Fibrosis; Gastric Inhibitory Polypeptide; Glucagon; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Male; Obesity; Receptor, Insulin | 1984 |
Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation?
Topics: Adult; Blood Glucose; C-Peptide; Gastric Inhibitory Polypeptide; Glucagon; Hemochromatosis; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Liver; Male; Middle Aged | 1984 |
Glucose counterregulation and waning of insulin in the Somogyi phenomenon (posthypoglycemic hyperglycemia).
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Epinephrine; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hyperglycemia; Insulin; Insulin Resistance; Male; Norepinephrine | 1984 |
Impaired plasma amino-acid clearance in patients with cirrhosis of the liver and portocaval shunt--its relation to insulin resistance.
Topics: 3-Hydroxybutyric Acid; Adult; Amino Acids; Blood Glucose; C-Peptide; Catecholamines; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hydroxybutyrates; Insulin; Insulin Resistance; Liver Cirrhosis; Male; Middle Aged; Portacaval Shunt, Surgical; Reference Values | 1984 |
Glucoregulation in obese man: effects of fasting, glucagon infusion, exercise and diabetes.
Topics: Diabetes Mellitus; Fasting; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Obesity; Physical Exertion | 1982 |
Insulin resistance and decreased insulin response to glucose in lean type 2 diabetics.
Topics: Adult; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male; Middle Aged | 1982 |
Mechanisms of insulin resistance following injury.
Topics: Adult; Blood Glucose; Female; Glucagon; Humans; Hyperglycemia; Insulin; Insulin Resistance; Male; Middle Aged; Wounds and Injuries | 1982 |
Evaluation of insulin resistance in non-obese subjects with impaired glucose tolerance.
Topics: Blood Glucose; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glucose Tolerance Test; Glycerol; Humans; Insulin; Insulin Resistance; Kinetics; Male; Propranolol; Reference Values | 1982 |
[Changes in carbohydrate metabolism in hepatic cirrhosis].
Topics: Carbohydrate Metabolism; Diabetes Mellitus; Glucagon; Glucose Tolerance Test; Humans; Insulin Resistance; Liver Cirrhosis; Male; Middle Aged | 1983 |
Therapy of insulin-independent diabetes mellitus: general considerations.
Topics: Blood Glucose; Diabetes Mellitus; Glucagon; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Obesity; Reference Values; Tolbutamide | 1980 |
Resistance to insulin but not to glucagon in lean human hypertriglyceridemics.
Topics: Adult; Blood Glucose; Cholesterol; Female; Glucagon; Glucose Tolerance Test; Humans; Hyperlipoproteinemia Type IV; Insulin; Insulin Resistance; Kinetics; Male; Middle Aged; Reference Values; Triglycerides | 1980 |
[Investigation of insulin resistance in fourteen children starting a diabetes mellitus (author's transl)].
Topics: Adolescent; Blood Glucose; Child; Child, Preschool; Diabetes Mellitus, Type 1; Fatty Acids; Female; Glucagon; Humans; Hydrocortisone; Insulin; Insulin Resistance; Male; Triglycerides | 1981 |
[Hyperinsulinism and peripheral resistance to insulin in a case of leprechaunism].
Topics: Blood Glucose; Dietary Carbohydrates; Dwarfism; Female; Glucagon; Humans; Hyperinsulinism; Infant; Insulin; Insulin Resistance | 1981 |
[Carbohydrate metabolic disorders in pancreonecrosis in the acute phase and in chronic conditions].
Topics: Adult; Blood Glucose; Carbohydrates; Female; Glucagon; Growth Hormone; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Necrosis; Pancreatic Diseases | 1982 |
Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity.
Topics: Adult; Aerobiosis; Aged; Blood Glucose; Cardiac Output; Case-Control Studies; Fatty Acids, Nonesterified; Female; Glomerular Filtration Rate; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Growth Hormone; Hemodynamics; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Kidney Failure, Chronic; Male; Middle Aged; Oxygen Consumption; Physical Exertion; Reference Values; Stroke Volume; Work Capacity Evaluation | 1995 |
Insulin sensitivity, hormonal levels and skeletal muscle protein metabolism in tumour-bearing exercising rats.
Topics: Animals; Female; Glucagon; Hydrocortisone; In Vitro Techniques; Insulin; Insulin Resistance; Muscle Proteins; Muscle, Skeletal; Neoplasms, Experimental; Physical Conditioning, Animal; Rats; Rats, Inbred WF; RNA | 1995 |
Splanchnic infusions of short chain fatty acids do not change insulin sensitivity of pigs.
Topics: Acetates; Acetic Acid; Animals; Blood Glucose; Butyrates; Fatty Acids, Nonesterified; Fatty Acids, Volatile; Female; Glucagon; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Insulin Resistance; Propionates; Random Allocation; Somatostatin; Swine; Tolbutamide | 1995 |
Hyperinsulinemia in children and adolescents after bone marrow transplantation.
Topics: Adolescent; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Blood Glucose; Bone Marrow Transplantation; C-Peptide; Child; Child, Preschool; Female; Glucagon; Glycated Hemoglobin; Growth Hormone; Humans; Hypogonadism; Hypothyroidism; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Leukemia; Lymphoma, Non-Hodgkin; Male; Prospective Studies; Radiation Injuries; Radioisotope Teletherapy; Whole-Body Irradiation | 1995 |
Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic rats.
Topics: Adipose Tissue; Adipose Tissue, Brown; Animals; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Experimental; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Clamp Technique; Glycogen; Glycolysis; Hyperglycemia; Insulin; Insulin Resistance; Liver; Liver Glycogen; Male; Muscle, Skeletal; Myocardium; Organ Specificity; Rats; Rats, Wistar; Reference Values | 1995 |
Adaptations in glucose homeostasis during chronic nutritional deprivation in rats: hepatic resistance to both insulin and glucagon.
Topics: Adaptation, Physiological; Animals; Blood Glucose; Drug Resistance; Food Deprivation; Glucagon; Glucose Clamp Technique; Glycogen; Homeostasis; Insulin; Insulin Resistance; Liver; Male; Rats; Rats, Sprague-Dawley; Receptors, Glucagon; Time Factors; Weight Gain | 1995 |
Modified glucagon test allowing simultaneous estimation of insulin secretion and insulin sensitivity: application to obesity, insulin-dependent diabetes mellitus, and noninsulin-dependent diabetes mellitus.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male; Obesity | 1995 |
Insulin resistance in microvascular angina (syndrome X)
Topics: Alanine; Angina Pectoris; Basal Metabolism; Blood Glucose; C-Peptide; Chest Pain; Coronary Circulation; Energy Metabolism; Fatty Acids, Nonesterified; Female; Forearm; Glucagon; Gluconeogenesis; Glucose Clamp Technique; Growth Hormone; Humans; Insulin; Insulin Resistance; Lactates; Male; Microcirculation; Middle Aged; Regional Blood Flow; Syndrome | 1993 |
Glucoregulation and hormonal changes during prolonged exercise in boys and girls.
Topics: Blood Glucose; Child; Epinephrine; Exercise; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Hormones; Humans; Insulin; Insulin Resistance; Male; Norepinephrine; Sex Characteristics | 1994 |
[A study on the mechanism of hyperinsulinemia in essential hypertension].
Topics: Adult; Aged; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypertension; Insulin; Insulin Resistance; Male; Middle Aged | 1993 |
Octreotide: a long-acting inhibitor of endogenous hormone secretion for human metabolic investigations.
Topics: Adult; Analysis of Variance; Blood Glucose; C-Peptide; Dose-Response Relationship, Drug; Female; Glucagon; Growth Hormone; Humans; Hyperglycemia; Hypoglycemia; Infusions, Intravenous; Insulin; Insulin Resistance; Male; Octreotide; Radioimmunoassay; Time Factors | 1994 |
Effect of porcine somatotropin on the response of growing pigs to acute challenges of glucose, insulin and epinephrine and during a hyperinsulinemic-euglycemic clamp.
Topics: Animals; Blood Glucose; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Clamp Technique; Growth Hormone; Homeostasis; Infusions, Intravenous; Injections, Subcutaneous; Insulin; Insulin Resistance; Male; Random Allocation; Swine; Time Factors | 1993 |
Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.
Topics: Albuminuria; Blood Glucose; Blood Pressure; Body Mass Index; C-Peptide; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fasting; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycated Hemoglobin; Humans; Hypertension; Insulin; Insulin Resistance; Lipids; Liver; Middle Aged; Reference Values; Triglycerides | 1993 |
Inhibitory effect of pregnancy on counterregulatory hormone responses to hypoglycemia in awake rat.
Topics: 3-Hydroxybutyric Acid; Analysis of Variance; Animals; Blood Glucose; Epinephrine; Fasting; Female; Glucagon; Hydroxybutyrates; Hypoglycemia; Insulin; Insulin Resistance; Pregnancy; Pregnancy in Diabetics; Rats; Rats, Sprague-Dawley | 1993 |
Study of the rate of early glucose disappearance following insulin injection: insulin sensitivity index.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Epinephrine; Female; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Growth Hormone; Humans; Hydrocortisone; Hypertension; Insulin; Insulin Resistance; Male; Norepinephrine; Obesity; Polycystic Ovary Syndrome; Reference Values; Sex Factors | 1993 |
Diabetes in chronic alcoholic pancreatitis. Role of residual beta cell function and insulin resistance.
Topics: Alcoholism; Blood Glucose; Chronic Disease; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Islets of Langerhans; Male; Middle Aged; Pancreatitis | 1993 |
The relation between clinical manifestations of polycystic ovary syndrome and beta-cell function.
Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Islets of Langerhans; Obesity; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1993 |
Impaired glucose tolerance after endurance exercise is associated with reduced insulin secretion rather than altered insulin sensitivity.
Topics: Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Electronic Data Processing; Exercise; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Insulin Resistance; Middle Aged; Norepinephrine; Physical Endurance; Radioimmunoassay; Rest; Running; Time Factors | 1993 |
Rats with portal-caval vein transposition show hyperinsulinemia and insulin resistance.
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Glucagon; Glucose Tolerance Test; Hyperinsulinism; Insulin; Insulin Resistance; Liver; Male; Pancreas; Portal Vein; Portasystemic Shunt, Surgical; Rats; Rats, Sprague-Dawley; Time Factors; Vena Cava, Inferior | 1996 |
Androgens and insulin resistance in type 1 diabetic men.
Topics: Adult; Calorimetry, Indirect; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Glucagon; Glycogen Synthase; Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 1; Lipid Peroxidation; Male; Muscle, Skeletal; Sex Hormone-Binding Globulin; Testosterone | 1995 |
Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Obesity | 1996 |
NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen-depleting exercise.
Topics: Adult; Analysis of Variance; Blood Glucose; Diabetes Mellitus, Type 2; Epinephrine; Female; Glucagon; Glucose; Glucose-6-Phosphate; Glucosephosphates; Glycogen; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Insulin; Insulin Resistance; Lactates; Magnetic Resonance Spectroscopy; Male; Muscle Contraction; Muscle, Skeletal; Nuclear Family; Phosphates; Phosphocreatine; Physical Exertion; Reference Values | 1996 |
Chromium and other insulin sensitizers may enhance glucagon secretion: implications for hypoglycemia and weight control.
Topics: Chromium; Down-Regulation; gamma-Aminobutyric Acid; Glucagon; Humans; Hypoglycemia; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Models, Biological; Weight Loss | 1996 |
Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.
Topics: Animals; Dogs; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerol; Insulin; Insulin Resistance; Lipolysis; Liver; Male | 1996 |
Dietary rat models in which the development of hypertriglyceridemia and that of insulin resistance are dissociated.
Topics: Animals; Blood Glucose; Corticosterone; Dietary Carbohydrates; Dietary Fats; Eating; Fasting; Fatty Acids, Nonesterified; Glucagon; Glucose Tolerance Test; Hypertriglyceridemia; Insulin; Insulin Resistance; Male; Polyethylene Glycols; Rats; Rats, Wistar; Triglycerides | 1995 |
Impact of nicotinic acid treatment on insulin secretion and insulin sensitivity in low and high insulin responders.
Topics: Adult; Blood Glucose; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Insulin; Insulin Antagonists; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Niacin | 1996 |
[How I explore... insulin secretion in clinical practice].
Topics: Basal Metabolism; Diabetes Mellitus; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemia; Insulin; Insulin Resistance; Insulin Secretion; Peptides | 1996 |
The effect of pioglitazone on hepatic glucose uptake measured with indirect and direct methods in alloxan-induced diabetic dogs.
Topics: Animals; Biological Transport; Blood Pressure; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dogs; Glucagon; Glucose; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Pioglitazone; Thiazoles; Thiazolidinediones | 1997 |
Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice.
Topics: Animals; Blood Glucose; Body Weight; Carbachol; Cholesterol; Dietary Fats; Eating; Fatty Acids, Nonesterified; Female; Fluorescent Antibody Technique, Indirect; Galanin; Gene Expression; Genotype; Glucagon; Glucose; Immunohistochemistry; In Situ Hybridization; Insulin; Insulin Resistance; Islets of Langerhans; Mice; Mice, Inbred C57BL; Muscarinic Agonists; Neuropeptide Y; Substance P; Triglycerides; Vasoactive Intestinal Peptide | 1997 |
Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus.
Topics: Aged; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Peptides | 1997 |
Insulin resistance prevented by portal delivery of insulin in rats with renal subcapsular islet grafts.
Topics: Anastomosis, Surgical; Animals; Blood Glucose; C-Peptide; Diabetes Mellitus, Experimental; Glucagon; Glucose Clamp Technique; Hyperinsulinism; Infusions, Intravenous; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans Transplantation; Liver; Male; Mesenteric Veins; Organ Size; Rats; Rats, Inbred Lew; Renal Veins | 1997 |
Post-marathon paradox in IDDM: unchanged insulin sensitivity in spite of glycogen depletion.
Topics: Adult; Arteries; Blood Glucose; Creatine Kinase; Diabetes Mellitus, Type 1; Energy Metabolism; Fatty Acids, Nonesterified; Female; Forearm; Glucagon; Glucose Clamp Technique; Glycogen; Glycogen Synthase; Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Resistance; Lipid Metabolism; Male; Muscles; Myoglobin; Oxidation-Reduction; Running | 1997 |
Theoretical analysis of the mechanisms of chronic hyperinsulinemia.
Topics: Adult; Blood Glucose; Computer Simulation; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucagon; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Liver; Obesity; Software | 1997 |
Site of insulin resistance after surgery: the contribution of hypocaloric nutrition and bed rest.
Topics: Adult; Alanine; Bed Rest; Blood Glucose; Energy Intake; Female; Glucagon; Glucose Clamp Technique; Glutamine; Glycerol; Humans; Insulin Resistance; Male; Middle Aged; Postoperative Period; Surgical Procedures, Operative | 1997 |
Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in conscious normal rats.
Topics: Animals; Blood Glucose; Blood Pressure; C-Peptide; Catecholamines; Glucagon; Glucose; Glucose Clamp Technique; Glycolysis; Heart Rate; Hyperinsulinism; Hypertension; Insulin Resistance; Liver; Male; Rats; Rats, Sprague-Dawley; Sodium | 1997 |
Effect of moderate exercise on insulin sensitivity and substrate metabolism during post-exercise recovery in cirrhosis.
Topics: Adult; Exercise; Female; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Lactic Acid; Liver Cirrhosis; Male; Middle Aged | 1997 |
Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat.
Topics: Animals; Apoptosis; Cohort Studies; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Glucagon; Glucose; Glucose Intolerance; Glucose Tolerance Test; Immunohistochemistry; In Vitro Techniques; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Pancreatic Polypeptide; Perfusion; Rats; Rats, Zucker; Somatostatin; Time Factors | 1998 |
Impact of family history of diabetes on the assessment of beta-cell function.
Topics: Adolescent; Adult; Age Factors; Aged; Biomarkers; Blood Glucose; Body Constitution; Body Mass Index; C-Peptide; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Family Health; Fasting; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Linear Models; Male; Middle Aged | 1998 |
PACAP stimulates insulin secretion but inhibits insulin sensitivity in mice.
Topics: Animals; Drug Combinations; Epinephrine; Glucagon; Glucose; Injections, Intravenous; Insulin; Insulin Resistance; Insulin Secretion; Mice; Mice, Inbred Strains; Neuropeptides; Neurotransmitter Agents; Pituitary Adenylate Cyclase-Activating Polypeptide; Sodium Chloride | 1998 |
Glucose turnover and insulin sensitivity in rats with pancreatic islet transplants.
Topics: Anastomosis, Surgical; Animals; Blood Glucose; C-Peptide; Diabetes Mellitus, Experimental; Food; Glucagon; Glucose; Glucose Tolerance Test; Insulin; Insulin Resistance; Islets of Langerhans Transplantation; Kidney; Liver; Male; Mesenteric Veins; Rats; Rats, Inbred Lew; Renal Veins | 1998 |
Tissue availability of insulin-like growth factor I is inversely related to insulin resistance in essential hypertension: effects of angiotensin converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Female; Follow-Up Studies; Glucagon; Growth Hormone; Humans; Hypertension; Insulin; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Lisinopril; Male; Middle Aged; Radioimmunoassay | 1998 |
Elevated serum tumour necrosis factor-alpha levels can contribute to the insulin resistance in Type II (non-insulin-dependent) diabetes and in obesity.
Topics: Age Factors; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin Resistance; Male; Middle Aged; Obesity; Reference Values; Sex Characteristics; Tumor Necrosis Factor-alpha | 1998 |
Potentiated beta-cell response to non-glucose stimuli in insulin-resistant C57BL/6J mice.
Topics: Animals; Antimetabolites; Blood Glucose; Body Weight; Carbachol; Deoxyglucose; Diet; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Mice; Mice, Inbred C57BL; Muscarinic Agonists; Peptide Fragments; Protein Precursors; Sincalide; Stimulation, Chemical | 1998 |
Lack of defect in insulin action on hepatic glycogen synthase and phosphorylase in insulin-resistant monkeys.
Topics: Adipose Tissue; Animals; Glucagon; Glucose Clamp Technique; Glycogen Synthase; Insulin; Insulin Resistance; Liver; Macaca mulatta; Male; Muscle, Skeletal; Obesity; Omentum; Phosphorylases | 1998 |
An insulin-dependent hypoglycaemia induced by electroacupuncture at the Zhongwan (CV12) acupoint in diabetic rats.
Topics: Acupuncture Points; Animals; beta-Endorphin; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Electroacupuncture; Glucagon; Hypoglycemia; Insulin; Insulin Resistance; Male; Naloxone; Narcotic Antagonists; Rats; Rats, Wistar; Tolbutamide | 1999 |
Surgery-induced insulin resistance in human patients: relation to glucose transport and utilization.
Topics: Arthroplasty, Replacement, Hip; Blood Glucose; Cell Membrane; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Transporter Type 4; Humans; Hydrocortisone; Hyperinsulinism; Insulin; Insulin Resistance; Lactates; Male; Middle Aged; Monitoring, Intraoperative; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Postoperative Period | 1999 |
Effect of large bowel fermentation on insulin, glucose, free fatty acids, and glucagon-like peptide 1 (7-36) amide in patients with coronary heart disease.
Topics: Aged; Blood Glucose; Coronary Disease; Fatty Acids, Nonesterified; Fermentation; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Intestinal Absorption; Intestine, Large; Lactulose; Male; Middle Aged; Peptide Fragments; Risk Factors | 1999 |
Apoptosis and remodelling of beta cells by paracrine interferon-gamma without insulitis in transgenic mice.
Topics: Animals; Apoptosis; Female; Gene Expression; Glucagon; Glucose; Glucose Tolerance Test; In Situ Nick-End Labeling; Insulin; Insulin Resistance; Insulin Secretion; Interferon-gamma; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Promoter Regions, Genetic; Rats; Tumor Necrosis Factor-alpha | 1999 |
The European Association for the Study of Diabetes Annual Meeting, 1998. Treatment of type 2 diabetes and the pathogenesis of complications.
Topics: Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin Resistance; Obesity; Peptide Fragments; Protein Precursors | 1999 |
Insulin resistance in HIV protease inhibitor-associated diabetes.
Topics: Adult; Animals; Anti-HIV Agents; C-Peptide; Cells, Cultured; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Glucagon; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Insulin; Insulin Resistance; Islets of Langerhans; Male; Phospholipases A; Proinsulin; Rats; Rats, Sprague-Dawley | 1999 |
The incretins--outdated terminology in man?
Topics: Animals; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Insulin Secretion; Papio; Peptide Fragments; Protein Precursors | 1999 |
Serum glucagon concentration and hyperinsulinaemia influence renal haemodynamics and urinary protein loss in normotensive patients with central obesity.
Topics: Adult; Analysis of Variance; Cardiovascular Diseases; Case-Control Studies; Fatty Acids, Nonesterified; Female; Glomerular Filtration Rate; Glucagon; Glucose Tolerance Test; Glycoproteins; Hemodynamics; Humans; Hyperinsulinism; Immunoglobulin G; Insulin; Insulin Resistance; Kidney; Male; Membrane Glycoproteins; Middle Aged; Obesity; Proteinuria; Risk Factors; Trypsin Inhibitor, Kunitz Soybean | 1999 |
Insulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivity.
Topics: Arginine; Blood Glucose; Dexamethasone; Fasting; Female; Glucagon; Glucocorticoids; Glucose Clamp Technique; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Infusions, Intravenous; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Middle Aged; Postmenopause | 1999 |
Insulin action during variable hyperglycemic-hyperinsulinemic infusions in hyperandrogenic anovulatory patients and healthy women.
Topics: Adolescent; Adrenal Glands; Adult; Anovulation; Blood Glucose; Body Composition; C-Peptide; Female; Glucagon; Human Growth Hormone; Humans; Hyperandrogenism; Insulin; Insulin Resistance; Leuprolide; Middle Aged; Ovary; Prospective Studies; Steroids | 1999 |
All patients with Werner's syndrome are insulin resistant, but only those who also have impaired insulin secretion develop overt diabetes.
Topics: Consanguinity; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin Resistance; Male; Pedigree; Werner Syndrome | 1999 |
Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice.
Topics: Animals; Blood Glucose; Dose-Response Relationship, Drug; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Insulin; Insulin Resistance; Insulin Secretion; Mice; Mice, Inbred Strains; Peptide Fragments; Peptides; Protein Precursors | 1999 |
Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Type 2; Dietary Fats; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glucose Intolerance; Glucose Tolerance Test; Homeostasis; Injections, Intraperitoneal; Insulin; Insulin Resistance; Insulin Secretion; Intestines; Islets of Langerhans; Mice; Mice, Knockout; Models, Biological; Peptide Fragments; Protein Precursors; Receptors, Gastrointestinal Hormone | 1999 |
Vegan proteins may reduce risk of cancer, obesity, and cardiovascular disease by promoting increased glucagon activity.
Topics: Animals; Cardiovascular Diseases; China; Diet, Vegetarian; Female; Glucagon; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Lipids; Liver; Male; Neoplasms; Obesity; Plant Proteins, Dietary; Puberty; Risk Factors; Weight Loss | 1999 |
Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man.
Topics: Adult; Dexamethasone; Female; Glucagon; Glucocorticoids; Glucose; Humans; Hyperinsulinism; Infusions, Intravenous; Insulin; Insulin Resistance; Liver; Male; Reference Values; Somatostatin; Time Factors | 2000 |
Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dietary Fats; Fatty Liver; Gene Expression; Glucagon; Glucose; Glucose Tolerance Test; Hyperinsulinism; Hyperplasia; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Islets of Langerhans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Obesity; Promoter Regions, Genetic; Rats; Recombinant Fusion Proteins; RNA, Messenger | 2000 |
Peripheral insulin sensitivity is decreased by elevated non-esterified fatty acid level in dexamethasone-treated rats.
Topics: Animals; Dexamethasone; Fatty Acids, Nonesterified; Glucagon; Glucocorticoids; Insulin; Insulin Resistance; Male; Palmitic Acid; Rats; Rats, Wistar | 1999 |
Beta-cell function of the pancreas after necrotizing pancreatitis.
Topics: C-Peptide; Diabetes Mellitus; Female; Follow-Up Studies; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Islets of Langerhans; Male; Middle Aged; Pancreatitis, Acute Necrotizing; Postoperative Complications | 1999 |
Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance.
Topics: Blood Pressure; Body Composition; Body Constitution; Body Mass Index; Female; Glucagon; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Middle Aged; Postmenopause | 2000 |
Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice.
Topics: Animals; Base Sequence; CCAAT-Enhancer-Binding Proteins; DNA Primers; DNA-Binding Proteins; Gene Expression; Glucagon; Humans; In Vitro Techniques; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Lipodystrophy; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Mice, Transgenic; Models, Biological; Nuclear Proteins; Obesity; Phosphoproteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sterol Regulatory Element Binding Protein 1; Transcription Factors | 2000 |
Intractable hypoglycemia in a patient with diabetes mellitus, bilateral nephrectomy, and chronic active hepatitis.
Topics: Adolescent; Diabetes Mellitus, Type 1; Diagnosis, Differential; Female; Glucagon; Hepatitis B, Chronic; Humans; Hyperinsulinism; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Kidney Failure, Chronic; Nephrectomy; Protein Synthesis Inhibitors; Substance Abuse, Intravenous; Treatment Outcome; Uremia | 2000 |
Nonhepatic response to portal glucose delivery in conscious dogs.
Topics: Animals; Consciousness; Dogs; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glycerol; Hepatic Veins; Insulin; Insulin Resistance; Lactic Acid; Liver; Liver Circulation; Male; Portal Vein; Signal Transduction | 2000 |
Impaired neural regulation of insulin secretion related to the leptin receptor gene mutation in Wistar fatty rats.
Topics: Animals; Atropine Derivatives; Blood Glucose; Carrier Proteins; Crosses, Genetic; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Injections, Intraventricular; Insulin; Insulin Resistance; Insulin Secretion; Mutation; Obesity; Peptide Fragments; Protein Precursors; Rats; Rats, Inbred WKY; Rats, Zucker; Receptors, Cell Surface; Receptors, Leptin; Vagotomy; Vagus Nerve | 2000 |
Early changes in islet hormone secretion in the hamster pancreatic cancer model.
Topics: Adenocarcinoma; Amyloid; Animals; Carcinogens; Cricetinae; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucagon; Glucose Tolerance Test; Insulin; Insulin Resistance; Insulin Secretion; Islet Amyloid Polypeptide; Islets of Langerhans; Male; Mesocricetus; Nitrosamines; Pancreatic Juice; Pancreatic Neoplasms; Somatostatin | 2001 |
Peripheral blood mitochondrial DNA content is inversely correlated with insulin secretion during hyperglycemic clamp studies in healthy young men.
Topics: Adult; Anthropometry; C-Peptide; DNA, Mitochondrial; Glucagon; Glucose Clamp Technique; Homeostasis; Humans; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Leukocytes; Male; Reference Values | 2001 |
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance.
Topics: Animals; Blood Glucose; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Heterozygote; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Leptin; Lipoprotein Lipase; Liver; Mice; Mice, Knockout; Mice, Transgenic; Muscle, Skeletal; Organ Specificity; Phosphatidylinositol 3-Kinases; Phosphoproteins; Signal Transduction; Triglycerides | 2001 |
Effect of selective denervation of the rat pancreas on pancreatic endocrine function.
Topics: Animals; Blood Glucose; Denervation; Glucagon; Glucose; Insulin; Insulin Resistance; Islets of Langerhans; Male; Pancreas; Rats; Rats, Sprague-Dawley; Reference Values | 2001 |
Temporal changes in insulin sensitivity following the development of acute liver failure secondary to acetaminophen.
Topics: Acetaminophen; Adult; Blood Glucose; C-Peptide; Fatal Outcome; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Kinetics; Liver Failure, Acute; Male; Metabolic Clearance Rate; Middle Aged; Multiple Organ Failure | 2001 |
Insulin resistance and type 2 diabetes: time for a new hypothesis.
Topics: Amyloid; Animals; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin Resistance; Islet Amyloid Polypeptide; Leptin; Mice; Peptide Fragments; Protein Precursors; Tumor Necrosis Factor-alpha | 2001 |
The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction.
Topics: Absorptiometry, Photon; Adult; Appetite; Area Under Curve; Energy Intake; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Obesity; Peptide Fragments; Postprandial Period; Satiation; Weight Loss | 2001 |
Insulin resistance induced in dairy steers by tumor necrosis factor alpha is partially reversed by 2,4-thiazolidinedione.
Topics: Animals; Blood Glucose; Cattle; Fatty Acids, Nonesterified; Glucagon; Glucose; Growth Hormone; Growth Hormone-Releasing Hormone; Insulin; Insulin Resistance; Male; Random Allocation; Recombinant Proteins; Thiazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2001 |
Hyperglycemia compensates for diet-induced insulin resistance in liver and skeletal muscle of rats.
Topics: Analysis of Variance; Animals; Body Weight; Diet; Dietary Fats; Dietary Sucrose; Glucagon; Glucose; Glucose Clamp Technique; Glycogen; Hyperglycemia; Insulin; Insulin Resistance; Liver; Male; Muscle, Skeletal; Rats; Rats, Sprague-Dawley; Starch | 2001 |
Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
Topics: Adult; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Dietary Carbohydrates; Fatty Acids, Nonesterified; Female; Food; Glucagon; Humans; Hyperglycemia; Insulin; Insulin Resistance; Kinetics; Lactic Acid; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Splanchnic Circulation | 2001 |
Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet.
Topics: Adaptation, Physiological; Adipose Tissue, Brown; Animals; Blood Glucose; Diabetes Mellitus; Dietary Fats; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Tolerance Test; Glucose Transporter Type 4; Insulin; Insulin Resistance; Leptin; Male; Mice; Mice, Inbred C57BL; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Myocardium; Obesity; RNA, Messenger; Weight Gain | 2002 |
Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Insulin; Insulin Resistance; Liver; Male; Middle Aged; Obesity; Somatostatin | 2002 |
Abnormal release of incretins and cortisol after oral glucose in subjects with insulin-resistant myotonic dystrophy.
Topics: Adult; Body Composition; DNA; Dose-Response Relationship, Drug; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Humans; Hydrocortisone; Insulin Resistance; Male; Middle Aged; Myotonic Dystrophy; Peptide Fragments; Regression Analysis; Repetitive Sequences, Nucleic Acid | 2002 |
Glutamic acid decarboxylase antibody positivity is associated with an impaired insulin response to glucose and arginine in nondiabetic patients with autoimmune thyroiditis.
Topics: Adult; Aged; Antibodies; Arginine; C-Peptide; Chronic Disease; Female; Follow-Up Studies; Glucagon; Glucose; Glutamate Decarboxylase; Humans; Injections, Intravenous; Insulin; Insulin Resistance; Islets of Langerhans; Male; Middle Aged; Thyroiditis, Autoimmune | 2002 |
Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: contrasting effects of GLP-1.
Topics: Animals; Drug Interactions; Exenatide; Glucagon; Glucagon-Like Peptide 1; Glucose; Insulin Resistance; Muscle, Skeletal; Peptide Fragments; Peptides; Phosphatidylinositol 3-Kinases; Protein Precursors; Rats; Tumor Cells, Cultured; Venoms | 2002 |
Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice.
Topics: Animals; Blood Glucose; Body Weight; Dietary Fats; Dipeptidyl Peptidase 4; Drinking; Eating; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Intolerance; Insulin; Insulin Resistance; Intubation, Gastrointestinal; Islets of Langerhans; Mice; Mice, Inbred C57BL; Nitriles; Organ Size; Peptide Fragments; Protease Inhibitors; Protein Precursors; Pyrrolidines; Time Factors | 2002 |
[Glucide intolerance and its pathogenic mechanisms during parenteral feeding].
Topics: Blood Glucose; Diuresis; Glucagon; Gluconeogenesis; Glycosuria; Humans; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Liver; Osmolar Concentration; Parenteral Nutrition; Risk | 1977 |
Role of glucagon and other hormones in development of diabetic ketoacidosis.
Topics: Adult; Blood Glucose; Catecholamines; Diabetes Mellitus; Diabetic Ketoacidosis; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Antagonists; Insulin Resistance; Keto Acids; Ketone Bodies; Lactates; Male | 1975 |
Severe diabetic ketoacidosis.
Topics: Bicarbonates; Diabetic Ketoacidosis; Glucagon; Humans; Infusions, Parenteral; Injections, Intramuscular; Insulin; Insulin Resistance; Potassium | 1978 |
Low-dose versus high-dose insulin therapy for diabetic ketoacidosis.
Topics: Adult; Diabetic Ketoacidosis; Glucagon; Half-Life; Humans; Infusions, Parenteral; Injections, Subcutaneous; Insulin; Insulin Resistance; Middle Aged | 1979 |
Insulin resistance caused by massive degradation of subcutaneous insulin.
Topics: Adipose Tissue; Adult; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Ethylmaleimide; Female; Glucagon; Humans; Infusions, Parenteral; Injections, Intravenous; Injections, Subcutaneous; Insulin; Insulin Resistance | 1979 |
Normalization of insulin and glucagon secretion in ketosis-resistant diabetes mellitus with prolonged diet therapy.
Topics: Adult; Diabetes Mellitus; Diabetic Ketoacidosis; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male | 1979 |
Congenital generalized lipodystrophy with insulin-resistant diabetes.
Topics: Acanthosis Nigricans; Arginine; Child; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Glucagon; Humans; Insulin Resistance; Leukocytes; Lipodystrophy; Lipoproteins, LDL; Male; Receptor, Insulin; Sulfonylurea Compounds; Triglycerides | 1978 |
Congenital lipodystrophy: An endocrine study in three siblings. I. Disorders of carbohydrate metabolism.
Topics: Adolescent; Adrenocorticotropic Hormone; Antigens; Arginine; Blood Glucose; Child; Child, Preschool; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Hormones; Humans; Infant; Insulin; Insulin Resistance; Insulin Secretion; Lipid Metabolism; Lipodystrophy; Male; Tolbutamide | 1978 |
Hormonal relationships of the endocrine pancreas in diabetes mellitus.
Topics: Diabetes Mellitus; Glucagon; Humans; Insulin; Insulin Resistance; Pancreas; Pancreatic Hormones; Receptor, Insulin; Somatostatin | 1979 |
Carbohydrate metabolism and insulin resistance in myotonia dystrophica.
Topics: Adult; Aged; Arginine; Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitus; Female; Fructose; Galactose; Glucagon; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Leucine; Male; Middle Aged; Myotonic Dystrophy; Sorbitol; Tolbutamide; Xylose | 1977 |
Glucagon and insulin binding to liver membranes in a partially nephrectomized uremic rat model.
Topics: Adenylyl Cyclases; Animals; Blood Urea Nitrogen; Cell Membrane; Creatinine; Disease Models, Animal; Glucagon; Glucose; Hyperglycemia; Hyperinsulinism; Hypersensitivity; Insulin; Insulin Resistance; Kidney; Liver; Nephrectomy; Protein Binding; Rats; Uremia | 1977 |
Investigation of insulin resistance during diabetic ketoacidosis: role of counterregulatory substances and effect of insulin therapy.
Topics: Adult; Blood Glucose; Child; Diabetic Ketoacidosis; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Resistance; Male | 1977 |
Glucose tolerance, plasma insulin levels and insulin sensitivity in elderly patients.
Topics: Adult; Age Factors; Aged; Alanine; Blood Glucose; Fatty Acids; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male | 1979 |
Glucose, insulin and somatostatin infusion for the determination of insulin resistance in liver cirrhosis.
Topics: Adult; Blood Glucose; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Liver Cirrhosis; Male; Middle Aged; Somatostatin | 1979 |
[Diet and insulin resistance].
Topics: Adult; Cell Membrane; Diabetes Mellitus; Diet, Reducing; Fatty Acids, Unsaturated; Glucagon; Humans; Insulin; Insulin Resistance; Middle Aged; Obesity; Receptor, Insulin | 1978 |
Pathophysiology of diabetes mellitus.
Topics: Amino Acids; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Dietary Carbohydrates; Glucagon; Homeostasis; Humans; Insulin; Insulin Resistance; Insulin Secretion; Lipid Metabolism; Somatostatin | 1978 |
Glucose kinetics and responsiveness to insulin in the rat injured by burn.
Topics: Animals; Blood Glucose; Body Weight; Burns; Glucagon; Glucose; Hematocrit; Insulin; Insulin Resistance; Kinetics; Male; Rats | 1978 |
[Insulin resistance not due to antibodies].
Topics: Blood Glucose; Glucagon; Humans; Hyperlipidemias; Insulin; Insulin Resistance; Obesity; Triglycerides | 1978 |
Successful immunosuppressive therapy in insulin resistant diabetes caused by anti-insulin receptor autoantibodies.
Topics: Autoantibodies; C-Peptide; Cyclophosphamide; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Humans; Immunosuppressive Agents; Insulin; Insulin Antibodies; Insulin Resistance; Middle Aged; Prednisolone; Receptor, Insulin; Sjogren's Syndrome | 1977 |
Does glucagon play a role in the insulin resistance of patients with adult non-ketotic diabetes?
Topics: Adult; Blood Glucose; Diabetes Mellitus; Fasting; Glucagon; Humans; Hyperglycemia; Insulin; Insulin Resistance; Middle Aged | 1977 |
Plasma glucagon levels in normal women during pregnancy.
Topics: Adult; Blood Glucose; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Tolerance Test; Heparin; Humans; Insulin; Insulin Resistance; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Triglycerides | 1975 |
Effects of islet amyloid polypeptide on hepatic insulin resistance and glucose production in the isolated perfused rat liver.
Topics: Amyloid; Animals; Cyclic AMP; Glucagon; Gluconeogenesis; In Vitro Techniques; Insulin; Insulin Resistance; Islet Amyloid Polypeptide; Kinetics; Lactates; Liver; Liver Glycogen; Male; Perfusion; Rats; Rats, Inbred Strains; Time Factors | 1992 |
The dawn phenomenon: comparison between normal and insulin-dependent diabetic adolescents.
Topics: Adolescent; Adrenocorticotropic Hormone; Blood Glucose; Circadian Rhythm; Diabetes Mellitus, Type 1; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Resistance; Male | 1992 |
Characterization of the insulin resistance in liver cirrhosis: a comparison with non-insulin dependent diabetes mellitus.
Topics: C-Peptide; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Erythrocytes; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Resistance; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Receptor, Insulin | 1992 |
The effect of tolbutamide on burn hypermetabolism.
Topics: Adult; Animals; Blood Glucose; Burns; Energy Metabolism; Female; Glucagon; Humans; Insulin; Insulin Resistance; Male; Oxygen Consumption; Prospective Studies; Rabbits; Tolbutamide | 1992 |
Markedly reduced beta-cell function does not result in insulin resistance in islet autografted dogs.
Topics: Animals; Arginine; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Dogs; Female; Glucagon; Insulin; Insulin Resistance; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Pancreatectomy; Transplantation, Autologous | 1992 |
Idiopathic reactive hypoglycemia: a role for glucagon?
Topics: Adult; Blood Glucose; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hypoglycemia; Insulin; Insulin Resistance; Male | 1992 |
Recovery and hypersecretion of insulin and reversal of insulin resistance after withdrawal of short-term cyclosporine treatment.
Topics: Animals; Body Weight; Cyclosporine; Dogs; Dose-Response Relationship, Drug; Glucagon; Glucose Clamp Technique; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male | 1992 |
[Glucose tolerance in the elderly--changes in insulin, C-peptide and glucagon secretion].
Topics: Adult; Aged; Aged, 80 and over; Aging; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Male; Reference Values | 1992 |
Encainide-induced diabetes: analysis of islet cell function.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Diet; Encainide; Glucagon; Humans; Hyperglycemia; Insulin Resistance; Islets of Langerhans; Male | 1992 |
Insulin resistance and action in hypertriglyceridemia.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Fatty Acids, Nonesterified; Glucagon; Glucose Clamp Technique; Glycerol; Humans; Hydroxybutyrates; Hypertriglyceridemia; Infusions, Intravenous; Insulin; Insulin Resistance; Kinetics; Lactates; Male; Middle Aged; Pyruvates; Reference Values; Triglycerides | 1991 |
Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells.
Topics: Adult; Arginine; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Obesity; Reference Values | 1991 |
Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.
Topics: Adult; Aged; Blood Glucose; Body Constitution; Catecholamines; Energy Metabolism; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Insulin Resistance; Lipids; Liver; Liver Cirrhosis; Male; Middle Aged; Oxidation-Reduction | 1991 |
Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Glucagon; Glucose; Growth Hormone; HIV Infections; Humans; Hydrocortisone; Insulin; Insulin Infusion Systems; Insulin Resistance; Male; Metabolic Clearance Rate; Middle Aged; Norepinephrine; Reference Values | 1991 |
[Apollinaire Bouchardat 1991 Award. Insulin resistance in an animal model of hypoinsulinism].
Topics: Animals; Blood Glucose; Disease Models, Animal; Female; Glucagon; Gluconeogenesis; Insulin; Insulin Resistance; Lactation; Metabolic Diseases; Rats | 1991 |
Influence of glucagon on protein and leucine metabolism: a study in fasting man with induced insulin resistance.
Topics: Adult; Fasting; Female; Forearm; Glucagon; Humans; Insulin Resistance; Leucine; Male; Muscles; Proteins; Somatostatin | 1990 |
[Glucose intolerance in pituitary disease].
Topics: Acromegaly; Bromocriptine; Cushing Syndrome; Glucagon; Gluconeogenesis; Glucose; Glucose Tolerance Test; Humans; Hypopituitarism; Insulin Resistance; Liver | 1991 |
Evidence for an insulin resistance in the adult offspring of pregnant streptozotocin-diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Insulin; Insulin Infusion Systems; Insulin Resistance; Pregnancy; Pregnancy in Diabetics; Rats; Rats, Inbred Strains; Reference Values | 1991 |
Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues.
Topics: Amyloid; Animals; Cell Line; Corticosterone; Epinephrine; Glucagon; Glucose; Glucose Clamp Technique; Insulin; Insulin Resistance; Islet Amyloid Polypeptide; Liver; Male; Norepinephrine; Organ Specificity; Rats; Rats, Inbred Strains; Receptor, Insulin | 1991 |
Insulin resistance in type 1 (insulin-dependent) diabetes: dissimilarities for glucose and intermediary metabolites.
Topics: Adult; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Glycated Hemoglobin; Glycerol; Humans; Insulin; Insulin Antibodies; Insulin Resistance; Ketone Bodies; Male; Reference Values | 1990 |
Inhibition of insulin release by cyclosporine and production of peripheral insulin resistance in the dog.
Topics: Animals; Blood Glucose; Cyclosporins; Dogs; Glucagon; Insulin; Insulin Resistance; Insulin Secretion; Liver; Secretory Rate | 1990 |
Glucoregulation and hormonal responses to maximal exercise in non-insulin-dependent diabetes.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Epinephrine; Exercise; Glucagon; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Norepinephrine | 1990 |
Characterization of the late posthypoglycemic insulin resistance in insulin-dependent diabetes mellitus.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Female; Glucagon; Glucose; Glucose Clamp Technique; Glycated Hemoglobin; Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Insulin; Insulin Resistance; Male; Random Allocation | 1990 |
Reduced insulin secretion by subtotal pancreatectomy: preservation of insulin sensitivity and glucose tolerance in postoperative patients.
Topics: Aged; Blood Glucose; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male; Pancreas; Pancreatectomy | 1990 |
Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose.
Topics: Adult; Catecholamines; Fasting; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Octreotide; Secretory Rate | 1990 |
Intraportal hyperinsulinemia decreases insulin-stimulated glucose uptake in the dog.
Topics: Animals; Blood Glucose; Dogs; Epinephrine; Glucagon; Glucose; Hydrocortisone; Hyperinsulinism; Infusions, Intravenous; Insulin; Insulin Resistance; Portal Vein; Time Factors | 1990 |
The second-messenger system for peptide hormones.
Topics: Adult; Animals; Cell Communication; Cyclic AMP; Dogs; Female; Glucagon; Glycogen; Homeostasis; Hormones; Humans; Infant, Newborn; Insulin; Insulin Resistance; Male; Peptides; Protein Kinases; Second Messenger Systems; Signal Transduction | 1989 |
Multiple defects occur in the guanine nucleotide regulatory protein system in liver plasma membranes of obese (fa/fa) but not lean (Fa/Fa) Zucker rats: loss of functional Gi and abnormal Gs function.
Topics: Adenosine Diphosphate Ribose; Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; Blotting, Western; Cell Membrane; Cholera Toxin; Colforsin; Diabetes Mellitus, Experimental; Glucagon; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Insulin Resistance; Liver; Male; NAD; Obesity; Pertussis Toxin; Phosphorus Radioisotopes; Rats; Rats, Inbred Strains; Rats, Zucker; Receptors, Gastrointestinal Hormone; Receptors, Glucagon; Virulence Factors, Bordetella | 1989 |
Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance.
Topics: Adult; Aged; Blood Glucose; Female; Glucagon; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Insulin Resistance; Islets of Langerhans; Male; Middle Aged; Somatostatin; Uremia | 1989 |
Indirect effect of catecholamines on development of insulin resistance in skeletal muscle from diabetic rats.
Topics: Adrenergic beta-Antagonists; Animals; Biological Transport; Blood Glucose; Catecholamines; Diabetes Mellitus, Experimental; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycogen; Insulin; Insulin Resistance; Male; Muscles; Propranolol; Rats; Rats, Inbred Strains; Streptozocin | 1989 |
Contribution of insulin resistance to catabolic effect of prednisone on leucine metabolism in humans.
Topics: Adult; Basal Metabolism; Glucagon; Glucose; Growth Hormone; Humans; Insulin; Insulin Infusion Systems; Insulin Resistance; Kinetics; Leucine; Models, Theoretical; Oxidation-Reduction; Prednisone; Reference Values; Somatostatin | 1989 |
Reversal of in vitro hepatic insulin resistance in chronic pancreatitis by pancreatic polypeptide in the rat.
Topics: Animals; Blood Glucose; Chronic Disease; Glucagon; Glucose; Insulin Resistance; Liver; Male; Oleic Acid; Oleic Acids; Pancreatic Polypeptide; Pancreatitis; Rats; Rats, Inbred Strains; Reference Values | 1989 |
Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Female; Glucagon; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Insulin Infusion Systems; Insulin Resistance; Male; Norepinephrine; Obesity | 1989 |
Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance.
Topics: Adult; Blood Glucose; Epinephrine; Glucagon; Humans; Hydrocortisone; Injections, Intravenous; Insulin Resistance; Islets of Langerhans; Male; Nicotinic Acids; Norepinephrine | 1989 |
Effect of interferon on glucose tolerance and insulin sensitivity.
Topics: Adult; Blood Glucose; C-Peptide; Circadian Rhythm; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin; Insulin Resistance; Interferon Type I; Male | 1989 |
In vitro hepatic insulin resistance in chronic pancreatitis in the rat.
Topics: Animals; Blood Glucose; Chronic Disease; Glucagon; Glucose; Glycogen; Insulin; Insulin Resistance; Liver; Male; Pancreatitis; Perfusion; Rats; Rats, Inbred Strains | 1989 |
Insulin-sensitive and insulin-resistant variants in NIDDM.
Topics: Adult; Autoantibodies; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Liver; Male; Middle Aged | 1989 |
In vivo insulin resistance during nonlethal hypermetabolic sepsis.
Topics: Animals; Blood Glucose; Escherichia coli Infections; Fasting; Glucagon; Glucose; Insulin; Insulin Resistance; Lactates; Lactic Acid; Liver; Male; Rats; Rats, Inbred Strains; Sepsis | 1989 |
Insulin and glucagon degradation in liver are not affected by hepatic cirrhosis.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Liver; Liver Cirrhosis; Male; Middle Aged | 1989 |
Insulin resistance in septic rats--a study by the euglycemic clamp technique.
Topics: Animals; Blood Glucose; Epinephrine; Glucagon; Glucose Clamp Technique; Hydrocortisone; Insulin; Insulin Resistance; Liver; Male; Norepinephrine; Rats; Rats, Inbred Strains; Sepsis | 1989 |
Normal insulin sensitivity during the phase of glucose intolerance but insulin resistance at the onset of diabetes in the spontaneously diabetic BB rat.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Crosses, Genetic; Diabetes Mellitus, Experimental; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Clamp Technique; Hydroxybutyrates; Insulin; Insulin Resistance; Male; Norepinephrine; Prediabetic State; Rats; Rats, Inbred BB; Reference Values | 1989 |
Hypoglycemia in IDDM.
Topics: Blood Glucose; Circadian Rhythm; Diabetes Mellitus, Type 1; Glucagon; Humans; Hypoglycemia; Insulin Resistance; Risk Factors | 1989 |
Insulin resistance after oral glucose tolerance testing in patients with major depression.
Topics: Administration, Oral; Adolescent; Adult; Aged; Blood Glucose; Depressive Disorder; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin; Insulin Resistance; Male; Middle Aged; Personality Inventory; Psychiatric Status Rating Scales; Somatostatin | 1988 |
Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uraemic subjects. Studies at physiologic and supraphysiologic hormone levels.
Topics: Adult; Aged; C-Peptide; Female; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Kinetics; Liver; Male; Middle Aged; Somatostatin; Uremia | 1988 |
Somatostatin reduces posthypoglycemic insulin resistance in insulin-dependent diabetes mellitus.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Epinephrine; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Insulin; Insulin Resistance; Male; Somatostatin | 1988 |
Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Lipolysis; Liver; Male; Metabolic Clearance Rate; Middle Aged; Sulfonylurea Compounds | 1986 |
Acromegaly and insulin resistance: a case study.
Topics: Acromegaly; Adenoma, Acidophil; Bromocriptine; C-Peptide; Female; Glucagon; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Insulin Resistance; Middle Aged; Pituitary Neoplasms; Tomography, X-Ray Computed | 1986 |
Bed-rest-induced insulin resistance occurs primarily in muscle.
Topics: Adult; Bed Rest; Glucagon; Gluconeogenesis; Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Liver; Male; Muscles | 1988 |
Glucoregulation in acute liver failure.
Topics: Acute Disease; Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Liver; Liver Diseases; Male; Middle Aged | 1986 |
Protein-energy malnutrition in pregnant rats improves the adaptation of the endocrine pancreas in malnourished offspring and induces insulin resistance after rehabilitation.
Topics: Adaptation, Physiological; Animals; Blood Glucose; Female; Glucagon; Homeostasis; Insulin; Insulin Resistance; Islets of Langerhans; Male; Pregnancy; Pregnancy Complications; Protein-Energy Malnutrition; Rats; Rats, Inbred Strains; Weaning | 1987 |
Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man.
Topics: Adult; Blood Glucose; C-Peptide; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Glucagon; Glycerol; Heparin; Humans; Insulin; Insulin Resistance; Kinetics; Lipolysis; Male; Triglycerides | 1988 |
Insulin resistance and delayed clearance of peptide hormones in cirrhotic rat liver.
Topics: Animals; Blood Glucose; Glucagon; Growth Hormone; Half-Life; Insulin; Insulin Resistance; Liver; Liver Cirrhosis, Experimental; Liver Function Tests; Male; Rats; Thioacetamide | 1987 |
Reduction of glycogen stores in a rat model of chronic hyperinsulinism.
Topics: Adrenal Glands; Animals; Blood Glucose; Chronic Disease; Disease Models, Animal; Glucagon; Glycogen; Hyperinsulinism; Insulin; Insulin Resistance; Liver; Male; Muscles; Organ Size; Rats; Rats, Inbred Strains | 1987 |
Antecedent chronic hyperglycaemia blocks phlorizin-induced insulin resistance in the dog.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dogs; Glucagon; Glycosuria; Hyperglycemia; Insulin Resistance; Kidney; Male; Phlorhizin | 1988 |
Basal glucagon replacement in chronic glucagon deficiency increases insulin resistance.
Topics: Adult; Aged; Blood Glucose; Female; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Monocytes; Pancreatectomy | 1986 |
Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver.
Topics: Adult; Blood Glucose; Glucagon; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Resistance; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Time Factors | 1986 |
Experimental hyperthyroidism does not induce hepatic insulin resistance in the miniature pig.
Topics: Animals; Blood Glucose; Glucagon; Gluconeogenesis; Hyperthyroidism; Hypothyroidism; Insulin; Insulin Resistance; Kinetics; Liver; Male; Swine | 1986 |
[Insulin resistance in liver diseases].
Topics: Blood Glucose; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Humans; Insulin; Insulin Resistance; Islets of Langerhans; Liver; Liver Diseases; Metabolic Clearance Rate; Proinsulin; Receptor, Insulin | 1986 |
Insulin action in aging man: evidence for tissue-specific differences at low physiologic insulin levels.
Topics: Adult; Aged; Aging; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Lipolysis; Liver; Male | 1987 |
Use of a variable insulin infusion to assess insulin action in obesity: defects in both the kinetics and amplitude of response.
Topics: Adult; Blood Glucose; Body Weight; C-Peptide; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Kinetics; Middle Aged; Obesity | 1987 |
Increased glucose turnover and glucose cycling in acromegalic patients with normal glucose tolerance.
Topics: Acromegaly; Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Glucose-6-Phosphate; Glucosephosphates; Humans; Insulin Resistance; Liver; Male; Middle Aged | 1986 |
Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus.
Topics: Adult; Arginine; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Epinephrine; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Norepinephrine; Obesity; Pregnancy; Pregnancy in Diabetics | 1985 |
Insulin receptors and insulin sensitivity in normo and hyperinsulinemic obese patients.
Topics: Adult; Blood Glucose; C-Peptide; Glucagon; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Middle Aged; Obesity; Receptor, Insulin | 1985 |
Diazoxide prevents the development of hormonal and metabolic abnormalities present in rats fed a sucrose rich diet.
Topics: Animals; Diazoxide; Dietary Carbohydrates; DNA; Glucagon; Heart; Hyperinsulinism; Insulin; Insulin Resistance; Liver; Male; Organ Size; Proteins; Rats; Rats, Inbred Strains; Sucrose; Triglycerides | 1985 |
On the decrease of glucose tolerance in pregnancy. A review.
Topics: Blood Glucose; Fasting; Female; Glucagon; Humans; Hydrocortisone; Insulin; Insulin Resistance; Insulin Secretion; Pregnancy; Reference Values | 1985 |
Carbohydrate intolerance in gonadal dysgenesis: evidence for insulin resistance and hyperglucagonemia.
Topics: Adolescent; Adult; Aging; Arginine; Blood Glucose; Body Weight; Child; Glucagon; Glucose Tolerance Test; Gonadal Dysgenesis; Growth Hormone; Humans; Insulin; Insulin Resistance; Malabsorption Syndromes; Male; Obesity; Tolbutamide | 1985 |
[Insulin resistance in chronic liver disease: the possible role of anti-insulin factors].
Topics: Adult; C-Peptide; Chronic Disease; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Humans; Insulin; Insulin Antagonists; Insulin Resistance; Liver Diseases; Male; Middle Aged | 1985 |
[Causes of insulin resistance in type 1 diabetes].
Topics: Animals; Diabetes Mellitus, Type 1; Epinephrine; Glucagon; Growth Hormone; Humans; Hydrocortisone; Insulin Antibodies; Insulin Resistance; Osmolar Concentration; Rats | 1985 |
Assessment of tissue sensitivity to insulin in uraemic patients on long-term haemodialysis therapy.
Topics: Adult; Blood Glucose; C-Peptide; Constriction; Female; Glucagon; Growth Hormone; Humans; Insulin Resistance; Male; Middle Aged; Renal Dialysis; Uremia | 1985 |
Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance.
Topics: Animals; Cell Fractionation; Cell Membrane; Electrophoresis, Disc; Genetics; Glucagon; Growth Hormone; Hypoglycemia; Insulin; Insulin Antibodies; Insulin Resistance; Iodine Isotopes; Isoproterenol; Liver; Mice; Mice, Inbred C57BL; Microscopy, Phase-Contrast; Obesity; Protein Binding; Proteins; Receptors, Cell Surface | 1973 |
Decreased binding of insulin to its receptors in rats with hormone induced insulin resistance.
Topics: Animals; Blood Glucose; Cell Membrane; Corticosterone; Dose-Response Relationship, Drug; Female; Glucagon; Growth Hormone; Insulin; Insulin Resistance; Iodine Isotopes; Liver; Neoplasms, Experimental; Pituitary Neoplasms; Protein Binding; Rats; Receptors, Cell Surface; Time Factors | 1973 |
Insulin, glucagon and growth hormone in primary adult myxoedema.
Topics: Arginine; Blood Glucose; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Hypoglycemia; Insulin; Insulin Resistance; Male; Myxedema | 1974 |
[Hyperglycemia and insulin resistance during glucagon infusion].
Topics: Aged; Female; Glucagon; Humans; Hyperglycemia; Injections, Intravenous; Insulin Resistance | 1972 |
Lipoprotein and carbohydrate disorders in nephrotic syndrome and uremia.
Topics: Adipose Tissue; Blood Glucose; Carbohydrate Metabolism; Cholesterol; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Insulin Antagonists; Insulin Resistance; Kidney Failure, Chronic; Lipid Metabolism; Lipoproteins; Liver; Male; Muscles; Nephrotic Syndrome; Protein Biosynthesis; Tolbutamide; Uremia | 1972 |
Hyperglycemic response to massive doses of commercial insulin.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucagon; Hyperglycemia; Insulin; Insulin Resistance; Male; Rabbits | 1970 |
Effect of enteric hormones on insulin secretion.
Topics: Adult; Blood Glucose; Cholecystokinin; Diabetes Mellitus; Female; Glucagon; Hormones; Humans; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Prediabetic State; Secretin; Tolbutamide | 1970 |
[Symposium: interrelations among hormones. 3. Spleen: effects of the digestive tract to insulin secretion (interrelation to glucagon)].
Topics: Animals; Blood Glucose; Diabetes Mellitus; Digestive System Physiological Phenomena; Glucagon; Glucose Tolerance Test; Humans; In Vitro Techniques; Injections, Intravenous; Insulin; Insulin Resistance; Insulin Secretion; Rabbits | 1970 |
[Problems of the pathogenesis and prospects of the study of diabetes mellitus in children].
Topics: Antibody Formation; Carbohydrate Metabolism; Child; Diabetes Mellitus, Type 1; Glucagon; Glucocorticoids; Humans; Insulin Antibodies; Insulin Resistance | 1967 |